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Abstract 
Flagellate protozoa from the order Trypanosomatida have developed a range of 
strategies to survive in their mammalian hosts. A consequence is that the glycolytic 
pathway has assumed an important role, especially in bloodstream-form 
Trypanosoma brucei, where it is essential as the sole producer of ATP. The seventh 
enzyme in the pathway, 2,3-bisphosphoglycerate-independent phosphoglycerate 
mutase (iPGAM) is particularly attractive as a drug target because it shares no 
common properties with the corresponding enzyme in humans. This enzyme 
catalyses the conversion of 3PGA to 2PGA, with the requirement for metal ions to 
assist the catalytic function. In this study, two important biochemical and structural 
aspects of the enzyme were investigated: i) The in vitro and in vivo requirements for 
biologically relevant metal ions to support the activity of iPGAM, and ii) The ability 
of trypanosomatid iPGAM to exist in multiple conformations and oligomeric states 
in solution.  
The maximum activity of iPGAM in vitro requires Co2+, but this cannot be the case 
in vivo where ICP-OES analyses confirmed that Co2+ was essentially undetectable in 
T. brucei cytosolic fractions. The activity of iPGAM in vivo is therefore one of the 
lowest among the glycolytic enzymes. By contrast, Mg2+ and Zn2+ were found to be 
the most abundant metals in both cytosolic fractions and in purified bacterially 
expressed iPGAM. Our newly-developed multimode-plate reader discontinuous 
assay further revealed that of the biologically relevant metals, only Mg2+ can support 
iPGAM activity, but at less than 50% of the level of Co2+. By contrast, Zn2+ strongly 
inhibits iPGAM. This assay which was developed with minimal metal interference 
on the coupling enzymes, also showed that in solution, the ratio of the concentrations 
of 3PGA:2PGA (substrate:product) at equilibrium is not 1:1 as observed in the 
crystal structure, but is in fact 12:1, which may be due to the tighter binding of 2PGA 
to the enzyme.  
A series of biophysical analyses, notably by SEC-MALS showed that iPGAM from 
Leishmania mexicana, another trypanosomatid protozoan parasite exists in different 
forms and oligomeric states in solution, either as the closed-form monomer, open-
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form monomer, or closed/open-form dimer which can be successfully separated by 
ion-exchange chromatography. The open-form LmiPGAM is particularly relevant for 
drug development, as the catalytic site in the closed-form structure is poorly 
inaccessible. Both virtual and high-throughput screening approaches were used to 
identify novel potential inhibitors. Out of a collection of 11 compounds tested at 1 
mM, two showed substantial inhibition with 49% and 14% remaining activity. Taken 
together, the findings from this study demonstrated the potential of iPGAM to be a 
key modulator in controlling glycolytic flux in trypanosomes, and thus further 
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Chapter 1:  
Introduction 
1.1 Leishmaniasis and African trypanosomiasis: The causes of the diseases and 
drug development at present 
For centuries, a group of kinetoplastid parasites, Leishmania spp and Trypanosoma 
brucei has been and still is one of the biggest threats to the inhabitants of many parts of 
the world (Steverding 2008; von Geldern et al. 2011). Both parasites caused fatal 
neglected diseases: leishmaniasis and human African trypanosomiasis respectively, 
resulting in epidemically affected 88 countries worldwide (Singh 2006). Tragically, the 
main factor contributing to the emergence of the diseases in the infected areas is 
poverty, which is associated with a number of social aspects: malnutrition, 
displacement, poor housing, illiteracy, weakness of the immune system and lack of 
resources (http://www.who.int/leishmaniasis/burden/en/). Since effective vaccines 
against the diseases are still under development, chemotherapy is the only mode of 
control (Chawla and Madhubala 2010). Advances in pharmacology have led to the 
introduction into the market of a number of drugs, yet unfortunately, these have 
promoted toxic side effects in the treated patients, have required long-term treatments 
and have generated resistance mechanisms (Castillo et al. 2010). Hence, there is 
urgency in discovering new anti-kinetoplastid drugs for the treatment of these diseases. 
The severity of leishmaniasis is exhibited by the number of people developing 
the symptomatic disease: cutaneous (1-1.5 million) and visceral (0.5 million), resulting 
in around 70 000 deaths per year (Murray et al. 2005). Third-world countries 
experienced the most infections, where 90% of both cutaneous and visceral 
leishmaniases have developed in some parts of Asia, Africa and Southern America. 
Leishmania spp are classified under the kingdom Protista and phylum Euglenozoa, and 
are mainly characterised by the presence of an associated cytostome (mouth) supported 
by one of three microtubule groups that arise from flagellar bases (Singh 2006). The 
vector for the parasites is the phlebotomine sandfly, which transmits the parasite into 
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the mammalian host. The life cycle of the parasite generally occurs with the existence 
of two morphologically distinct forms: a motile flagellated form (promastigotes) and an 
intracellular non-flagellated form (amastigotes) which exist in the sand fly and human 
stages, respectively (Castillo et al. 2010). Four main clinical syndromes are identified 
depending on the symptoms of the disease: cutaneous (Minodier and Parola 2007), 
muco-cutaneous (Amato et al. 2008), visceral (Sundar and Chatterje 2006) and post-
kala-azar dermal leishmaniasis (Zijlstra et al. 2003). At present, anti-leishmanial control 
depends solely on chemotherapy, with several drugs available for treatment: pentavalent 
antimonials, amphotericin and more recently, paromomycin, miltefosine and liposomal 
amphotericin B (Castillo et al. 2010). Unfortunately these drugs have limitations in their 
capability to treat the disease (Table 1.1). Hence, the present scenario exhibits the 
urgency of discovering more affordable, less toxic, orally-taken drugs that are 
efficacious in HIV patients and against resistant strains (Golgher et al. 2011).   
Human African trypanosomiasis, also known as sleeping sickness, is another 
severe disease, and is caused by the protozoan parasite T. brucei, affecting the sub-
Saharan Africa regions with 50 000-70 000 cases currently reported (Brun et al. 2010). 
The disease remains endemic in the region due in part to the suitability of the habitats 
for the transmitting vector, the tsetse flies of the genus Glossina (Brun et al. 2010). The 
parasite causes different variants of trypanosomiasis caused by different sub-species: i) 
T. brucei gambiense, ii) T. brucei rhodesiense (Barrett et al. 2003) and iii) T. brucei 
brucei (Vanhamme et al. 2003). Out of the three sub-species, only T. brucei brucei is 
not human infective, and thus has been used for laboratory research. On the other hand, 
the other two subspecies: T. brucei gambiense and T. brucei rhodesiense cause a 
slowly-developed chronic disease and an acute form of the disease, respectively. The 
life cycle of the parasite involves stages in human and the tsetse fly which mainly exist 
as: i) the non-pathogenic form known as  procyclic trypomastigotes which refers to the 
parasite that lives in the midgut of the fly and ii) bloodstream trypomastigotes that are 
associated with the pathogenic form which lives in human blood (Silverman and Bangs 
2012). The current treatment depends on the disease stage which can be differentiated 
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into two major phases: a) the first infectious stage and b) the second neurological stage 
when the parasite has crossed the blood-brain barrier and affects the central nervous 
system (http://www.who.int/mediacentre/factsheets/fs259/en/). The treatment also 
depends on the causative agent (Brun et al. 2010), for example pentamidine, 
eflornithine and melarsoprol for T. brucei gambiense, and suramin and melarsoprol for 
T. brucei rhodesiense (Table 1.1). More recently, nitroimidazoles (antibacterial and 
antiprotozoal drugs) (Trunz et al. 2011), as well as SCYX-7158, an orally-active 
benzoxaborole (Jacobs et al. 2011; Jacobs et al. 2011) have been proposed to be 
promising leads for the disease, including at the second stage. While the present drugs 
are available for treatment, there are substantial problems of toxicity, and thus new 
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Table 1.1  The current treatments for human African trypanosomiasis and 
leishmaniasis. Most information was obtained from the WHO website, 
(http://www.who.int/mediacentre/factsheets/fs259/en/) and Castillo et al. 
2010. The table was adapted from a presentation by Dr. Linda Gilmore. 
 
Drug Date first used Limitations 
Human African Trypanosomiasis 
 
Suramin 
(First stage treatment) 
 
Pentamidine 




(Second stage treatment) 
 
Eflornithine 
(Second stage treatment) 
 
Combination of eflornithine and 
nifurtimox 




















Toxicity, only effective in the early 
stage, injected 
 
Toxicity, only effective in the early 
stage, required injection and 
resistance 
 
Toxicity, resistance and required 
injection 
 
Costly, injected and only effective 
against T. gambiense 
 




























Available in 1960 
but abandoned until  
2005 
 
2010 (predicted to 
be a safe and 




Toxicity, resistance and required 
injection 
 
Toxicity, resistance and required 
injection 
 
Costly and required injection 
 
Contraindicated in pregnancy 
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Various aspects of parasite metabolism have been studied, in order to discover 
new drugs for the treatment for the diseases. For instance, enzymes in the glycolytic 
pathway such as phosphofructokinase (PFK) (EC 2.7.1.11), phosphoglycerate kinase 
(PGK) (EC 2.7.2.3), cofactor-independent phosphoglycerate mutase (iPGAM) (EC 
5.4.2.1), enolase (ENO) (EC 4.2.1.11) and pyruvate kinase (PYK) (EC 2.7.1.40) 
(Verlinde et al. 2001; Albert et al. 2005; Coley et al. 2011), the pentose phosphate 
pathway (glucose-6-phosphate dehydrogenase (G6PDH) (Shreedhara et al. 2011) and 
folate metabolism (Gilbert 2002) as well as thiolases  (Sommer and Wang 1994) have 
been validated as drug targets. For these enzymes, the knock-out of the corresponding 
target genes by RNA interference experiments (RNAi) (Albert et al. 2005; Owino et al. 
2008) resulted in the death of the cultured parasites, which provides hope for new drug 
discoveries.  
1.2 Targeting enzymes involved in glycolysis for trypanosomatid chemotheraphy 
The role of glycolysis in nearly all living organisms has been elucidated for many years, 
indicating that it is one of the most primeval metabolic pathways that has ever existed 
(Fothergill-Gilmore and Michels 1993; Romano and Conway 1996). The glycolytic 
pathway essentially is a key player in converting glucose to pyruvate through a series of 
biochemical reactions, producing high-energy compounds such as adenosine 
triphosphate (ATP) and reduced nicotinamide adenine dinucleotide (NADH). In 
trypanosomatids, glycolysis is indeed very important, and in particular, plays an 
essential role as the sole producer of ATP for the bloodstream form of T. brucei. While 
glycolytic enzymes in humans and most other organisms are located in the cytosol, 
trypanosomatids possess specialised peroxisome-like organelles called glycocomes 
(Figure 1.1), which sequester the first seven enzymes in the pathway (Opperdoes and 
Borst 1977; Verlinde et al. 2001; Gualdrón-López et al. 2011). In this case, the initial 
glucose molecule is converted to 3-phosphoglycerate (3PGA) in the glycosome, before 
being transported through the membrane into the cytosol, where the other three 
enzymes, iPGAM, ENO and PYK, are located (Verlinde et al. 2001) (Figure 1.2). For 
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over ten years, several enzymes in the glycolytic pathway of T. brucei have been 
validated as potential drug targets, where any inhibition of the enzymes involved should 
lead to the disruption of the glycolytic flux, thus resulting in the death of the parasite. 
The majority of these enzymes exhibit distinct molecular properties from the 
corresponding enzymes in humans, offering possibilities for discovering parasite-
specific potent inhibitors for drug development (Verlinde et al. 2001).  
 
Figure 1.1 Electron micrograph of bloodstream-form T. brucei indicating the 
presence of various organelles in the parasite cell, which are labelled: G 
(glycosome) where the majority of glycolytic enzymes are located, ER 
(endoplasmic reticulum), F (flagellum), FP (flagellar pocket) and N 
(nucleus). Precise identification of the organelles is not straight-forward 
and requires immunostaining to identify markers and/or serial sectioning. 
iPGAM however, is present in the cytosol. The diagram was obtained 
from Prof. Paul Michels.  
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Figure 1.2 The glycolytic enzymes in trypanosomatids, which are located in the 
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Several enzymes in the glycosome, such as hexokinase (HXK) (Seed and 
Baquero 1965; Sharlow et al. 2010), PFK (Cronin and Tipton 1987; Michels et al. 1997; 
Martinez-Oyanedel et al. 2007; McNae et al. 2009), fructose 1,6-bisphosphate aldolase 
(EC 4.1.2.13) (Callens et al. 1991; de Walque et al. 1999; Dax et al. 2006) and PGK 
(Colasante et al. 2007) have been characterised both structurally and biochemically. 
This has shed further light on understanding their catalytic mechanisms, as well as their 
biochemistry, which are important steps in designing inhibitory approaches. Recent 
studies have also reported the discovery of novel compounds which may well be 
developed into leads for some of these enzymes, for example, HXK (Sharlow et al. 
2010) and PGK (Bressi et al. 2000). The three final glycolytic enzymes in 
trypanosomatids which are located in the cytosol have also been characterised 
extensively. The iPGAM (Poonperm et al. 2003; Guerra et al. 2004; Nowicki et al. 
2009; Fuad et al. 2011), ENO (Quiñones et al. 2007; Avilán et al. 2011) and PYK 
(Ernest et al. 1998; Rigden et al. 1999; Morgan et al. 2011) structural and biochemical 
studies have greatly progressed in recent years. Moreover the location of these enzymes 
may provide better access for inhibitors, rather than having to go through the 
glycosomal membrane to reach the target molecules.   
It is indeed interesting to correlate drug design with the control of glycolytic 
flux. This has been shown in a study by Bakker et al. in 2000, where both the computer 
simulation and experimental studies exhibited the roles of several steps in glycolysis in 
controlling the glycolytic flux in T. brucei. Based on earlier studies by Bakker et al. 
1997, a subsequent mathematical model was proposed by using experimentally-
determined kinetics as the foundation (Albert et al. 2005). The outcome from this study 
revealed that the concentrations of five glycolytic enzymes (HXK, PFK, iPGAM, ENO 
and PYK) could be substantially decreased by RNAi experiments. Moreover, enzymes 
in the glycosome and the cytosol were all affected by the RNAi knockdowns, which 
further suggested a unique regulatory mechanism of glycolysis in trypanosomatid 
parasites. More recently, Achcar et al. 2012 revealed that two enzymes in particular, 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) and iPGAM 
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maximally controlled the glycolytic flux based on the control coefficients that have 
been analysed in the dynamic model. It is interesting too that the model in this study has 
been built by taking into account parameter uncertainty, which occurred due to 
experimental errors or lack of data, and thus increased the knowledge of control 
hierarchy that is important in prioritising potential drug targets (Achcar et al. 2012).   
1.3 Phosphoglycerate mutase  
Glycolysis occurs by a series of biochemical reactions catalysed by individual enzymes. 
There are ten separate reactions in the metabolic pathway, in which some are reversible, 
forming the basis of the gluconeogenic pathway which runs in the opposite direction. 
PGAM is the enzyme catalysing the seventh step of glycolysis, converting 3PGA to 2-
phosphoglycerate (2PGA) (Figure 1.2). In humans and vertebrates, as well as yeasts and 
bacteria (Rigden et al. 2001; Chiba et al. 2012), the enzyme requires 2,3-
bisphosphoglycerate as the cofactor for the catalytic function (dPGAM). By contrast, 
the iPGAM found in protists, including T. brucei (Chevalier et al. 2000) and L. 
mexicana (Guerra et al. 2004), as well as in plants (Grana et al. 1992; Wang et al. 1996; 
Zhao and Assman 2011) and some nematodes (Raverdy et al. 2007), bacteria (Jedrzejas 
et al. 2000a; Jedrzejas et al. 2000b), archaea (Johnsen and Schönheit 2007), filarial 
parasites Dirofilaria immitis (Li et al. 2011) and its Wolbachia endosymbiont and the 
same endosymbiont from Brugia malayi (Foster et al. 2009) are active in the absence of 
the cofactor (Guerra et al. 2004; Nowicki et al. 2009; Fuad et al. 2011). On the other 
hand, iPGAM requires divalent metal ions to support its activity. These two enzymes, 
although they essentially play the same role in the metabolic pathway, are not 
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i) Cofactor-independent phosphoglycerate mutase and metal requirements 
for enzymatic activity 
The NCBI database lists 1232 iPGAM sequences (March 2012), across a fairly wide 
variety of organisms. Out of these, 16 sequences representing different bacterial, algal, 
nematode, fungal, kinetoplastid and plant species were aligned using the program 
CLUSTALW2 from the EMBL-EBI database (Figure 1.3). It can be seen directly that 
residues corresponding to important features of these enzymes are identical among the 
organisms, for example the sequences encoding the metal sites (green and yellow 
shading), as well as the phosphorylated Ser75 (pink shading) and other active-site 
residues (cyan shading). However, it is also a striking observation that there are regions 
which are conserved only among the plants and kinetoplastid iPGAMs, in particular the 
inserted Tyr201 (red shading) and hinge residues (gray shading). This observation 
indicates the possibility that iPGAMs could be divided into two different families, 
where trypanosomatid and plant iPGAMs are in one family, while bacterial, nematode, 
algal and fungal iPGAMs are in another family. The distinguishing properties appear to 
be related to the differences in catalytic mechanism involving metal ions, which will be 
discussed in chapter 4. Moreover, the similarity between plants and kinetoplastid 
iPGAMs is highlighted by the higher percentage of sequence identity between the two 
groups of organisms. Table 1.2 tabulates the overall percent sequence identity across the 
wide range of organisms in Figure 1.3, where the percentage of identities between 
plants and kinetoplastid iPGAMs are 53-58%. Meanwhile, the overall sequence 
identities between the bacterial, algal, nematode and fungal iPGAMs with kinetoplastid 
iPGAMs are found to be between 26 and 35%. Nevertheless, all iPGAMs from different 
organisms are reported to be monomeric enzymes of about ~60 kDa. A phylogenetic 
analysis for the cofactor independent PGAM is shown in Figure 1.4, which is based on 
the sequence alignment in Figure 1.3. 
 
 
Bste            -------------MSKK---PVALIILDGFALR---DETYGNAVAQANKPNFDRYWNEYP 41 
Bant            --------------MRK---PTALIILDGFGLR---EETYGNAVAQAKKPNFDGYWNKFP 40 
Ecol            -----------MLVSKK---PMVLVILDGYGYR---EEQQDNAIFSAKTPVMDALWANRP 43 
Avar            -------------MTKAPVAPVVLVILDGWGYC---EETRGNAIAAAKTPVMESLWTAYP 44 
Ppur            -------------MMKKKVHPIVLAILDGWGHS---NSHQGNAIKIAKTPTIDSLLETYP 44 
Acla            --------------MTKVDHKVVLIVIDGWGIPGPDSPKDGDAIAAAETPYMSGFADPNS 46 
Bmal1           --------------MAEAKNRVCLVVIDGWGIS---NETKGNAILNAKTPVMDELCVMNS 43 
Atha1           -MATSSAWKLDDHPKLPKGKTIAVIVLDGWGES---APDQYNCIHNAPTPAMDSLKHGAP 56 
Mcry            MGSTEFSWKLADHPKLPKGKTLAMVVLDGWGEA---SANQYNCIHVAETPTMDSLKQGAP 57 
Ntab            MGSSGDAWKLKDHPKLPKGKTVAVIVLDGWGEA---KPNEFNAIHVAETPVMYSLKNGAP 57 
Rcom            ---GEFTWKLADHPKLPKGKTIAMVVLDGWGEA---KPDQYNCIHVAETPTMDSFKKTAP 54 
Zmay            MGSSGFSWTLPDHPKLPKGKSVAVVVLDGWGEA---NPDQYNCIHVAQTPVMDSLKNGAP 57 
Osat1           -MAETRRWELAAHRRLEKGKVVGVVVLDGWGEA---APDTFNCIHVADTPTLDALKKGGP 56 
Tbru            -----MALTLAAHKTLPR-RKLVLVVLDGVGIG---PRDEYDAVHVAKTPLMDALFND-P 50 
Tcru            ----MSALSLQLHTALPR-RKLLLVVMDGVGIG---PGDEYDAVHVAKTPFIDSMCAD-A 51 
Lmex            ----MSALLLKPHKDLPR-RTVLIVVMDGLGIG---PEDDYDAVHMASTPFMDAHRRD-N 51 
                                       : ::** .          :.:  * .* :         
 
Bste            -----HTTLKACGEAVGLP-EGQMGNSEVGHLNIGAGRIVYQSLTRINIAIREGEFDRNE 95 
Bant            -----HTTLTACGEAVGLP-EGQMGNSEVGHLNIGAGRIVYQSLTRVNVAIREGEFDKNE 94 
Ecol            -----HTLIDASGLEVGLP-DRQMGNSEVGHVNLGAGRIVYQDLTRLDVEIKDRAFFANP 97 
Avar            -----HTLIHTSGKAVGLP-EGQMGNSEVGHLNIGAGRVVPQELVRISDAVEDGSILSNS 98 
Ppur            -----NTLLVASGEEVGLP-KGQMGNSEVGHTTIGGGRVVEQELVKIGNSIENKSFFNNV 98 
Acla            KTAQGFTELEASSLAVGLP-EGLMGNSEVGHLNIGAGRVVWQDSVRIDQTLKNGELNKVD 105 
Bmal1           ------HPIQAHGLHVGLP-EGLMGNSEVGHLNIGAGRVVYQDIVRINLAVKNKTLVENK 96 
Atha1           DTWT---LIKAHGTAVGLPSEDDMGNSEVGHNALGAGRIFAQGAKLCDQALASGKIFEGE 113 
Mcry            EKWR---LIRAHGKAVGLPTEDDMGNSEVGHNALGAGRIYAQGAKLVDLALESGKIYDGE 114 
Ntab            EKWR---LIKAHGNAVGLPTEDDMGNSEVGHNALGAGRIFAQGAKLVDLALASGKIYEGE 114 
Rcom            ERWR---LIKAHGTAVGLPTEDDMGNSEVGHNALGAGRIYAQGAKLVDLALASGKIYEGE 111 
Zmay            EKWR---LVKAHGTAVGLPSDDDMGNSEVGHNALGAGRIFAQGAKLVDQALASGKIYDGD 114 
Osat1           ERWR---VIKAHGTAVGLPTDDDMGNSEVGHNALGAGQIYAQGAKLVDMALASGKIYEGE 113 
Tbru            KHFR---SICAHGTAVGLPTDADMGNSEVGHNALGAGRVVLQGASLVDDALESGEIFTSE 107 
Tcru            KHFR---SVCAHGTAVGLPTDADMGNSEVGHNALGSGRVVLQGASLVDDAIKTGEIFTSD 108 
Lmex            RHFR---CVRAHGTAVGLPTDADMGNSEVGHNALGAGRVALQGASLVDDAIKSGEIYTGE 108 
                        : : .  **** .  ********  :*.*::  *     .  :    :     
                               :*: ** * *****.  ::  ::         .: :: : ****. 
 
Figure 1.3  Alignment of iPGAM sequences, with residues coloured according to type. 
Abbreviations: Bste, Bacillus stearothermophilus; Bant, Bacillus 
anthracis; Ecol, Escherichia coli; Avar, Anabaena variabilis (blue-green 
alga) ; Ppur, Porphyra purpurea (red alga); Acla, Aspergillus clavatus 
(fungus); Bmal1, Brugia malayi isoform 1 (nematode); Atha1,Arabadopsis 
thaliana gene 1 (plant); Mcry, Mesembryanthemum crystallinum; Ntab, 
Nicotiana tabacum; Rcom, Ricinus communis; Zmay, Zea mays; Osat1, 
Oryza sativa subsp. japonica; Tbru, Trypanosoma brucei; Tcru, 
Trypanosoma cruzi; Lmex, Leishmania mexicana. Colour highlighting 
indicates the following: Metal site 1; Metal site 2; phosphorylated Ser75; 
other active-site residues; inserted Tyr201; hinge residues which are 
located in linker 1 and 2. The multiple sequence alignment was performed 
using CLUSTALW2 (http://www. ebi.ac.uk/ Tools/msa/clustalw2/) with 
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Bste            TFLAAMNHVKQHGTSLHLFGLLSDGGVHSHIHHLYALLRLAAKEGVKRVYIHGFLDGRDV 155 
Bant            TFQSAIKSVKEKGTALHLFGLLSDGGVHSHMNHMFALLRLAAKEGVEKVYIHAFLDGRDV 154 
Ecol            VLTGAVDKAKNAGKAVHIMGLLSAGGVHSHEDHIMAMVELAAERGAEKIYLHAFLDGRDT 157 
Avar            ALVKICQEVRNRNGKLHLVGLCSEGGVHSHITHLFGLLDLAKEQRISEVCIHAITDGRDT 158 
Ppur            QLNCACDHAISTQTSLHLIGLCSNGGVHSHLDHLLALIHVAESKKVPNLYIHLITDGRDT 158 
Acla            NIVKSFTRAKEGNGRLHLLGLISDGGVHSNITHLVGLLKVAKEMEIPHVFIHFFGDGRDT 165 
Bmal1           HLKEAAERAIKGNGRMHLCGLVSDGGVHSHIDHLFALITALKQLKVPKLYIQFFGDGRDT 156 
Atha1           GFKYVSESFETN--TLHLVGLLSDGGVHSRLDQLQLLIKGSAERGAKRIRVHILTDGRDV 171 
Mcry            GFNYIKESFETN--TLHLIGLLSDGGVHSRLDQLQLLLKGSAERGAKRIRVHILTDGRDV 172 
Ntab            GFKYVKECFEKG--TLHLIGLLSDGGVHSRLDQVQLLLKGAAKHGAKRIRVHALTDGRDV 172 
Rcom            GFKYVKECFDKG--TLHLIGLLSDGGVHSRLDQLQLLLKGAAEHGAKRIRVHVLTDGRDV 169 
Zmay            GFNYIKESFESG--TLHLIGLLSDGGVHSRLDQLQLLLKGVSERGAKKIRVHILTDGRDV 172 
Osat1           GFKYIQQSFENG--TLHLIGLLSDGGVHSRIDQLQLLLKGASEHGAKRIRVHILTDGRDV 171 
Tbru            GYRYLHGAFSQPGRTLHLIGLLSDGGVHSRDNQVYQILKHAGANGAKRIRVHALYDGRDV 167 
Tcru            GYRYLHGAFSQPGRTLHLIGLLSDGGVHSRDNQLYEIINHASSNGAKRIRLHVLYDGRDV 168 
Lmex            GYRYLHGAFSKEGSTLHLIGLLSDGGVHSRDNQIYSIIEHAVKDGAKRIRVHALYDGRDV 168 
 
 
Bste            GPQTAPQYIKELQEKIKEYGVGEIATLSG-----RYYSMDR-DKRWDRVEKAYRAMVYGE 209 
Bant            GPKTAQSYIDATNEVIKETGVGQFATISG-----RYYSMDR-DKRWDRVEKCYRAMVNGE 208 
Ecol            PPRSAESSLKKFEEKFAALGKGRVASIIG-----RYYAMDR-DNRWDRVEKAYDLLTLAQ 211 
Avar            APTDGINAISALEDYINHVGIGRIVTVSG-----RYYAMDR-DRRWDRIQRAYDVMTQDG 212 
Ppur            NSNSAKSFIKLIADHIEKKSFVIISTISG-----RYYAMDR-DFRWSRTKAAYTVLTSDN 212 
Acla            DPKSAAKYMQDLLDHMKEIGTGEIATVVG-----RYYAMDR-DKRWDRVEVAMKGIVSGE 219 
Bmal1           SPTSGVGFLQQLIDFVNKEQYGEISTIVG-----RYYAMDR-DKRWERIRVCYDALIGGV 210 
Atha1           LDGSSVGFVETLEADLVALRENGVDAQIASGGGRMYVTLDRYENDWEVVKRGWDAQVLGE 231 
Mcry            LDGSSVGFVETLENDLAQLRAKGVDAQIASGGGRMYVTMDRYENDWSVVKRGWDAQVLGE 232 
Ntab            LDGSSVGFMETLENSLAQLREKGIDAQVASGGGRMYVTMDRYENDWDVVKRGWDAQVLGE 232 
Rcom            IDGTSVGFAETLEKDLENLREKGVDAQVASGGGRMYVTMDRYENDWNVVKRGWDAQVLGE 229 
Zmay            LDGSSIGFVETLENDLLELRAKGVDAQIASGGGRMYVTMDRYENDWDVVKRGWDAQVLGE 232 
Osat1           LDGSSVKFVELIENDLAKLRDKGVDARIASGGGRMYVTMDRYENDWQVVKRGWDAQVLGE 231 
Tbru            PDKTSFKFTDELEEVLAKLREGGCDARIASGGGRMFVTMDRYEADWSIVERGWRAQVLGE 227 
Tcru            PDKSSFKFTDDLESVLEKARAKGCDARIASGGGRMFVTMDRYEADWSVVERGWRAQVLGE 228 
Lmex            PDGSSFRFTDELEAVLAKVRQNGCDAAIASGGGRMFVTMDRYDADWSIVERGWRAQVLGD 228 
                    .    .     .         :  .      : ::** :  *.  .           
 
Bste            ---GPTYRDPLECIEDSYKHGIYDEFVLPSVIVREDGRPVATIQDNDAIIFYNFRPDRAI 266 
Bant            ---GPTYKSAEECVEDSYANGIYDEFVLPSVIVNEDNTPVATINDDDAVIFYNFRPDRAI 265 
Ecol            G--EFQADTAVAGLQAAYARDENDEFVKATVIRAE-GQPDAAMEDGDALIFMNFRADRAR 268 
Avar            ---AGDGRKAVDVLQASYAEGVNDEFIVPVRIAP------GTVESGDGVIFFNFRPDRSR 263 
Ppur            SDITNQPLNYNDLIDHYYNKGISDEFIPPSRINT------GSIKDGDAIIFFNFRPDRMR 266 
Acla            G-EES--SDPVKTIKERYEKGENDEFLKPIIVGG----KDRRVQDDDTLFFFNYRSDRVR 272 
Bmal1           G-EKTTIDKAIDVIKGRYAKDETDEFLKPIILS-----DEGRTKDGDTLIFFDYRADRMR 264 
Atha1           APHKFKNAVEAVKTLRKE-PGANDQYLPPFVIVDESGKAVGPIVDGDAVVTFNFRADRMV 290 
Mcry            APYKFKNAVEAVKTLRQE-PKANDQYLPPFVVVDESGKAVGPIVDGDAVVTLNFRADRMV 291 
Ntab            APHKFKDPVEAVKKLRQE-PNANDQYLAPFVIVDDNGKPVAAILDGDAVVTFNFRADRMV 291 
Rcom            APYKFKSAVEAIKKLREE-PKANDQYLPPFVIVDENGKPVGPIVDGDAVVTINFRADRMV 288 
Zmay            APYKFKSALEAVKTLRAQ-PKANDQYLPPFVIVDDSGNAVGPVLDGDAVVTINFRADRMV 291 
Osat1           APHKFQNALEAVKKLRED-PKANDQYLPPFVIVDERGRPIGPIMDGDAVVTFNFRADRMV 290 
Tbru            G-RAFKSAREALTKFREEDANISDQYYPPFVIAGDDGRPIGTIEDGDAVLCFNFRGDRVI 286 
Tcru            A-RAFASAGEAIKTFRKEDPNVSDQYYPPFIISDVDGKAIGPIEDGDAVLCFNFRGDRVI 287 
Lmex            A-RHFHSAKEAITTFREEDPKVTDQYYPPFIVVDEQDKPLGTIEDGDAVLCVNFRGDRVI 287 
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Bste            QISNTFTNEDFREFDRGPKHPKHLFFVCLTHFSETVKGYVAFKPTNLDNTIGEVLSQHGL 326 
Bant            QIARVFTNGDFREFDRGEKVPHIPEFVCMTHFSETVDGYVAFKPMNLDNTLGEVVAQAGL 325 
Ecol            EITRAFVNADFDGFAR--KKVVNVDFVMLTEYAADIKTAVAYPPASLVNTFGEWMAKNDK 326 
Avar            QLTQAFVSPEFTGFAR--QQIKPLSFVTFTQYDSDLSVSVAFEPQNLTNILGEVIANQGL 321 
Ppur            QLVQALVQKPFNCFLT--KSLSHLHVLTFTNYDSSLNTALAFPPNTLNNFLGETISKYGL 324 
Acla            EITQLLG-DFDRSPKPDFPYPKNISITTMTQYKTDYTFPVAFPPQHMGNVLAEWLSKKDI 331 
Bmal1           EITECMGMERYKDLNSNIKHPKNMQVIGMTQYKAEFTFPALFPPESHKNVLAEWLSVNGL 324 
Atha1           MHAKALEYEDFDKFDRVRYPKIRYAGMLQYDGELKLPSRYLVSPPEIDRTSGEYLTHNGV 350 
Mcry            MLAKALEYEDFDKFDRVRFPKIRYAGMLQYDGELKLPNRYLVSPPEIERTSGEYLVHNGV 351 
Ntab            MLAKALEYENFDKFDRVRVPKIRYAGMLQYHGELQLPSHYLVSPPEIARHSGEYLVRNGV 351 
Rcom            MLAKALEYENFDTFDRVRFPKIHYAGMLQYDGELKLPSHYLVSPPEIERTSGEYLVHNGV 348 
Zmay            MLAKALEYADFDNFDRVRVPKIRYAGMLQYDGELKLPSRYLVSPPEIDRTSGEYLVKNGI 351 
Osat1           MLAKALEYESFDKFDRVRFPKIRYAGMLQYDGELKLPSHFLVAPPEIERTSGEYLARNGI 350 
Tbru            EMSRAFEEEEFDKFNRVRLPKVRYAGMMRYDGDLGIPNNFLVPPPKLTRTSEEYLIGSGC 346 
Tcru            EMSRAFEEEDFDKFNRVRVPKVRYAGMMRYDGDLGIPNNFLVPPPRLSRTSEEYLVGSGC 347 
Lmex            EMTRAFEDEDFNKFDRVRVPKVRYAGMMRYDGDLGIPNNFLVPPPKLTRVSEEYLCGSGL 347 
                   . :                        .            *    .   * :   .  
 
Bste            RQLRIAETEKYPHVTFFMSGGREEKFPG--EDRILINSPKVPTYDLKPEMSAYEVTDALL 384 
Bant            KQLRIAETEKYPHVTFFFSGGREAEFPG--EERILINSPKVATYDLKPEMSIYEVTDALV 383 
Ecol            TQLRISETEKYAHVTFFFNGGVEESFKG--EDRILINSPKVATYDLQPEMSSAELTEKLV 384 
Avar            NQFRTAETEKYAHVTYFFNGGLEEPFAG--EDRELVSSPMVATYDKAPAMSATAVTDTAI 379 
Ppur            KQFRVAETEKYAHVTYFFNGGAEEPFSG--EDRELVSSPSVTTYDLSPDMSAELVTQKSI 382 
Acla            SQCHVAETEKYAHVTFFFNGGIEKQFPG--EVRDMIPSPKVATYDLDPEMSAADVGKKMS 389 
Bmal1           TQFHCAETEKYAHVTFFFNGGVEKQFAN--EERCLVVSPKVATYDLEPPMSSAAVADKVI 382 
Atha1           STFACSETVKFGHVTFFWNGNRSGYFNEKLEEYVEIPSDSGISFNVQPKMKALEIGEKAR 410 
Mcry            RTFACSETVKFGHVTFFWNGNRSGYFKPEMEEYVEIPSDSGITFNVQPKMKALEIAEKAR 411 
Ntab            RTFACSETVKFGHVTFFWNGNRSGYFNEKLEEYVEIPSDSGITFNVKPKMKALEIAERTR 411 
Rcom            HTFACSETVKFGHVTFFWNGNRSGYFNPEMEEYVEIPSDVGITFNVQPKMKAIEIAEKAR 408 
Zmay            RTFACSETVKFGHVTFFWNGNRSGYFDATKEEYVEVPSDSGITFNVAPNMKALEIAEKAR 411 
Osat1           RTYACSETVKFGHVTFFWNGNRSGYFHPNLEKYEEIPSDIGIPFNEQPKMKAVEIAKKTR 410 
Tbru            NIFALSETQKFGHVTYFWNGNRSGKLSEERETFCEIPSDR-VQFNQKPLMKSKEITDAAV 405 
Tcru            NIFACSETQKFGHVTYFWNGNRSGKLDEEHETFFEIPSDR-VQFNEKPLMKSKEITEAAI 406 
Lmex            NIFACSETQKFGHVTYFWNGNRSGKIDEKHETFKEVPSDR-VQFNEKPRMQSAAITEAAI 406 
                     :** *: ***:* .*. .  :    *    : *     ::  * *.   : .    
 
Bste            KEIEADKYDAIILNYANPDMVGHSGKLEPTIKAVEAVDECLGKVVDAILAKGGIAIITAD 444 
Bant            NEIENDKHDVIILNFANCDMVGHSGMMEPTIKAVEATDECLGKVVEAILAKDGVALITAD 443 
Ecol            AAIKSGKYDTIICNYPNGDMVGHTGVMEAAVKAVEALDHCVEEVAKAVESVGGQLLITAD 444 
Avar            AAIQKGIYSLIVINYANPDMVGHTGQIEPTIQAIETVDRCLGRLLEGVSKAGGTTIITAD 439 
Ppur            SAINKGIYSCIVINYANADMLGHTGKLKETIRSIETVDNCIALLFDAVSQSNGTLIITAD 442 
Acla            ERIAEDKFDFVMNNFAPPDMVGHTGVYEAAIKGVTATDKAIGEIYEACKKHGYILFITSD 449 
Bmal1           EQLHMKKHPFVMCNFAPPDMVGHTGVYEAAVKAVEATDIAIGRIYEACKKNDYILMVTAD 442 
Atha1           DAILSGKFDQVRVNIPNGDMVGHTGDIEATVVACEAADLAVKMIFDAIEQVKGIYVVTAD 470 
Mcry            DAILSGKFDQVRVNLPNSDMVGHTGDIEATVVACKAADEAVKMIIDAIEQVGGIYVITAD 471 
Ntab            DAILSGKFDQVRVNLPNGDMVGHTGDIKATIEACKSADEAVKMILEAIEQVGGIYLVTAD 471 
Rcom            DAILSGKFQQVRVNIPNGDMVGHTGDVEATVVGCKAADEAVKMIIDAIEQVGGIYVVTAD 468 
Zmay            DALLSGKFDQVRVNLPNGDMVGHTGDIEATVVACKAADEAVKIILDAVEQVGGIYLVTAD 471 
Osat1           DAILSRKFDQVRVNIANGDMVGHTGDIEATIVGCKAADEAVKIVLDAIEQVGGIFVVTAD 470 
Tbru            DAIKSGKYDMIRINYPNGDMVGHTGDLKATITSLEAVDQSLQRLKEAVDSVNGVFLITAD 465 
Tcru            EALKSGKYDVVRINFPNGDMVGHTGDLAATVTAVEAVDASLQRLKEAVDAVNGVFLITAD 466 
Lmex            EALKSGMYNVVRINFPNGDMVGHTGDLKATITGVEAVDESLAKLKDAVDSVNGVYIVTAD 466 

















Bste            HGNADEVLTPD------------GKPQTAHTTNPVPVIVTKKG----------IKLRDGG 482 
Bant            HGNADEELTSE------------GEPMTAHTTNPVPFIVTKND----------VELREDG 481 
Ecol            HGNAEQMRDPAT-----------GQAHTAHTNLPVPLIYVGDK---------NVKAVEGG 484 
Avar            HGNAEYMLDEA------------GNSWTAHTTNPVPLILVEGEKVKIPGYGTNVELRSDG 487 
Ppur            HGNAECMLTNE------------GTSCTSHTTNLVPFILIEGEQATISGHGGQVEFRKNG 490 
Acla            HGNAEEMLNEK------------GTPKTSHTTNKVPFVLANAPEGWS-------LKKEEG 490 
Bmal1           HGNAEKMMAPD------------GSKHTAHTCNLVPFTCSSMKYKFMD-----KLPDREM 485 
Atha1           HGNAEDMVKRDKSGKPALDKEGKLQILTSHTLKPVPIAIGGPGLAQGVRFR---KDLETP 527 
Mcry            HGNAEDMVKRDKKGQPAMDKNGNIQILTSHTLEPVPIAIGGPGLTPGVRFR---NDIPTG 528 
Ntab            HGNAEDMVKRNKKGEPALDKNGNIQILTSHTCEPVPIAIGGPGLAPGVRFR---QDLPTG 528 
Rcom            HGNAEDMVKRDKSGKPMADKSGKIQILTSHTLQPVPIAIGGPGLTPGVRFR---SDIPTG 525 
Zmay            HGNAEDMVKRNKSGKPLLDKNDRIQILTSHTLQPVPVAIGGPGLHPGVKFR---NDIQTP 528 
Osat1           HGNAEDMVKRDKSGKPLRDKDGNVQPLTSHTLNPVPIAIGGPGLQPGVRFR---SDLPSA 527 
Tbru            HGNSDDMVQRDKKGKPVRDAEGNLMPLTSHTLAPVPVFIGGAGLDPRVQMR---TDLPRA 522 
Tcru            HGNSDDMAQRDKKGKPILGKDGKVLPLTSHTLAPVPVFIGGAGLDARVQMR---TGLPKA 523 
Lmex            HGNSDDMAQRDKKGKPMKDGNGNVLPLTSHTLSPVPVFIGGAGLDPRVAMR---TDLPAA 523 
                ***::                      *:**   **.                        
 
Bste            ILGDLAPTMLDLLGLPQPKEMTGKSLIVK----------------- 511 
Bant            ILGDIAPTMLTLLGVEQPKEMTGKTIIK------------------ 509 
Ecol            KLSDIAPTMLSLMGMEIPQEMTGKPLFIVE---------------- 514 
Avar            KLADIAPTILDILQLPQPPEMTGRSLLQPAEYDVQSPRTRIPVGLN 533 
Ppur            SLADVAPTILDILNLKKPPEMTGKSLIINSKYETRN-LDKTFIEL- 534 
Acla            VLGDVAPTVLAAMGIEQPEEMSGKSLLVKA---------------- 520 
Bmal1           ALCDVAPTVLKVMGVPLPSEMTGQPLVNEA---------------- 515 
Atha1           GLANVAATVMNLHGFVAPSDYEPTLIEVVE---------------- 557 
Mcry            GLANVAATVMNLHGFEAPSDYEPTLIEVVSN--------------- 559 
Ntab            GLANVAATFMNLHGSEAPSDYEPSLIEVVDN--------------- 559 
Rcom            GLANVAATVMNLHGFEAPSDYEPTLIEAVDN--------------- 556 
Zmay            GLANVAATVMNLHGFEAPADYEQTLIEVADN--------------- 559 
Osat1           GLANVAATVMNLHGFEAPDHYEPTLIEVVDK--------------- 558 
Tbru            GLANVTATFINLMGFEAPSDYEPSLIEVA----------------- 551 
Tcru            GLANVTATFLNLMGFTAPTDYEPSLIEVIPN--------------- 554 
Lmex            GLANVTATFINLLGFEAPEDYEPSLIYVEK---------------- 553 
                 * :::.*.:       * .     :                     
 





























































































































































































































































































































































































































































































































































































































































































Figure 1.4 A phylogenetic tree of iPGAMs show the sequence relationships across a 
range of different species, and unite the plant and kinetoplastid iPGAMs 
under one family, while bacterial, fungal, nematode and algal iPGAMs 
are in another. The abbreviations for the species can be found in the 






The iPGAM metal requirement has been elucidated in various biochemical and 
structural studies (Guerra et al. 2004; Jedrzejas et al. 2000). This distinctive feature as 
well as structural comparisons categorised the enzyme under the metal-dependent 
alkaline phosphatase superfamily, uniting it with a few other enzymes, such as alkaline 
phosphatases (EC 3.1.3.1) (Anderson et al. 1975; Rej and Bretaudiere 1980) and 
sulfotases (EC 3.1.6) (Lassila and Herschlag 2008) with similar metal-binding sites and 
conserved structural folds (Galperin et al. 1998; Galperin and Jedrzejas 2001). The 
members of the family catalyse phospho transfer reactions, which involve basic 
biochemical processes including energy storage, biosynthesis, or replication of genetic 
material (Boyer et al. 1973; Vetter and Wittinghofer 1999; Lόpez-Canut et al. 2011). 
iPGAM from different organisms have been reported to require a particular divalent 
metal ion to support their catalytic functions (Jedrzejas et al. 2000; Collet et al. 2001; 
Guerra et al. 2004). Bacterial iPGAMs were shown to have a preference for Mn2+, for 
example in Bacillus species (Jedrzejas et al. 2000a; Jedrzejas et al. 2000b; Nukui et al. 
2007). E.coli, which interestingly has been shown to possess both iPGAM and dPGAM, 
was also reported to contain Mn2+ for the former enzyme (Fraser et al. 1999). The 
activity of iPGAM from nematodes: Onchocerca volvulus, Brugia malayi and 
Caenorhabditis elegans after EDTA treatment were reported to be effectively restored 
by Mn2+ and Mg2+ (Raverdy et al. 2007), while plant iPGAM, specifically Triticum 
aestivum (wheat) was reported to be reactivated by Mn2+ and Co2+ (Smith et al. 1986). 
Interestingly, iPGAM from kinetoplastids, T. brucei and L. mexicana were previously 
known to require Co2+ for their activities (Collet et al. 2001; Guerra et al. 2004), before 
it was revealed that Co2+ is essentially absent in the cytosol, where the enzyme is 
located (Fuad et al. 2011). The conserved metal-binding site residues among iPGAMs 
from different organisms fits beautifully with the discovery of two different families of 
iPGAM, which can be classified based on protein sequences, metal-mechanism and 
domain movements. In this case, kinetoplastid and plant iPGAMs possess a one-metal 
mechanism, which resulted in smaller open conformation, while the bacterial, algal, 
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nematode, and fungal iPGAMs have a larger open conformation, due to the two-metal 
mechanism used during catalysis.    
The understanding of iPGAM metal requirements has improved in the last 
decade, especially as enzyme structural information has become available. In 2000, the 
crystal structure of B. stearothermophilus iPGAM in complex with 3PGA and two Mn2+ 
ions (Figure 1.5 a) was been solved at 1.9-Å resolution (Jedrzejas et al. 2000a), as was 
the complex with 2PGA with two Mn2+ ions (Jedrzejas et al. 2000b), solved at 1.7-Å 
resolution. These were the first crystal structures of iPGAM ever reported, thus 
shedding light on understanding the mechanism of action of iPGAM from a structural 
viewpoint. The two steps which are involved during catalysis: i) the phosphatase 
reaction which removes the phospho group from carbon 2 or 3, and vice versa while 
generating the phosphoserine intermediates in which both Mn2+ ions with distorted 
square pyramidal geometry play an important role, and ii) the phosphotransferase 
reaction that occurs as the phospho group is transferred from the enzyme back to the 
glycerate molecule. This mechanism is consistent with the existence of two distinct 
domains: the phosphatase and transferase. The residues involved during catalysis thus 
are located in the active site which involves residues in both domains. In 2007, the 
enzyme open-form structure in B. anthracis was solved (Nukui et al. 2007) (Figure 1.5 
b) in the presence of a water molecule and two Mn2+ ions, showing structural 
differences from that of the closed-form enzyme from B. stearothermohillus. 
Nevertheless, both the individual domains and the catalytic mechanisms are similar, 
which is consistent with the high sequence identity observed between these two Bacillus 
species (77%) (Table 1.2). The BaiPGAM open-form structure also highlighted a new 
coordination geometry of the two Mn2+ ions which differs from the previous BsiPGAM 
structure, and thus allows a   better understanding of pH-dependent regulation of 





Figure 1.5  a)The closed-form crystal structure of BsiPGAM in complex with 3PGA 
and two Mn2+ ions (Jedrzejas et al. 2000a, PDB ID 1EJJ) and b) The 
open-form crystal structure of BaiPGAM in the presence of two Mn2+ 






In recent years, our understanding of the structural aspects of trypanosomatid 
iPGAMs has significantly improved. The crystal structure of LmiPGAM in complex 
with 3PGA and two Co2+ ions at high and low concentrations have successfully been 
solved at 2 and 1.9 Å resolution, respectively (Poonperm 2005; Nowicki et al. 2009) 
(Figure 1.6 a). The overall topologies are similar to the previously reported Bacillus 
iPGAM structures, where two domains are present which play individual roles for the 
catalytic function of the enzyme. The occupancies of both the substrate and product 
appeared to be equal in the active site, while both Co2+ ions are coordinated within the 
active site with different geometries and binding affinities. Co2+ in the first metal site 
(M1) possesses a distorted octahedral geometry with 100% occupancy, with a 
dissociation constant (Kd) value that is much lower than Co2+ in the second site (M2). 
Meanwhile, Co2+ in the M2 site possesses a tetrahedral geometry and coordinates with 
Ser75, a residue involved in phosphotransfer. The latter showed partial occupancy with 
an estimated Kd of > 1mM (Nowicki et al. 2009). One of the highlights from this 
structure is the observation that the side chain of Ser75 adopts an unfavourable position 
for catalysis when the M2 site is occupied, suggesting that catalysis occurs by a one-
metal mechanism, instead of two as observed in the Bacillus iPGAM structure. Instead, 
Ser75 may be activated for phosphotransfer via H-bonding to the nearby residues. 
Another important structural feature which contributes to the difference from the 
bacterial enzyme is the existence of the inserted Tyr210 which causes the size of M2 to 
decrease, and correlates well with the lower metal-affinity. This was observed despite 
the conservation of 16 residues that are involved during catalysis (Figure 1.6b).     
More recently, the open-form structure of TbiPGAM has been solved at 2.3 Å 
resolutions in the presence of a sulphate and two Co2+ ions (Mercaldi et al. 2012). While 
the enzyme possess an α/β topology almost identical to LmiPGAM with two individual 
phosphatase and transferase domains, the catalytic residues from both domains of 
TbiPGAM lie farther apart, hence exposing them to solvent (see chapter 4). The 
structure is reported to represent the biologically relevant open conformation, and is 
strikingly less open than the previously reported BaiPGAM open-form structure. 
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Nevertheless, this new structure also revealed that iPGAM possesses flexible hinges 
(Kempner 1993) that connect both domains, and thus confirms that the reaction 
mechanism is based on substrate-induced conformational change (Mercaldi et al. 2012). 
A highlight from the structure is the involvement of a metal-binding residue, Asp319, 
which coordinates the metal ion within the M1 site. The substitution of this residue with 
Ala resulted in complete loss of activity. It was thus concluded that the M1-
metal/Asp319 interaction is important for the enzyme’s structural function. Identical to 

















Figure 1.6 a) The closed-form crystal structure of LmiPGAM (Nowicki et al. 2009, 
PDB ID 3IGY) in the presence of 3PGA/2PGA, two Co2+ ions and a Na+ 
ion which may be important for the enzyme structural integrity and b) 16 
residues which are conserved in the active site. The green text indicates 
residues in the phosphatase domain, whereas the red text indicates 





In an earlier section (see section 1.2), the potential of glycolytic enzymes as 
excellent drug targets has been discussed in general terms. Amongst all these enzymes, 
iPGAM may well be regarded as one of the key players in controlling glycolytic flux, as 
shown by the metabolic-associated mathematical model (Albert et al. 2005; Achcar et 
al. 2012). It is interesting to observe that iPGAM from T. brucei exhibits the lowest 
activity in vivo compared to the other enzymes, for example ENO (598 nmol. min-1.mg-
1) and PYK (1020 nmol. min-1.mg-1) when measured experimentally (Albert et al. 2005), 
and this has also been shown in unpublished data obtained from the Brussels research 
group (Table 1.3). The low specific activity was also observed in this study, as 
discussed in chapter 5. The possibility of iPGAM as an important modulator for 
glycolytic flux makes it an exceptionally important drug target, and the characterisation 
of the enzyme, both from the structural and biochemical aspects is thus vital. 
Table 1.3 The specific activities of trypanosomatid iPGAMs in the cytosol at in 
vivo conditions.   
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ii) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase 
The 2,3-bisphosphoglycerate-dependent PGAM (dPGAM) is the corresponding 
evolutionarily-unrelated enzyme that can be found in humans and vertebrates, yeast, 
and several bacteria (Rigden et al. 2001; Chiba et al. 2012). Interestingly, some 
bacteria such as E. coli (Fraser et al. 1999), and archaea (Johnsen and Schönheit 
2007) contain both the cofactor-dependent and independent PGAMs in their active 
forms, although the former has been reported to be the more predominant enzyme 
(Johnsen and Schönheit 2007; Rigden et al. 2001). While iPGAMs have been 
reported to be monomeric enzymes, dPGAMs are oligomers of 25 kDa subunits 
(Fothergill-Gilmore and Watson 1989; Rigden et al. 2001). As a more well-
characterised enzyme, a significant number of crystal structures for dPGAM have 
been reported, for instance from yeast (Campbell et al. 1974; Crowhurst 1999) which 
was the first crystal structure reported for this enzyme, E. coli (Bond et al. 2001; 
Bond et al. 2002), Gram-positive pathogen Mycobacterium tuberculosis (Müller et 
al. 2005), human B type (Wang et al. 2005) and more recently from Burkholderia 
pseudomallei (Davies et al. 2011). The enzyme belongs to the dPGAM superfamily, 
together with acid phosphatases and fructose 2,6-bisphosphatases (Rigden et al. 
2001). One of the most prominent features of dPGAM is the reversible inhibition by 
vanadate in the micromolar range (Carreras et al. 1980; Bond et al. 2002; Johnsen 
and Schönheit 2007). All dPGAM sequences contain a conserved histidine in the 
active site, which becomes phosphorylated during catalysis (Fothergill-Gilmore and 
Watson 1989; Rigden 2008). The lack of evolutionary relationship between 
trypanosomatid iPGAMs and human dPGAMs further augments the potential for the 







1.4 The biologically relevant metal ions 
Metal ions are essential in many natural processes on earth, and play an important 
role in various biochemical processes in living cells. Most biochemical reactions 
such as cell signalling processes, enzyme catalysis and gene expression require metal 
ions for specific functions. Currently, there are at least 13 metals which are important 
for plants and animals (Bertini et al. 1994; Lippard and Berg 1994; Gomes and 
Wittung-Stafshede 2011). Out of this number, four of them: sodium (Na), potassium 
(K), magnesium (Mg) and calcium (Ca) are found to be abundant (Fenton 1995; 
Gomes and Wittung-Stafshede 2011), whereas the remaining nine are present in 
smaller quantities. These metals are known as trace metals, and consist of transition 
metal elements such as vanadium (V), chromium (Cr), molybdenum (Mo), 
manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu) and zinc (Zn). It is 
interesting that Fe2+ is the most widely-used trace metal, and for example reaches 4-5 
g in human bodies (Fenton 1995; Gomes and Wittung-Stafshede 2011). Although the 
trace metals are present in cells and essentially important for various biological 
systems (Haraguchi 2004), unnecessary accumulation, analytical difficulties, the 
possibilities of contaminations at trace levels and the tendency of competition of 
different elements for the same chemical sites may contribute to the difficulties in 
understanding the nature of metals in a particular biological environment (Fraústo da 
Silva and Williams 2001). This thus affects the metal content and characterisation of 
metalloproteins, which depends on species, location, metal ion availability and redox 
states (Maret 2010). Hence it is important to analyse metal preferences by also 
bearing in mind the biologically-significant concentrations that may present in the 
biological system of interest.     
i) The role of transition metal ions in biological systems 
Homeostatic regulation of the transition metal ions is systematically controlled in 
living cells. This is vital to ensure that sufficient amounts of metals are present to 
assist metabolic functions, while at the same time preventing toxicity in the context 
of available binding sites in metalloproteins (Maret 2010). In biological systems, the 
order of trace divalent metal ion concentrations (excluding the bulk metals: Mg2+ and 
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Ca2+) can generally be ordered as: Fe2+, Zn2+ > Cu2+ > Mn2+ > Co2+, Ni2+. Table 1.4 
tabulates the total metal concentrations measured in E. coli, humans, and the 
kinetoplastids T. cruzi and L. major. Each of the metals has distinct roles in explicit 
biological functions, and must be tightly buffered, in order not to interfere with the 
functions of other metal ions (Maret 2010).  
Mg2+ is essential in all types of cells in organisms, and is reported to be the 
most abundant divalent metal ion that has been measured within cells (Andersson et 
al. 1997). Mg2+ is required for enzymatic reactions and structural roles (Cowan 
1995), cell-signalling processes (Wu and Veillette 2011), nucleic acid biochemistry 
(Black and Cowan 1995) and also all reactions which require the hydrolysis of ATP. 
It is also found to be important in modulating cell proliferation, cell cycle 
progression and differentiation, and also is associated with the immune system (Tam 
et al. 2003). The wide functions of Mg2+ thus make it vital to be sufficiently available 
in all types of cells in animals, where the concentrations are found to be maintained 
at relatively different levels (Valberg et al. 1965; Iyengar et al. 1978).  
Ca2+ plays an exceptionally important role in various biochemical processes, 
and has been well characterised, revealing its multiple functions in biological 
systems. For instance, it is important in controlling metabolic pathways, involved in 
common signalling mechanisms by binding to proteins such as calmodulin, apart 
from contributing to the mechanical stability of membranes, cell division and 
hormonal activities (Fraústo da Silva and Williams 1991; Lin et al. 2009). Zn2+ on 
the other hand, is involved in various catalytic and structural functions for enzymes, 
and plays a role in DNA regulatory functions in eukaryotic cells (Fraústo da Silva 
and Williams 1991). It is reported that Zn2+ can be found in almost 300 enzymes, 
which makes it significantly abundant in living cells, and widespread in nature (Lin 
et al. 2009). 
Fe2+ is involved in various biological roles, for example in transportation of 
oxygen in haemoglobin, playing a role in electron-transfer and redox chemistry, or 
utilisation of hydrogen peroxide catalysed by the enzyme peroxidase (Fraústo da 
Silva and Williams 2001). Meanwhile, the role of Mn2+ has been elucidated mostly 
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by its wide functions as a cofactor in enzymatic reactions. One of the well known 
enzymes containing Mn2+ is superoxide dismutase (SOD) of prokaryotes and of the 
organelles of eukaryotes (Fraústo da Silva and Williams 2001). Earlier in this 
chapter, the role of Mn2+ as the cofactor for iPGAM has been discussed where it is 
vital for the enzyme’s catalytic function (Jedrzejas et al. 2000a; Jedrzejas et al. 
2000b). Cu2+ is best known for its involvement in electron transfer, as well as for 
assisting enzymatic functions such as transportation of oxygen, removal of 
hormones, or reduction of oxygen to hydrogen peroxides (Fraústo da Silva and 
Williams 2001).  
Co2+ and Ni2+ are two of the transition metals that are found to be the least 
abundant in eukaryotic cells (Maret 2010). The functions of these two elements may 
represent a relic of early life before the advent of dioxygen (Fuad et al. 2011). The 
role of Ni2+ is very limited in higher organism, and is particularly well-known in 
urease. However, in free anaerobic bacteria such as methanogens, Ni2+ is important 
for the functions of some enzymes, for example Ni2+ dehydrogenases (Fraústo da 
Silva and Williams 2001). Meanwhile, Co2+ is important for the functions of vitamin 
B12 or cobalamin, which is necessary for various biological purposes, such as DNA 
synthesis, formation of red blood cells and maintenance of the nervous system 
(Karmi et al. 2011). Co2+ also plays a role as a component of the cofactor corrin 
(Harding et al. 2010). Nevertheless, Co2+ and Ni2+ are relatively rare in nature and 
may well be considered to be eliminated from biology, as neither seems to possess 
special chemistry in acid/base catalysis (Fraústo da Silva and Williams 2001), 
although they have recently been recognized to be essential in some living systems 
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ii) Metalloenzymes and the biochemistry of metals in protein structures 
It has been reported that more than 30% of proteins in living cells utilise metals to 
perform their biological functions (Gray et al. 2003; Gomes and Wittung-Stafshede 
2011), and 40% of all enzymes possess metals, either for structural or catalytic 
reasons (Bertini et al. 1994; Lippard and Berg 1994; Harding et al. 2010; Gomes and 
Wittung-Stafshede  2011). Most metalloenzymes have one or two metal binding sites 
that usually exist in the catalytic domains. The choice of metals which the protein 
prefers is predicted to depend upon the concentrations of the elements in the cells 
(Maret 2010), as well as the geometrical topology of the catalytic site that determines 
the interactions between the corresponding metal ions and the coordinating ligands 
(Harding et al. 2010). In proteins, atoms which usually interact with metal ions are 
imidazole nitrogen from histidine, sulphur from cysteine, carboxylate oxygen from 
aspartic and glutamic acids, and oxygen of threonine or serine, and also the main 
chain carbonyl oxygen from any amino acid residues. Different metal ions may have 
different ranges of Kd when it comes to binding affinity towards the ligands, which 
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may vary in orders of magnitude (Harding et al. 2010). The Irving-Williams series 
(Irving and Williams 1953) lists the interactions of metal ions and ligands in the 
following order of affinity: Mn2+ < Fe2+ < Co2+ < Ni2+ < Cu2+ < Zn2+, where Mn2+ 
and Fe2+ were reported to bind rather weakly, while Zn2+ and Cu2+ bind more 
strongly (Maret 2010). Nevertheless, the affinity of the metals for proteins are 
considered to be high if the metals are required to be bound for specific functions 
(Maret 2010), which depend upon i) careful considerations on protein preferences 
and geometrical coordination of the metal atoms to the interacting protein and ii) the 
availability of the metals at a biologically relevant concentration.  
Advances in protein crystallography have allowed detailed structural 
information to be revealed, but often the identification of specific metals in a 
structure requires knowledge of the preferred geometrical coordination. The ‘first 
coordination sphere’ refers to the group of atoms within chemical bonding distance 
of the metals (Harding et al. 2010). This determines the coordination number and the 
geometry that are preferred and commonly found for specific coordination groups, as 
tabulated in Table 1.5. However, substantial distortions from the idealised structures 
may occur too in metalloproteins (Bertini et al. 1994; Gomes and Wittung-Stafshede 
2011). In some cases, there may well be more than one possibility when trying to 
identify a particular metal based on coordination with the neighbouring atoms. For 
example, Mg2+ and Co2+ both possess the coordination number 6, with octahedral as 
the ideal geometry. Interactions between the metals and the neighbouring atoms from 
the nearby residues may also depend on the possible metal-donor atom distances. In 
addition, the preference may well be associated with the ionic radii of the metals, in 
which specific metals may appropriately fit into a particular binding site. Once these 
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iii) Metals affecting protein folding and conformation  
Crystallography is obviously an excellent method to obtain protein structural 
information. Over the years, numerous high-resolution metalloprotein structures have 
been solved, allowing better understanding of the occurring interactions at the 
macromolecular level. However, little is known about the biosynthesis of these 
proteins (Wittung-Stafshede 2002), or how living cells may be populated with 
proteins with weakly-bound metals, and at the same time, allow the existence of 
proteins that have tightly-bound metals (Gomes and Wittung-Stafshede 2011). Two 
main ideas have been proposed as explanations: i) the compartment (with its metal 
composition) where the protein folds may control the metal-binding preference and 
metal content (Tottey et al. 2008), and ii) metal insertion into proteins is controlled 
by specific or non-specific protein-chaperones or protein-based delivery systems 
(Gomes and Wittung-Stafshede 2011). Figure 1.7 illustrates the biosynthesis of 






Figure 1.7  The illustration of metalloprotein biosynthesis and possible connections 
to metal binding. Metals could be inserted into the proteins at different 
stages of the protein biogenesis process. Metals insertion could occur 
either i) after the polypeptide has released from the ribosome, but before 
it is completely folded or, ii) after the polypeptide has folded into its 
conformation. The figure was adapted from Gomes and Wittung-
Stafshede 2011.  
 
It has been postulated that metals also play roles during protein folding and 
act as modulators for protein conformational changes. At in vitro conditions, it has 
been observed that metals are incorporated and bind into proteins after polypeptide 
unfolding (Robinson et al. 1997; Gomes and Wittung-Stafshede 2011), which thus 
suggested that in vivo, the metals may interact with proteins before the polypeptide 
folds. This may affect the folding reaction, in which protein misfolding may occur, 
due to specific coordination of the metal cofactor (Pozdnyakova et al. 2000). On the 
other hand, metals also play a role in structure stabilisation, and thus are essential for 
the protein’s integrity, as observed in the Zn2+-coordination in zinc-finger motifs 
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(Petsko and Ringe 2004). In some cases, metal-binding may also trigger aggregation 
to oligomerisation-prone proteins, which may cause oligomeric intermediates, non-
native protein conformations and destabilisation of the molecules. This has been 
shown in some cases, for example, Cu2+ and Zn2+ ions have been observed to induce 
aggregation of the amylogenic peptide β-microglobulin (Villanueva et al. 2004; 
Blaho and Miranker 2009; Gomes and Wittung-Stafshede 2011). This phenomenon 
is prone to happen if the metals are present in large amounts or are freely available in 
biological fluids, under a non-physiological condition (Gomes and Wittung-
Stafshede 2011). 
Protein conformations may change too, due to binding of metal ions to a 
folded polypeptide. This affects the conformations of the proteins by creating cross-
links between a specific set of residues in the protein structure, resulting in 
stabilisation and maintenance of a specific structure (Gomes and Wittung-Stafshede 
2011). For example, human plasminogen activator inhibitor type 1 (PAI-1) was 
found to be stabilised by Ca2+, Mg2+ and Mn2+, but on the other hand, exhibited 
destabilisation in the presence of Co2+, Cu2+ and Ni2+ (Thompson et al. 2011). 
Moreover, the stabilisation and destabilisation effects have been shown in S100A2 
protein, a regulator of the cell-cycle, which was activated and stabilised by Ca2+, and 
shown to be in the opposite condition by Zn2+ binding (Botelho et al. 2009). 
Conformational changes were also observed in CheY cytoplasmic protein, where the 
binding of divalent metal ions: Mg2+, Ca2+, Sr, Zn2+ and Mn2+ resulted in metal-free 
and metal-bound conformational changes (Kar et al. 1992). In another case, Zn2+ was 
shown to affect the conformational and oligomerisation pattern of the p53 tumor 
suppressor proteins (Coffer and Knowles 1994). Effects of different metal ions on the 
3-dimensional structure of human carbonic anhydrase have also been reported in an 
earlier literature (Coleman 1965). These observations thus show the importance of 
metals in maintaining protein native structures for biological functions.      
ii) Non-native metals affecting enzymatic activities  
Almost one quarter of proteins require metal ions to maintain their structure and 
function (Harding et al. 2010), but many of the observations on the biologically 
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relevant metals that regulate enzyme activity have remained unclear. Metal content 
normally depends on the species, environment, metal availability and redox state, 
and these may affect the allocation of the correct metals in the protein structure. In 
some cases, the native metals that function in vivo may be substituted by non-native 
ones in vitro. This may also occur in organisms with few selectivity filters, which 
allows more diverse metal ions to enter the cell and bind to the binding sites, or when 
the native metals dissociate from the metal-protein complexes and are replaced by 
others (Maret 2010). Often too, metal-binding may be masked by metals that possess 
tighter binding affinity, and thus cause changes in the catalytic reactions (Maret 
2010). Hence, the study of metalloproteins and enzymatic regulation by metal ions 
have always been a challenging task to researchers, in which sometimes there are no 
definite answers to the questions that were being raised, such as the proteins 
biologically relevant or native metal requirement .  
Over the years, numerous studies have shown that there can be misleading 
information on the metal ions that are found in metalloproteins. In some cases, non-
native metals can be incorporated into proteins during expression in the culture 
medium or in the purification procedure. The insertion of the artificial metals may 
substantially hyper activate or decrease the protein’s activity, if the metals are 
present in the buffers and solutions. This phenomenon has been demonstrated in 
some cases, for example, the incorporation of Co2+ instead of Zn2+ into yeast alcohol 
dehydrogenase when the cells were grown in Co2+ (II) enriched medium (Curdel and 
Iwatsubo 1968). Metal substitution in vitro can cause hyper activation with the non-
native metals, for example Co2+, Cu2+ and Ni2+ insertion instead of Zn2+ in amino 
peptidase enhanced the activity of the enzyme by up to 10-fold (Prescott et al. 1985). 
By contrast, the substitution of Zn2+ by Co2+ in carbonic anhydrase in marine diatoms 
was reported to cause the enzyme to be less active than the native Zn2+ form (Yee 
and Morel 1996; Lane and Morel 2000), and is an example of in vivo metal 
substitution. 
The correct assignment of metals in proteins that possess two metal sites is 
also of particular interest. Some proteins function with a one-metal mechanism for 
catalysis, but the presence of metals in the second site may affect the enzyme 
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function (Tainer et al. 1982; Holz et al. 2003). More explicitly, the regulation of 
enzymatic activity may vary, either by inhibitory or activating effects by the second 
metal, and may also determine substrate specificity (Sugiura and Noguchi 2009; 
Maret 2010). This has been shown in some cases, for example in carboxypeptidase 
A, where Zn2+ in the second metal site inhibits the enzyme as confirmed when the 
structure of the zinc-inhibited enzyme was solved (Gomez-Ortiz et al. 1997; 
Bukrinsky et al. 1998; Maret 2010). Another interesting example occurred when in 
vitro metal substitution provides illusory information about the metal requirement of 
an enzyme, such as in human phosphodiesterases. In this case, the enzyme appeared 
to be regulated by Mg2+ and Zn2+ with the latter metal exhibiting an inhibitory effect, 
but the interpretation was not correct because the former metal had been replaced by 
Mn2+ in vitro (Cowan 1997). These observations sound a note of caution in assigning 
the correct metals in proteins, or in distinguishing between two or one-metal 
mechanisms during catalysis (Maret 2010).     
1.5 Overall aims of the project 
This study concerns the molecular and structural properties of the enzyme 
phosphoglycerate mutase from L. mexicana and T. brucei, with the aim of obtaining 
substantial biochemical information in relation to drug design and discovery. For the 
purpose of obtaining structural and biochemical information that complement the 
previous LmiPGAM closed-form structure, this enzyme has been the main focus in 
this project. The aspects of this study mainly cover: 
1. Elucidation of the biologically relevant metal requirements of the 
trypanosomatid iPGAM under physiological conditions.  
2. Biophysical characterisation with the aim of obtaining information on 
directing the LmiPGAM towards the open-form conformation, which is the 
conformation desired for the purpose of drug design. 
3. Drug design and inhibition studies to acquire knowledge for potential novel 
inhibitors, which ideally possess particular chemical properties that may 
resemble the substrate 3PGA or product 2PGA.     
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The chapters in this thesis cover various aspects to achieve these aims, as listed 
below: 
1. Chapter 2 discusses the materials and methods that have been employed 
in this study. 
2. Chapter 3 mainly revolves around the molecular biology, expression and 
new purification approaches for both LmiPGAM and TbiPGAM. 
3. Chapter 4 covers various biophysical techniques in relation to 
distinguishing the different conformational and oligomeric states of 
trypanosomatid iPGAM in solution. 
4. Chapter 5 elucidates the significance of metal content in vitro and in vivo 
in determining the biologically relevant metals for the trypanosomatid 
iPGAMs. 
5. Chapter 6 focuses on the development of the multimode-plate reader 
discontinuous assay in providing biochemical information on the 
enzyme’s metal requirements. 
6. Chapter 7 covers the approaches utilised to find novel inhibitors for the 
trypanosomatid iPGAMs.  
7. Chapter 8 concludes the main findings, discusses significant contributions 











Chapter 2:  
Experimental 
2.1 Experimental for Chapter 3 
The pET28a plasmids encoding His-tagged LmiPGAM and TbiPGAM were obtained 
from Prof. Paul Michels, and all the steps outlined below are the same for both, 
unless otherwise stated.  
 
2.1.1 Basic molecular cloning 
 
The purpose of molecular cloning is to obtain the un-tagged version of the enzymes, 
hence all the steps outlined below is specifically designed for the un-tagged 
LmiPGAM and TbiPGAM.   
   
i) Plasmid DNA isolation 
  
A single colony from a freshly streaked selective plate containing pET28a plasmids 
with LmiPGAM or TbiPGAM genes was inoculated into 1-5 ml LB medium 
containing 50 µg/ml kanamycin (Melford Labs). The culture was incubated for 12-16 
h at 37ºC with vigorous shaking before being harvested by centrifugation at 13,000 
rpm in a table-top micro centrifuge for 3 min at room temperature. The plasmid DNA 
isolation was carried out using QIAGEN Plasmid Mini Kit (Qiagen). 
 
ii) Digestion with restriction enzymes 
 
Digestion with restriction enzymes was carried out in a 20 µl reaction mixture 
containing 1 µl 1X buffer (50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl2, 1 mM 
dithiothreitol), 3 µl plasmid DNA, 0.5 µl 100 mg/ml BSA, 1 µl 20,000 units/ml 
restriction enzymes and 14 µl water. The restriction enzymes that were utilised in 
this study were NcoI and XhoI for the construction of the un-tagged LmiPGAM, and 
NdeI and BamHI for the construction of the un-tagged TbiPGAM. The mixture was 
incubated at 37ºC for 2-4 h. A subsequent incubation was performed at 65ºC for 20 
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min to inactivate residual restriction enzymes that were left in the mixture. Agarose 
gel electrophoresis was carried out using 0.8% (w/v) agarose gel prior to ethidium 
bromide staining. The resulting digested plasmids were then analysed under the UV 
light. 
 
iii) Gel extraction 
The DNA fragments were excised from the agarose gel with a clean and sharp 
scalpel. The subsequent procedure was performed using QIAquick® Gel Extraction 
Kit (Qiagen).   
iv) Ligation of DNA fragments  
Ligation was carried out following gel extraction for both the vector and insert. For 
TbiPGAM, the cloning process was carried out using Rapid DNA Ligation Kit 
(Roche). Table 2.1 tabulates the composition of the ligation mixture for the 
construction of the un-tagged TbiPGAM constructs. The ligation mixture was 
incubated at 15ºC-25ºC for 5 min before being used for transformation. 
Table 2.1   The composition of the ligation reaction, which consists of vector, 
insert, and the T4 DNA ligase enzyme.   
Component Volume (µl) 
Vector  (pET30a) (dilution in 5X dilution buffer *)            
Insert (dilution in 5X dilution buffer *)                               
2X Ligation buffer **                                                           
U/µl T4 DNA ligase enzyme       






*    DNA Dilution Buffer, 5x concentrated (Rapid DNA Ligation Kit (Roche))        





Meanwhile, LmiPGAM underwent a PCR cloning step prior to 
transformation, in order to clone the gene into the final vector. For this purpose, the 
CloneJET™ PCR Cloning Kit (Fermentas) was utilised to clone the amplified 
LmiPGAM gene fragment into pJET 1.2/blunt cloning vector, which played a role as 
the intermediate vector. Two major steps were involved in the cloning process: i) the 
blunting reaction (Table 2.2) and ii) the ligation reaction (Table 2.3). The ligation 
mixture was incubated at room temperature for 5 min and was used directly for 
bacterial transformation.The LmiPGAM gene was subsequently cloned into pET28a, 
as discussed in chapter 3.   
Table 2.2  The composition of the blunting reaction of the PCR product 
(LmiPGAM gene) before insertion into pJET 1.2/blunt vector.    
Component Volume (µl) 
2X reaction buffer                                                     
PCR product                                                              
Nuclease-free water                                                   








Table 2.3 The composition of the ligation reaction for the blunt PCR product 
(LmiPGAM gene), for insertion into pJET 1.2/blunt vector.      
Component Volume (µl) 
Blunting reaction mixture                                         
50ng/µl pJET 1.2/blunt cloning vector                     
5 U/µl T4 DNA ligase     










v) Primers for PCR  
 
In the process of constructing the un-tagged versions of both LmiPGAM and 
TbiPGAM, a set of primers for gene amplification was designed. PCR amplification 
for LmiPGAM was essential for cloning, but for TbiPGAM the PCR was used 
analytically. Both the forward and reverse primers (Table 2.4) were constructed 
based on LmiPGAM and TbiPGAM gene sequences and have been designed by the 
program Primer3.  
 
Table 2.4   The set of primers which were used to amplify LmiPGAM and TbiPGAM   
genes.  














vi)  Transformation 
Competent cells were prepared using the rubidium chloride method (Promega). 
Transformation was carried out with the addition of 20 ng of recombinant plasmid 
into a vial of competent E. coli cells strain dH5α (for cloning) or various cell lines 
(for protein expression, see next section). The mixture was subsequently incubated 
on ice for 5 min before been heat-shocked for 45 s at 42ºC in the heating block. The 
tubes were immediately transferred onto ice just before the addition of 250 µl of 
SOC medium before being incubated at 37ºC with slow agitation for approximately 1 
h. The cells were finally spread onto pre-warmed selective LB plates containing 50  
µg/ml kanamycin and incubated overnight at 37ºC. As a negative control where 
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possibilities of contaminants could be observed, an aliquot of cells was included 
through the whole transformation process in the absence of added plasmids. 
2.1.2 Initial culture and protein expression 
A single colony from an overnight-grown LB plate was inoculated into 50 ml LB 
broth containing 50µg/ml kanamycin. The inoculated culture was left overnight in 
the incubator shaker at 250 rpm. Following the overnight incubation, 1/50 from the 
overnight culture was re-inoculated into fresh LB medium containing 50µg/ml 
kanamycin and left to shake again at 250 rpm. Once the OD600 reached 0.5-0.7, the 
expression was induced by adding a final concentration of 1 mM of IPTG (Melford 
Labs). The expression system for LmiPGAM has already been established in the 
Edinburgh Structural Biochemistry Group, and this study has utilised the same 
conditions as follows: BL21 (DE3) used as the cells line, with incubation at 17°C for 
20 h (Poonperm 2005).  
Meanwhile, TbiPGAM expression trials were carried out with four different 
cell lines. Table 2.5 indicates the cell lines used in the expression trials and the 
antibiotics required for each cell line. A volume of 1-2 µl (30-40 ng/µl) of His-
tagged and un-tagged TbiPGAM plasmids were transformed into the cell lines, and 
the colonies from the plates were inoculated overnight in 50 ml Falcon tubes 
containing a volume of 5 ml LB or 2XYT medium before being left to shake at 37°C 
at 170 rpm. Final concentrations of 1 mM IPTG were added once the OD600 reached 
up to 0.5 to 0.7. The cultures were subsequently left at three different temperatures: 
37°C, 30°C and 18°C. Samples in the absence of IPTG were included as negative 
control.  
Protein expression analysis was carried out by taking a 1 ml samples which 
had been cultured at the different temperatures. At 37°C, an aliquot of the culture 
was taken every hour until 6 h.  For both 18°C and 30°C, the same procedure was 
conducted, but only for every 3 h, 6 h, 14 h and 23 h. The cultures were centrifuged 
at 13,000 rpm for 10 min in order to analyse the levels of expression. At this stage, 
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PBS buffer was added to resuspend the cells prior to cell lysis. Both enzymatic and 
mechanical (sonication) approaches were carried out in the cell lysis procedure.   
Table 2.5 The cell lines and antibiotics used in TbiPGAM expression trials. 
Cell lines Antibiotics 
BL21 (DE3) Kanamycin 
Rosetta 2 (DE3) pLysS Kanamycin, Chloramphenicol (Duchefa 
Biochemie) 
BL21 (DE3) Gold Kanamycin, Tetracyclin (Melford Labs) 
BL21 (DE3) CodonPlus Kanamycin, Tetracyclin, Chloramphenicol 
 
In the enzymatic method, a final concentration of 4 mM MgCl2 was added 
into the lysate, followed by 1 mg/ml lysozyme (Fluka Biochemica). 0.1 mg/ml 
DNase1 from bovine pancreas (Sigma-Aldrich) was subsequently added before the 
tubes were inverted gently and left in the rotator at room temperature (approximately 
20°C) for 2 h. The samples were sonicated twice, with 10 s bursts and 20 s rest. The 
lysate was centrifuged for 10 min, 4 °C at 13, 000 rpm to separate the soluble and 
insoluble fractions. The supernatant and pellet, corresponding to the soluble and 
insoluble proteins were analysed by 12% SDS-PAGE (see section 2.1.4 ii). 
2.1.3 Protein purification 
i) Cell lysis 
The cell pellet from a litre of culture was resuspended with Buffer A (50 mM 
NaH2PO4 (AnalaR Normapur®), 300 mM NaCl (Fisher Scientific) pH 8.0) in the 
presence of two tablets EDTA free protease inhibitors (Roche), until it reached a 
final volume of 25 ml per 5 g of cell pellet. After the pellet was fully dissolved in the 
buffer, the cells were lysed in a Constant System TS Cell Disruptor set to a 
maximum pressure of 25 000 psi. The lysate was subsequently centrifuged at 4°C, 
23,000 rpm for 45 min, using a JA 25.50 rotor. The supernatant was filtered through 
a 0.22 µm filter before being loaded onto a 5 ml IMAC Fast FlowTM (GE Healthcare 
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Life Sciences) column that had been pre-charged with 0.1 M Ni2+ (GE Healthcare 
Life Sciences) on an ÅKTAPurifierTM  instrument (GE Healthcare Life Sciences), 
which was controlled by UnicornTM version 5.1.1 software. All purification steps 
were performed using the same liquid chromatography instrument with the 
temperature maintained at 10°C. It is noteworthy that only the His-tagged enzymes 
were purified in this study, and hence discussed in the following sections.  
ii) First step: Immobilised metal affinity chromatography 
As the first step of purification, Immobilised Metal Affinity Chromatography 
(IMAC) was performed by exploiting the N- and C-terminal His-tags that are present 
in TbiPGAM and LmiPGAM, respectively. This step is a classical primary 
chromatography method, and performed on the basis of manipulating the affinity of 
His-tags towards divalent metal ions which are immobilised in the column. Prior to 
the purification step, the un-charged column was washed with three column volumes 
(CV) of water before being charged with 5 CV of 0.1 M NiSO4 (Sigma Life 
Sciences). Subsequently, the column was thoroughly washed with 3 CV of water, 
before the equilibration step. If multiple runs have been carried out using the column, 
thorough cleaning must be carried out by stripping the metals with EDTA-containing 
buffer (0.1 M EDTA (Fisher Scientific), 0.5 M NaCl and 20 mM Tris-HCl 
(Invitrogen) pH 7.9) for 5 CV, followed by subsequent cleaning with water and 
buffer for 10 CV each. The column would then be recharged with the chosen metal 
ions for 5 CV. It is also important to prepare the column for sample application by 
equilibrating it with buffer A (see below) for 5 CV. All steps were performed by 
maintaining the flow-rate at 3 ml/min during the whole run. Following sample 
injection, the non-binding molecules were washed with buffer A for 20 CV (50 mM 
NaH2PO4 buffer pH8, 300 mM NaCl and 20 mM imidazole (Fisher Scientific) and 
recognised as the flow-through, followed by a long wash for 20 CV with 5% buffer 
B to wash out non-specifically binding molecules. LmiPGAM was then eluted in a 
step-wise fashion, by increasing the imidazole concentration with buffer B to 500 
mM. The corresponding peak fractions from the elution profile (see chapter 3) were 
pooled before being applied to the desalting column.  
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iii) Second step: Desalting 
In order to remove unwanted smaller molecules, such as imidazole and excessive salt 
in the protein samples, a desalting step was employed using a 53 ml HiPrep 26/10 
desalting column (GE Healthcare Life Sciences). This approach is a convenient 
method in a typical buffer-exchange procedure, which is also an alternative to the 
dialysis method. Prior to sample application, the column was equilibrated with 
desalting buffer containing 20 mM HEPES (Sigma Life Sciences) pH 7.6, for 2 CV. 
The flow-rate was 3 ml/min through the whole run. Sample application was 
performed by applying 8 ml samples on to the column. The eluted fractions were 
subsequently measured for protein concentration before being applied onto the 
anion-exchange column. 
iv) Third step: Ion-exchange chromatography 
Charge distribution differences on the surface of protein molecules enable proteins to 
be separated using ion-exchange chromatography. In this experiment, a 1 ml MonoQ 
5/50 GL (GE Healthcare Life Sciences) anion-exchange column was utilised. In this 
particular step, the interaction between the negatively-charged residues on the 
surface of the proteins and the positively-charged resin resulted in the binding of the 
protein of interest. The high maximum back pressure for the column would only 
allow a low flow-rate to be employed during running, which was maintained at 0.5 
ml/min. Prior to sample application, the column was equilibrated with 5 CV of 
washing buffer (buffer A) containing 20 mM HEPES pH 7.6. The maximum capacity 
of proteins that could be loaded is 50 mg for each run. Following sample application, 
the washing step took place by using buffer A for 2 CV before the elution step with 
buffer B (20 mM HEPES, 1 M NaCl pH 7.6) took place in a linear gradient for 80 
CV. The resulting separated peaks eluted at this stage were pooled separately and 
buffer-exchanged using a desalting or PD10 column into a storage buffer containing 





2.1.4 Protein determination 
i) Protein concentration and UV absorbance at A280 
Pure proteins were concentrated by using a Vivaspin concentrator with a 10 000 
molecular weight (MW) cut off by centrifugation at 13, 000 rpm at 4°C, to achieve 
the highest concentration of proteins. Subsequently, the concentrations of purified 
LmiPGAM were determined by UV absorbance at A280 nm using a Jasco V-550 UV-
VIS spectrophotometer determined by the standard Beer-Lambert law, with the 
known extinction coefficient (42 080 M-1 cm-1) and molecular mass (61788.5 Da), 
which had been calculated by the Expasy ProtParam software 
(http://web.expasy.org/cgi-bin/protparam/protparam). The calculation of the protein 
extinction coefficient by the Expasy ProtParam software was performed based on the 
amino acid sequences following the protocol from Gill and von Hippel 1989. The 
protein was stored in the cold room (4°C) for further biochemical and biophysical 
assays or at -20°C with the presence of 10% glycerol. 
ii) SDS-PAGE analysis 
A standard procedure for examining the purity of the proteins was performed using 
SDS-PAGE analysis. This technique allows proteins to migrate through 
polyacrylamide gel pores after reaction with SDS. For iPGAM, 12% SDS-PAGE was 
chosen as the optimal gel percentage to observe significant separation of the protein 
bands. The following chemical components were used to prepare the 12% SDS 
PAGE gel; 30% acrylamide (Severn Biotech Ltd), 10% sodium dodecyl sulphate 
(SDS) (Sigma Life Sciences), 10% ammonium persulphate (APS) (Sigma Life 
Sciences) and TEMED (Sigma Life Sciences). Both the resolving and stacking 
buffers contained Tris-base (Invitrogen) with pH adjusted to 6.8 and 8.8, 
respectively, while the running buffer contained 250 mM Tris, 2 M glycine (Sigma 
Life Sciences) and 10% SDS pH 8.3. Samples were prepared by mixing 5 µl 2-4 µg 
proteins with 5 µl of 2X loading buffer (Tris-base buffer pH 6.8, 10% SDS, 10% 
glycerol (BDH Prolabo) and bromophenol blue (Sigma Life Sciences) with the 
addition of 1mM of freshly prepared DTT (Melford Labs). The mixture was then 
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heated at 100°C for 5 min before being loaded into the wells. The electrophoresis 
took place at room temperature at 200V for 1 h and 5 min.  
2.2 Experimental for Chapter 4 
2.2.1 Computational programs 
PyMOL, MODELLER, HYDROPRO and STP 
The program PyMOL (DeLano 2002) was used to generate protein structure 
diagrams. The open-form model of LmiPGAM was produced using MODELLER 
from Friend (Abyzov et al. 2005), by utilising the open-form BaiPGAM as the 
available model structure. The predicted hydrodynamic radii of the protein molecules 
were obtained from the program HYDROPRO (Garcia de la Torre et al. 2000; 
Ortega and Garcia de la Torre 2007; Ortega et al. 2011) by utilising the molecular 
masses of LmiPGAM, TbiPGAM and BaiPGAM separately and the specific volume 
of water (0.974 cm3/g). The rest of the parameters were set up as default values. The 
program Surface Triplet Propensities (STP) (Mehio et al. 2010) was used to predict 
the most likely areas on the protein surface that may interact with another protein 
molecule for them to form a dimer. The analysis was performed by uploading the 
ligand-free LmiPGAM PDB file into the program, which automatically coloured the 
the most or least likely areas on the protein surface that may interact with another 
macromolecule. The program can be accessed through the CTCB website with the 
link: http://opus.bch.ed.ac.uk/stp/.     
2.2.2 Continuous coupling enzyme assay 
iPGAM activity was assayed by monitoring the conversion of 3PGA to 2PGA, 
coupled with the oxidation of NADH to NAD+ by LDH via ENO and PYK. Assays 
done during the purification of LmiPGAM used 10 µl samples containing 0.2 mg/ml 
iPGAM which were added into a cuvette to give a final reaction mixture of 1000 µl 
containing 100 mM TEA-HCl buffer pH 7.6, 1.5 mM 3PGA (Sigma-Aldrich), 5 mM 
MgCl2 (Fisher Scientific), 50 mM KCl (Fisher Scientific), 0.2 mM NADH (Roche), 
1 mM ADP (Sigma-Aldrich), 2 units of ENO from bakers yeast (Sigma-Aldrich), 4 
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units of PYK from rabbit muscle (Sigma-Aldrich) and 6 units of LDH from rabbit 
muscle (Fluka Analytical). Controls were carried out with the addition of 2PGA into 
the reaction mixture, in the absence of LmiPGAM and 3PGA. The decrease in A340 
nm was monitored using a Jasco V-550 UV-VIS spectrophotometer and was used to 
obtain the rate of reaction for specific activity measurements (one unit corresponds to 
the conversion of 1 µmol of substrate min-1 mg-1 protein under standard conditions) 
(Fuad et al. 2011).  
2.2.3 Gel filtration 
Gel filtration is a conventional macromolecular separation technique that is 
performed on the basis of protein molecular masses and 3-dimensional shapes. In this 
study, analytical gel filtration was employed to characterise the distinct peaks eluted 
from the ion-exchange column. 5-10 mg of concentrated LmiPGAM in 200 µl were 
applied onto a 24 ml Superdex 200 10/300 GL (GE Healthcare Life Sciences) 
column, which had been equilibrated for 2 CV with 20 mM TEA-HCl pH 7.6 and 50 
mM NaCl. The column has the ability to separate molecules in a range of 10 kDa to 
600 000 kDa, thus iPGAM which is ~60 kDa in size is a suitable candidate. The 
flow-rate was maintained at 0.5 ml/min, thus resulting in a total run time of ~50 min. 
The estimated molecular weights of the eluted fractions were based on the previous 
calibration of the column by a range of protein standards with varying molecular 
weights (see Appendix I (c)).     
2.2.4 Dynamic Light Scattering (DLS) 
In this study, DLS experiments were employed by analysing 50 µl of 1 mg/ml 
iPGAM that had been centrifuged for 10 min at 13, 000 rpm, and filtered through a 
0.2µm filter. The samples were analysed using a 384 well plate, and the temperature 
for the analysis was set to be 10°C. The buffer containing 20 mM TEA pH 7.6 and 
50 mM NaCl has to be freshly prepared. This analysis was performed using a 
Malvern instrument and analysed using the Malvern Zetasizer® software version 
6.20. The data were expressed as the mode values of hydrodynamic diameter of the 




Native-PAGE analysis allows proteins to be separated based on the proteins shapes 
and conformational states, as well as the charge distribution on the surface of the 
macromolecules. In this experiment, 9% polyacrylamide gel was prepared using the 
chemicals described previously in section 2.1.4 ii, but in the absence of SDS. The 
running buffer contains 250 mM Tris and 2 M glycine pH 8.3, which allows the 
forward movement of iPGAM with a lower pI of 5.62. Samples were prepared by 
mixing 5 µl of 5-10 µg proteins with 5 µl of 2X loading buffer (see section 2.1.4 ii, 
without the presence of SDS and bromophenol blue) with the addition of 1mM of 
freshly prepared DTT. The electrophoresis took place in the cold room at 4°C, and 
set up to be running at 100V for 2 h and 10 min.  
2.2.6 Size-exclusion chromatography coupled with Multi-Angle Light 
Scattering (SEC-MALS)  
SEC-MALS analysis was performed to characterise iPGAM on the basis of its 
absolute molecular mass. This technique offers an advantage by combining 
macromolecular separation by size-exclusion chromatography, with the absolute 
molecular mass values from the MALS detector. Two other detectors are also 
important to quantify the concentration of the macromolecules, which are the 
Refractive Index detector (RI) and the UV detector. In this experiment, 40 µg of 
iPGAM was applied onto Superdex 200 10/300 GL column following the 
experimental conditions that had been established for the previous gel filtration 
analysis (see section 2.2.3). The EttanTM LC (GE Healthcare) instrument was 
connected to a DAWN HELIOS II™ multiangle light scattering (MALS) instrument 
with 18 detectors and an Optilab® T-rEX refractometer (Wyatt Technology Corp., 
Santa Barbara, CA), which was controlled by the ASTRA light scattering software 
version 5.3.4 (Wyatt Technology Corp., Santa Barbara, CA). The analysis was 
performed at room temperature, approximately at 21°C. The data processing 
followed an earlier method as described in Folta-Stogniew and Williams 1999. The 
results obtained were expressed as the absolute molecular mass of the protein 
molecules in solution. This analysis was performed by Dr. Martin Wear and Dr. 
Elizabeth Blackburn.   
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2.2.7 MALDI-TOF mass spectrometry and ICP-MS 
Mass spectrometry analysis, specifically MALDI-TOF is an important tool in 
characterising the masses of bio molecules, which are known to be easily fragmented 
with the traditional ionisation methods, as well as arbitrating the elemental 
composition in biological samples. Meanwhile, ICP-MS is also a type of mass 
spectrometry which is greatly sensitive, and possess the ability to determine the 
concentrations of metal ions at a range below one part per trillion. Both analyses are 
based on the ionisation of particles that are present in the sample, thus resulting in 
the generation of charged molecules. Molecules (or metals for ICP-MS) with 
different mass-to-charge ratios were then separated and measured by a mass 
spectrometer (Sparkman 2000). In the case of ICP-MS, the signal was proportional to 
the concentrations of the metals. The experimental protocols for both analyses are 
described below. 
i) MALDI-TOF mass spectrometry 
The MALDI-TOF analysis was performed by mixing a 0.5 µl aliquot of 1 mg/ml 
iPGAM with 0.5 µl sinapinic acid matrix, before loading onto a Voyager DE-STR 
MALDI-TOF gold target plate. The plate containing the samples was placed in a 
Voyager DE-STR MALDI–TOF mass spectrometer (Applied Biosystems, 
Warrington, Cheshire, U.K.). The mass map for the proteins were subsequently 
analysed with the computer program Data ExplorerTM, following the 
recommendation from the supplier, with help from Dr. Andrew Cronshaw.  
ii) ICP-MS 
Purified protein samples (1.5-2 ml), which were all later normalised to 60 µg/ml 
were analysed using an Agilent 7500ce (with octopole reaction system) instrument, 
employing a radio frequency (RF) forward power of 1540 W and reflected power of 
1 W, with argon gas flows of 0.82 L/min and 0.2 L/min for carrier and makeup 
flows, respectively. Sample solutions were taken up into the Micro mist using a 
peristaltic pump at a rate of approximately 1.2 ml/min. Skimmer and sample cones 
were made of nickel. The instrument was operated in spectrum multi-tune acquisition 
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mode and five replicate runs per sample were employed. Each mass was analysed in 
fully quantitiative mode (three points per unit mass). The following masses were 
selected for analysis: 26Mg, 55Mn, 56Fe, 57Fe, 59Co, 60Ni, 63Cu, 65Cu, and 66Zn. Two 
tune steps were used to analyse the metals: ‘no gas’ mode then ‘helium mode’ for 
26Mg, 56Fe, 57Fe, 60Ni, 63Cu, 65Cu, and 66Zn to remove any polyatomic interferences. 
Calibration standards with a range of metal concentrations (0, 1, 10 and 100 
µg/L) were prepared by sequential dilution from single element 1000 mg/L stock 
solutions (Fisher Scientific UK LTD Bishop Meadow Road, Loughborough, 
Leicestershire LE11 5RG) in 20 mM TEA-HCl buffer pH 7.6 and 50 mM NaCl, as 
well as in water to assess matrix effects. Samples were analysed using the standards 
prepared in 20 mM TEA-HCl buffer pH 7.6. Ten blank samples of the 20 mM TEA-
HCl buffer pH 7.6 were analysed to calculate the LOD for each metal. Where values 
fell below the limit of detection they were quoted as a < value (Fuad et al. 2011). 
This analysis was performed by Dr. Lorna Eades.  
2.3 Experimental for Chapter 5 
2.3.1 Preparation of T. brucei cytosolic fractions 
T. brucei cytosolic fractions were prepared by differential centrifugation as described 
previously, in isotonic buffer (250 mM sucrose (Fisher Scientific), 25 mM Tris-HCl 
(Sigma Life Sciences) pH7.4, 1 mM EDTA) (Misset and Opperdoes 1984). EDTA 
was included primarily as a proteolytic inhibitor, but is also a useful form of metal 
sequestration. It was not removed from the fractions, and would thus still be present 
with its bound metals during the ICP-OES measurements. Soluble proteins in the 
cytosolic fractions were prepared by Melisa-Gualdron Lopez and Muriel Mazet, de 
Duve Institute, Brussels, Belgium.  
The concentrations of proteins in cytosolic samples were measured by 
Bradford assay (Bradford 1976) with Coomassie Plus Protein Assay Reagent 
(Thermo Scientific), and BSA as a standard (see Appendix I (a)). Seven samples (3 
ml each) were obtained that had been prepared on different occasions: three cytosolic 
samples from in vitro cultured procyclic insect-stage parasites (S1, S2, S3), and four 
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cytosolic samples from pathogenic bloodstream-form parasites (S4, S5, S6 and S7). 
Samples S5 and S6 gave metal analysis results with relatively high standard 
deviations, and have been omitted. iPGAM enzymatic assays of each cytosolic 
fraction were done using a Multimode Plate Reader-Molecular Devices M5 
instrument, controlled by SoftMax Pro software version 5.4, by the addition of a 10 
µl sample of the cytosolic fraction to give a final reaction mixture of 100 µl 
containing 100 mM TEA-HCl buffer pH 7.6, 1.5 mM 3PGA, 5 mM MgCl2, 50 mM 
KCl, 0.8 mM NADH, 1 mM ADP, 2 units of ENO, 4 units of PYK and 6 units of 
LDH. The decreased absorbance of NADH at A340 nm was used to obtain the rate of 
reaction for specific activity measurements (one unit corresponds to the conversion 
of 1 µmol of substrate min-1 mg-1 protein under standard conditions) (Fuad et al. 
2011). 
2.3.2 ICP-MS and ICP-OES 
The experimental details for ICP-MS are given in section 2.2.7 ii because the 
analysis is also relevant for chapter 4. It is relevant to note that these analyses 
measure total metal concentrations in the samples, and are regardless of the metals 
oxidation state.  
ICP-OES was used to analyse 2.5-3 ml of cytosolic fractions with a Perkin 
Elmer Optima 5300 DV instrument, using an RF forward power of 1400 W, with 
argon gas flows of 15, 0.2 and 0.75 L/min for plasma, auxiliary, and nebuliser flows, 
respectively. Using a peristaltic pump, the samples were taken up into a Gem Tip 
cross-Flow nebuliser and Scotts spray chamber at a rate of 1.50 ml/min. The 
instrument was operated in axial mode, and the selected wavelengths for each 
element were analysed in fully quantitative mode (three points per unit wavelength). 
The different cytosolic fractions were all normalised to 1mg/ml protein, and three 
replicate runs per sample were carried out. Initially two wavelengths were selected 
for each element, but after the analysis was completed the following wavelengths 
were chosen for reporting results: Co 228.616 nm, Cu 327.393 nm, Fe 238.204 nm, 
Mg 285.213 nm, Mn 257.610 nm, Ni 231.604 nm and Zn 206.200 nm.  
 
52 
To assess the limit of detection (LOD) for each metal and the matrix effects 
of the buffers, a range of calibration standards was prepared both in deionised water 
(18Ω, Elga USF) and in cytosol buffer (250 mM sucrose, 25 mM Tris-HCl, pH 7.4). 
Standards of 0, 0.1, 10 and 100 mg/L were prepared by sequential dilution from 
single element 1000 mg/L stock solutions (Fisher Scientific UK LTD Bishop 
Meadow Road, Loughborough, Leicestershire LE11 5RG). With all of the calibration 
results the correlation coefficients for the linear regression were 0.9992 or better. Ten 
blank samples of each buffer were analysed after the instrument was calibrated, and 
the LOD is given by the formula 2.26*SDb/Slope (where b is the standard deviation 
of the 10 blanks). The limits of detection are shown in chapter 5. 
For analysis of the samples, a range of calibration standards from 0-500 mg/L 
was prepared in cytosol buffer. The majority of the samples fell in the range 200-500 
mg/L, and results were calculated against a calibration from 10-500 mg/L. However 
where values were lower than 20 mg/L, the samples were reintegrated against a 
calibration only extending to 10 mg/L. Where values fell below the limit of detection 
they were quoted as a < value. It is relevant to mention that attempts were initially 
made to analyse the cytosolic fractions by ICP-MS, but were found to be unsuitable 
because of technical problems (Fuad et al. 2011). This analysis was performed by Dr. 
Lorna Eades.  
2.3.3 MESPEUS 
The MESPEUS database offers information concerning the geometry of metal sites 
in protein structures (Hsin et al. 2008), and was accessed through the CTCB website 
with the link: http://mespeus.bch.ed.ac.uk/MESPEUS_10/_1.jsp.  
2.4 Experimental for Chapter 6 
2.4.1 Discontinuous coupling enzyme assay 
The discontinuous assay was employed by incubating a sample of iPGAM (0.162 
µM) with a final concentration of 50 mM 3PGA for 15 min at 25°C, after an earlier 
incubation of the enzyme with a final concentration of 1 mM of each of these metal 
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salts: CaCl2, CoCl2, CuCl2, FeCl2, MgCl2, MnCl2, NiCl2 and ZnCl2 (Sigma Life 
Sciences) for 1 h at the same temperature, in the presence of 200 mM TEA-HCl 
buffer pH 7.6 and 50 mM NaCl which was prepared for a maximum buffering 
capacity. The stock solutions of the enzyme components and the metal salts were 
prepared using 200 mM TEA-HCl pH 7.6. The reaction was quenched by incubating 
the mixture at 100°C for 2 min, before adding 5 µl samples from the first tubes into 
the 96 well-plates containing 95 µl of the reaction mixture (100 mM TEA-HCl buffer 
pH 7.6, 5 mM MgCl2, 50 mM KCl, 1 mM NADH, 1 mM ADP, 1 unit of ENO, 2 
units of PYK and 3 units of LDH. Controls were carried out with the addition of 
2PGA into the reaction mixture, in the absence of LmiPGAM and 3PGA. The 
oxidation of NADH to NAD+ was observed as the end absorbance values, which was 
compared to the calibration curves in order to obtain the concentrations of 2PGA in 
the wells. The NADH conversion was monitored using the Multimode Plate Reader-
Molecular Devices M5 instrument.      
Prior to the analysis, a series of calibration curves was generated. These 
standard curves were obtained by experimentally adding known concentrations of 
2PGA (0.63 mM, 0.31 mM, 0.16 mM, 0.08 mM and 0 mM) into the assay mixture 
containing the same components as stated above. Calibration standards were also 
generated in the presence of different metals, explicitly at three different metal 
concentrations: 0.05 mM, 0.1 mM and 0.5 mM. 
2.5 Experimental for Chapter 7 
2.5.1 Virtual screens programs: UFSRAT, AutoDock, and AutoDock Vina 
The program UFSRAT was used to screen 3PGA/2PGA analogues from a 
multiconformer library comprising 4,853,000 molecules from various suppliers: 
Chembridge, Asinex, Maybridge, Enamine, LifeChemicals (InfLab) Specs, 
InterBioScreen and ChemDiv. The SDF files which represent the atom distributions 
of the query molecules were used as the input. This program can be accessed through 
the CTCB website with the link: http://opus.bch.ed.ac.uk/ufsrat/. The results obtained 
were listed based on the similarity scores and were saved as SDF files. Subsequently, 
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AutoDock and AutoDock Vina screens were performed by using the closed-form 
structure of LmiPGAM and 2PGA as the input structure and original ligand, 
respectively. The screen was conducted against the SDF files comprising the 
previous UFSRAT results, and were listed based on the AutoDock and AutoDock 
Vina scores. The COmbining Docking and Similarity Search (CODASS) analysis 
was performed by Dr. Douglas Houston.  
2.5.2 The quantitative high-throughput screening (qHTS) 
The qHTS was conducted in the NIH, Bethesda, USA. The screening was performed 
using the Kinase-Glo® Luminescent Kinase assay method which quantifies the 
amount of ATP remaining in the sample following a kinase reaction (Promega). The 
qHTS screen for LmiPGAM was employed initially with the Library of 
Pharmacologically Active Compounds (LOPAC®) (Sigma-Aldrich). 
2.5.3 Inhibition analysis with selected compounds 
The inhibition analysis was performed using both the continuous and discontinuous 
coupling enzyme assay approaches, following the same conditions as stated in 
sections 2.2.2 and 2.4.1, respectively, except for the incorporation of an additional 
step: the incubation with the selected compounds. Both assays were performed by 
incubating a final concentration of 0.01 mg/ml LmiPGAM from the ion-exchange 
column with a final concentration of 1 mM Co2+ at 25°C for 1 h, before adding a 
final concentration of 1 mM compounds individually with further incubation for 
another hour. The remaining steps were as described in the previous 2.2.2 and 2.4.1 
sections. It is noteworthy that the initial stock solutions of the compounds were 
prepared by dissolving them with 100% DMSO except for compound C5 and C10 
(50% DMSO), before being further diluted to prepare a 10 mM stock solution with 
200 mM TEA-HCl pH 7.6. The oxidation of NADH to NAD+ was monitored using 





Chapter 3:  
Development of Protein Expression Systems and New Purification Approaches 
for Trypanosomatid iPGAMs 
3.1 Aims 
Trypanosomatid iPGAMs, as members of the alkaline phosphatase superfamily, 
require metal ions to support their integrity and catalytic function (Chevalier et al. 
2000; Guerra et al. 2004; Poonperm 2005; Nowicki et al. 2009). Co2+ was shown to 
stabilise LmiPGAM (Poonperm 2005), and has often been included in the whole 
protein characterisation process: from enzyme purification to the crystallisation 
stage. The closed-form crystal structure of LmiPGAM (Poonperm 2005; Nowicki et 
al. 2009) as well as the open-form TbiPGAM (Mercaldi et al. 2012) suggest that Co2+ 
is in the active site, indicating that Co2+ has high affinity to the enzyme. In fact, 
LmiPGAM has always been purified in the presence of Co2+, and the metal is 
required for activity measurements and crystallisation conditions too. However, these 
are in vitro conditions, and similar circumstances are unlikely to occur in vivo, where 
the Co2+ concentration may not be present at a sufficient concentration to support 
iPGAM activity.  
An investigation into the roles played by Co2+ in the structure and function of 
LmiPGAM requires that the enzyme be purified in the absence of added Co2+. Thus, 
for the purpose of eliminating the presence of Co2+ in the whole process in vitro, 
assuming that there is no residual metal obtained from the bacterial cells during 
expression, the purification steps have to be employed in its absence. This would 
necessitate either: i) avoiding the use of a Talon metal-affinity column, or ii) 
replacing Co2+ with other metals, for example Ni2+ during the metal-affinity 
chromatography step. Apart from preventing Co2+ contamination, another important 
aspect in LmiPGAM analysis is to direct the enzyme conformation into the open-
form state which is important for the purpose of drug design, as well as a completion 
to the previous closed-form structure. In this case, additional chromatography steps 
would be required, such as ion-exchange and gel filtration steps, which have the 
ability to separate proteins based on the charge distribution on the surface of the 
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folded proteins, as well as by shape and size, respectively. Hence, in this chapter, a 
new purification system for iPGAM will be discussed in detail.  
It is noteworthy that in this study, only the His-tagged versions of LmiPGAM 
and TbiPGAM were expressed and purified. While the un-tagged version of 
TbiPGAM was successfully overexpressed, neither the un-tagged versions of 
LmiPGAM nor TbiPGAM were purified. This is due to the efficiency of the His-
tagged purification protocol in yielding high purity protein samples.    
3.2 Introduction 
Protein purification involves a number of important stages which begin with a 
disruption of the cells that contain the specific protein of interest, usually bacteria, 
insect, yeast or mammalian cells (Marino 1989; Makrides 1996). Overexpression of 
soluble protein is normally required to ensure maximal protein production can be 
achieved through purification. The starting material however, does not only contain 
the intended protein, but other macromolecules such as DNA and RNA, as well as a 
mixture of polysaccharides, lipids, smaller molecules as well as other proteins 
(Burgess 2008). It is vital thus, to disrupt the particular cells to release the protein, 
and therefore enable successful separation of the protein of interest from the other 
macromolecules, including other proteins. Often the explicit characteristics of a 
specific protein are taken into account before any purification procedure is chosen, 
for example, whether the intended protein possesses distinct structural properties that 
are distinguishable from the others. Chromatography is one of the techniques utilised 
for this purpose, in which proteins in the mobile phase may be separated according to 
their ability to adsorb to a matrix (stationary phase) (Price and Nairn 2009). The 
interaction between the protein and the matrix varies, and the matrix is specifically 
chosen based on the protein’s properties. For example, ion-exchange and 
hydrophobic interaction chromatography are based on the surface charge of the 
protein, gel filtration depends on size, and affinity relies on specific binding sites in 
the protein structure (Price and Nairn 2009). 
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While chromatography is an excellent technique for protein purification, it is 
important to note that the incorporation of “non-native” metals, especially in 
metalloproteins, may occur significantly. This has been shown in some proteins, for 
example the expression of Pseudomonas aeruginosa azurin in E. coli has 
misleadingly introduced Zn2+, instead of Cu2+, the native metal for the protein (Nar et 
al. 1992). It is important thus, to carefully select the expression and purification 
system so as to minimise the introduction of non-biologically relevant metals in the 
protein structure. Otherwise, the interpretation from the enzymatic activity or crystal 
structure may provide a misleading understanding. 
Over the years, purification of LmiPGAM and TbiPGAM has frequently been 
conducted by a TALON metal-affinity resin (Chevalier et al. 2000; Guerra et al. 
2004; Poonperm 2005), except for a Ni2+-NTA agarose column in a study by Collet 
et al. 2001. The separation is based on the interaction between a His-tag that is 
attached to the specific protein, with the affinity column containing the bound metal. 
For LmiPGAM in particular, Co2+ was chosen as the bound metal in the resin, which 
was reported to be the only metal that could maximally reactivate iPGAM activity 
after metal-chelating experiments (Guerra et al. 2004). It is known that Co2+ has 
higher selectivity for His-tags compared to other metals 
(http://www.gbiosciences.com/ResearchProducts/Cobalt-Chelating-Resin.aspx), thus 
providing a reason for choosing Co2+ over other metals, such as Ni2+. The issue of 
which metal ions support iPGAM activity in the parasite cell, based on the 
knowledge that Co2+ concentrations in eukaryotic cells are very low (Finney and 
O’Halloran 2003; Maret 2010), raised the concern that Co2+ is not the biologically 
relevant metal for the trypanosomatid iPGAMs. Hence, for the purpose of preventing 
Co2+ from being trapped in the active site of iPGAM during the whole purification 
process, Ni2+ would be utilised in the metal-affinity chromatography step, and any 
initial enzymatic activity would be measured in the absence of added Co2+. A high 
sequence similarity between LmiPGAM and TbiPGAM (Figure 3.1) suggested that a 
similar procedure could be performed in purifying both enzymes. By combining this 
procedure with metal analysis studies which will be discussed in detail in chapter 5 
and 6, the biologically relevant metal for trypanosomatid iPGAMs may be 
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unravelled.  The amino acid sequences of TbiPGAM and LmiPGAM which have 
been used as constructs in the experiments are shown in Figure 3.2.   
        Tb  -MALTLAAHKTLPRRKLVLVVLDGVGIGPRDEYDAVHVAKTPLMDALFND 49 
          Lm  MSALLLKPHKDLPRRTVLIVVMDGLGIGPEDDYDAVHMASTPFMDAHRRD 50 
                ** * .** ****.:::**:**:****.*:*****:*.**:***  .* 
 
          Tb  PKHFRSICAHGTAVGLPTDADMGNSEVGHNALGAGRVVLQGASLVDDALE 99 
          Lm  NRHFRCVRAHGTAVGLPTDADMGNSEVGHNALGAGRVALQGASLVDDAIK 100 
               :***.: *****************************.**********:: 
 
          Tb  SGEIFTSEGYRYLHGAFSQPGRTLHLIGLLSDGGVHSRDNQVYQILKHAG 149 
          Lm  SGEIYTGEGYRYLHGAFSKEGSTLHLIGLLSDGGVHSRDNQIYSIIEHAV 150 
              ****:*.***********: * *******************:*.*::**  
 
          Tb  ANGAKRIRVHALYDGRDVPDKTSFKFTDELEEVLAKLREGGCDARIASGG 199 
          Lm  KDGAKRIRVHALYDGRDVPDGSSFRFTDELEAVLAKVRQNGCDAAIASGG 200 
               :****************** :**:****** ****:*:.**** ***** 
 
          Tb  GRMFVTMDRYEADWSIVERGWRAQVLGEGRAFKSAREALTKFREEDANIS 249 
          Lm  GRMFVTMDRYDADWSIVERGWRAQVLGDARHFHSAKEAITTFREEDPKVT 250 
              **********:****************:.* *:**:**:*.*****.::: 
 
          Tb  DQYYPPFVIAGDDGRPIGTIEDGDAVLCFNFRGDRVIEMSRAFEEEEFDK 299 
          Lm  DQYYPPFIVVDEQDKPLGTIEDGDAVLCVNFRGDRVIEMTRAFEDEDFNK 300 
              *******::..::.:*:***********.**********:****:*:*:* 
 
          Tb  FNRVRLPKVRYAGMMRYDGDLGIPNNFLVPPPKLTRTSEEYLIGSGCNIF 349 
          Lm  FDRVRVPKVRYAGMMRYDGDLGIPNNFLVPPPKLTRVSEEYLCGSGLNIF 350 
              *:***:******************************.***** *** *** 
 
          Tb  ALSETQKFGHVTYFWNGNRSGKLSEERETFCEIPSDRVQFNQKPLMKSKE 399 
          Lm  ACSETQKFGHVTYFWNGNRSGKIDEKHETFKEVPSDRVQFNEKPRMQSAA 400 
              * ********************:.*::*** *:********:** *:*   
 
          Tb  ITDAAVDAIKSGKYDMIRINYPNGDMVGHTGDLKATITSLEAVDQSLQRL 449 
          Lm  ITEAAIEALKSGMYNVVRINFPNGDMVGHTGDLKATITGVEAVDESLAKL 450 
              **:**::*:*** *:::***:*****************.:****:** :* 
 
          Tb  KEAVDSVNGVFLITADHGNSDDMVQRDKKGKPVRDAEGNLMPLTSHTLAP 499 
          Lm  KDAVDSVNGVYIVTADHGNSDDMAQRDKKGKPMKDGNGNVLPLTSHTLSP 500 
              *:********:::**********.********::*.:**::*******:* 
 
          Tb  VPVFIGGAGLDPRVQMRTDLPRAGLANVTATFINLMGFEAPSDYEPSLIE 549 
          Lm  VPVFIGGAGLDPRVAMRTDLPAAGLANVTATFINLLGFEAPEDYEPSLIY 550 
              ************** ****** *************:*****.*******  
 
          Tb  VA- 551 
          Lm  VEK 553 
              *   
 
Figure 3.1 Sequence alignment of LmiPGAM and TbiPGAM resulted in 78% 
sequence identity. Amino acids with similar properties are shown with 
specific colours. The red colour corresponds to small and hydrophobic 
amino acids, the pink corresponds to basic amino acids, the blue 
corresponds to acidic amino acids and the green corresponds to 
hydroxyl and amine amino acids. The symbols under the residues 
indicate “*” as identical residues; “:” as semi-conserved residues; and 
“.” as low conservation. The analysis was done using the sequence 
alignment program CLUSTALW2 (http://www. ebi.ac.uk/ 









His-tagged TbiPGAM  
 
MGSSHHHHHH SSGLVPRGSH MALTLAAHKT LPRRKLVLVV LDGVGIGPRD EYDAVHVAKT  
 
PLMDALFNDP KHFRSICAHG TAVGLPTDAD MGNSEVGHNA LGAGRVVLQG ASLVDDALES  
 
GEIFTSEGYR YLHGAFSQPG RTLHLIGLLS DGGVHSRDNQ VYQILKHAGA NGAKRIRVHA  
 
LYDGRDVPDK TSFKFTDELE EVLAKLREGG CDARIASGGG RMFVTMDRYE ADWSIVERGW  
 
RAQVLGEGRA FKSAREALTK FREEDANISD QYYPPFVIAG DDGRPIGTIE DGDAVLCFNF  
 
RGDRVIEMSR AFEEEEFDKF NRVRLPKVRY AGMMRYDGDL GIPNNFLVPP PKLTRTSEEY  
 
LIGSGCNIFA LSETQKFGHV TYFWNGNRSG KLSEERETFC EIPSDRVQFN QKPLMKSKEI  
 
TDAAVDAIKS GKYDMIRINY PNGDMVGHTG DLKATITSLE AVDQSLQRLK EAVDSVNGVF  
 
LITADHGNSD DMVQRDKKGK PVRDAEGNLM PLTSHTLAPV LFLSEALVLI PVCKCGQTFR  
 





His-tagged LmiPGAM  
 
MSALLLKPHK DLPRRTVLIV VMDGLGIGPE DDYDAVHMAS TPFMDAHRRD NRHFRCVRAH  
 
GTAVGLPTDA DMGNSEVGHN ALGAGRVALQ GASLVDDAIK SGEIYTGEGY RYLHGAFSKE  
 
GSTLHLIGLL SDGGVHSRDN QIYSIIEHAV KDGAKRIRVH ALYDGRDVPD GSSFRFTDEL  
 
EAVLAKVRQN GCDAAIASGG GRMFVTMDRY DADWSIVERG WRAQVLGDAR HFHSAKEAIT  
 
TFREEDPKVT DQYYPPFIVV DEQDKPLGTI EDGDAVLCVN FRGDRVIEMT RAFEDEDFNK  
 
FDRVRVPKVR YAGMMRYDGD LGIPNNFLVP PPKLTRVSEE YLCGSGLNIF ACSETQKFGH  
 
VTYFWNGNRS GKIDEKHETF KEVPSDRVQF NEKPRMQSAA ITEAAIEALK SGMYNVVRIN  
 
FPNGDMVGHT GDLKATITGV EAVDESLAKL KDAVDSVNGV YIVTADHGNS DDMAQRDKKG  
 
KPMKDGNGNV LPLTSHTLSP VPVFIGGAGL DPRVAMRTDL PAAGLANVTA TFINLLGFEA  
 




Figure 3.2 a) The amino acid sequence of TbiPGAM including the His-tag. 
b) The amino acid sequence of LmiPGAM including the His-tag. 
The first and the last residues of the native sequences are highlighted 








3.3 The expression systems for LmiPGAM 
The bacterially expressed trypanosomatid iPGAMs were initially proposed to be 
purified in the presence and absence of His-tags. Both the His-tagged LmiPGAM and 
TbiPGAM plasmids were available in the laboratory, and had been obtained from 
Prof. Paul Michels, De Duve Institute, Brussels. The genes were present in pET28a 
plasmids, and were carried by E. coli strain DH5α. The construction of both the 
untagged LmiPGAM and TbiPGAM genes was employed to produce plasmids 
suitable for purification of the enzymes in the absence of metal-affinity 
chromatography. The general molecular cloning techniques were described in 
chapter 2, and the steps involved in the development of the expression systems will 
be discussed in detail in the next sections. However, for the purpose of purification, 
only the His-tagged versions of the protein were purified. This is due to the 
efficiency of the protocol to yield high purity protein samples.  
i) Histine-tagged LmiPGAM expression system  
The His-tagged LmiPGAM expression system was a gift from Prof. Paul Michels and 
has been developed in the Brussels research group. The 6His-tag was present at the 
C-terminus of the protein (LEHHHHHH), and the molecular mass was calculated to 
be 60723.3 Da (excluding the His-tag and including the initiator methionine), with a 
theoretical pI of 5.43. Since the protein was expressed in E. coli, the initiator 
methionine was translated and included in the mass calculation, but the formyl group   
was normally removed after protein translation (Sherman et al. 1985; Spector et al. 
2003). Meanwhile, when the His-tag was included in the calculation, the molecular 
mass increased to 61788.5 Da, with a theoretical pI of 5.62. The protein parameters, 
which were calculated using the Expasy ProtParam (http://web.expasy.org/cgi-
bin/protparam/protparam) are tabulated in Table 3.1. In the subsequent purification 
experiment (see section 3.4i), the plasmid encoding the His-tag protein was 
transformed into E. coli strain BL21 (DE3) before protein expression following 
standard conditions as described by Poonperm 2005. The purification steps will be 
discussed in detail in section 3.4 i.  
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Table 3.1 LmiPGAM parameters obtained from the Expasy database. 
Protein Molecular mass 
(Da) 




(M-1 cm-1) * 










* As measured in water at A280 nm  
 
ii) Un-tagged LmiPGAM expression system 
The un-tagged Lm-iPGAM expression plasmid was initially developed to eliminate 
the presence of the His-tag in the construct. As mentioned earlier, the LmiPGAM 
gene had been originally inserted into the pET28a vector, which carries an N-
terminal His-tag, thrombin cleavage site and a T7 promoter, with an optional C-
terminal His-tag sequence (Novagen®). Since the LmiPGAM gene was fused with the 
C-terminal His-tag, two restriction sites in the multiple cloning site (MCS), NcoI and 
XhoI (Figure 3.3) were used to excise the iPGAM gene, hence leaving the C-terminal 
His-tag in the original pET28a vector. The next step involved PCR amplification of 
the target gene (LmiPGAM) before being inserted into an intermediate vector 
(pJET1.2/blunt). In this case, a set of primers has been designed (see chapter 2), 
where the same restriction sites were added directly to the 5’ and 3’ ends of the 
primers. The resulting amplified PCR product with approximately 1.6 kb in size 
(Figure 3.4 a) was subsequently ligated into pJET1.2/blunt, which is a highly-
efficient PCR-cloning vector, with the ability to insert either phosphorylated or non-
phosphorylated DNA fragments (Fermentas). The success of the cloning procedure 
was evaluated by double digesting the clones with NcoI and XhoI, which clearly 
indicates the separation of the vector pJET1.2/blunt (2.95 kb) and LmiPGAM insert 
(1.6 kb) (Figure 3.4 b). The final molecular cloning step was performed by insertion 
of the target gene from the intermediate vector into the final pET28a, with the 
utilisation of the same enzymes. The successful insertion of the LmiPGAM gene was 
determined with a similar strategy as mentioned above, by double digesting with 
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both NcoI and XhoI, as well as a single digestion with the enzyme NcoI. The 
resulting bands (Figure 3.4 c) confirmed the attainment of the LmiPGAM gene 
integration into pET28a. The constructed plasmid map is shown in Figure 3.5, and 
the correct sequence was later confirmed by Dundee Sequencing Service, the 





Figure 3.3   The cloning strategy for LmiPGAM which involved two separate steps: 
(i) the insertion of the LmiPGAM PCR product into an intermediate 
vector (pJET1.2/blunt), and (ii) the insertion of the LmiPGAM gene 




Figure 3.4 Agarose electrophoresis (0.8% (w/v)) of the PCR amplified 
LmiPGAM and the digestion results. a) PCR amplified LmiPGAM 
(well 1). b) The pJET1.2/blunt containing the undigested LmiPGAM 
(well 1), and the pJET1.2/blunt containing digested LmiPGAM with 
NcoI and XhoI (well 2). c) The undigested pET28a containing the un-
tagged LmiPGAM (well 1), recombinant clone single-digested with 
NcoI (well 2), and recombinant clone double-digested with NcoI and 





Figure 3.5 The plasmid map of the constructed un-tagged LmiPGAM. 
 
3.4 Purification steps for His-tagged LmiPGAM 
In the previous literature (Guerra et al. 2004; Poonperm 2005), LmiPGAM was 
purified with a two-step procedure, involving a metal-affinity chromatography step 
using a Co2+-containing TALON column, followed by a desalting/buffer-exchange 
step. The present study in contrast, involved three main purification steps for 
LmiPGAM: immobilised metal-affinity chromatography, desalting and ion-exchange. 
It is noteworthy that the expression procedure was performed following the method 
described by Poonperm 2005, which produced a substantial amount of over-
expressed protein (Figure 3.6 b). It is also important to note that Co2+ was not added 
in any purification steps or buffer preparation (see chapter 2). The un-tagged 
LmiPGAM expression trials (see Appendix I (b)) were unsuccessful in obtaining 
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soluble LmiPGAM for protein purification, thus it was decided that the purification 
procedure would only focus on the His-tagged LmiPGAM.    
i) Step one: immobillised metal-affinity chromatography 
The utilisation of polyhistidine-tags in proteins for chromatographic purposes has 
been widely reported (Hemdan 1989; Porath 1992; Gaberc-Porekar and Menart 
2001). The principle of the technique lies on the interaction between metal ions that 
are entrapped in chromatographic supports containing covalently bound chelating 
compounds (Gaberc-Porekar and Menart 2001) with specific amino acid residues 
which are exposed on the surface of the protein molecule. One of the most attractive 
features for this chromatographic step is the ability to purify a large amount of 
protein during a rapid purification process. The specificity of the technique to purify 
explicit proteins however, is considered to be moderate (Gaberc-Porekar and Menart 
2001), hence frequently requiring further additional purification procedures. 
Nevertheless, it has evolved as one of the most efficient steps in a chromatographic 
procedure for larger scale-ups.  
In this study, the chromatographic step was employed through immobilisation 
of Ni2+ ions in a column containing a Sepharose 6 matrix, which is packed with 
highly cross-linked agarose beads with a covalently immobilised chelating group 
(GE Healthcare). The cell lysate containing LmiPGAM flowed over the 5 ml Fast 
Flow IMAC column (GE Healthcare), where the specifically engineered His-tagged 
protein bound to the stationary phase through the interactions between imidazole side 
chains of histidines and the Ni2+ ions, while any unbound molecules were washed 
away as the flow-through. The elution was achieved in the presence of increasing 
imidazole concentration, which involved two separate stages, known as the washing 
and elution steps. In the initial washing step, 20 mM imidazole was included in the 
buffer (see chapter 2) with His-tagged protein bound to the solid matrix, while any 
other weakly-bound proteins, which are contaminants from the bacterial culture pass 
through the column (Figure 3.6 a). Surprisingly however, SDS-PAGE analysis 
(Figure 3.6 b) showed that the peak corresponding to the washing contaminants also 
contains a significant presence of iPGAM, which suggests that the washing could be 
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done at a lower imidazole concentration. After an additional 20 CV wash at 5% 
buffer B, the elution step was performed in a step-wise fashion, from 25 mM to 500 
mM imidazole. A peak was detected by UV sensor at A280 nm (Figure 3.6 a) which 
corresponds to LmiPGAM (Figure 3.6 b). The total yield of the protein from 1L of 







Figure 3.6   a)  The elution profile of LmiPGAM from 5 ml Fast Flow IMAC column 
resulting in two distinct elution sections (1 and 2) as well as an earlier 
flow-through (F/T) section (blue trace) b) A 12% SDS-PAGE is shown 
with 2-4 µg samples of each protein fraction with the initial extract (I), 
flow-through (F/T) and fractions from sections 1 and 2. A red arrow 
shows that the pure protein corresponds to the size of His-tagged 
LmiPGAM (61.8 kDa). The protein markers are shown as M and 
labelled as kDa.   
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ii) Step two: desalting 
The IMAC step is advantageous for rapid and large-scale protein purification, but 
nevertheless, also contributes to significant concentrations of buffer salts and 
imidazole introduced into the protein samples. This is a direct consequence of the 
high ionic strength required during the adsorption and elution steps in the 
chromatography procedure (Price and Nairn 2009). Often biophysical techniques are 
not compatible with high salt concentrations, thus requiring the samples to be 
exchanged into low salt environment. In the case of LmiPGAM, salt removal was 
vital to provide a low ionic strength environment as a preparation for the subsequent 
chromatographic procedure, ion-exchange chromatography. It is important to note 
however, that Na+ is always included through the whole purification process (50mM 
-300 mM at different steps of purification, see chapter 2) as it was found to stabilise 
LmiPGAM (Poonperm 2005). The significant difference between the size of proteins 
and salts or smaller molecules made it plausible for the separation to be employed 
successfully. The principle of the technique is the same as size-exclusion 
chromatography (see chapter 4): higher molecular weight substances are unable to 
enter the gel pores and elute earlier, while lower molecular weight substances have 
the ability to enter the gel pores, resulting in a delayed elution (GE Healthcare).  
Pure LmiPGAM was passed through a HiPrep 26/10 desalting column, which 
is a pre-packed Sephadex G-25 Fine column. 20 mM HEPES buffer was used during 
column equilibration prior to sample application, as explained in detail in chapter 2. 
As depicted in Figure 3.7 a, a sharp UV peak at A280 nm was observed, indicating the 
successful elution of the protein of interest (LmiPGAM). Subsequently, the 
conductivity signal rose as an indication of salts or any other smaller molecules 
eluted from the column. The fractions corresponding to the UV peak were analysed 
by SDS-PAGE analysis (Figure 3.7 b), where a single prominent band was exhibited 





Figure 3.7 a) The elution profile of LmiPGAM from the HiPrep 26/10 desalting 
column gave a single protein elution (blue trace), followed by salt and 
smaller molecules (brown trace) b) A 12% SDS-PAGE is shown with 
2-4 µg samples of each protein fraction corresponding to the blue 
trace. The red arrow shows that the pure proteins correspond to the 
size of His-tagged LmiPGAM (61.8 kDa). The protein marker is 
shown as M and labelled as kDa.   
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iii) Step three: ion-exchange chromatography 
Different surface charges on the protein molecules contribute to the ability of 
proteins to be separated based on their surface charges through electrostatic 
interactions with a charged matrix (Price and Nairn 2009). In the analysis of 
LmiPGAM, anion-exchange chromatography was employed to observe the 
interactions between the positively charged matrix and the protein molecules, which 
subsequently resulted in elution of proteins with theoretically distinct surface 
charges. The purification method can also be conducted as a polishing step to obtain 
higher purity protein samples.  
MonoQ 5/50 GL is an anionic-exchange pre-packed glass column with 
monodispersed 10-µm porous beads giving high performance ion-exchange 
chromatography of proteins and other biomolecules (GE Healthcare). Protein 
samples in a low ionic strength environment, with a pH value that generates opposite 
net charges on the surface of the protein molecules from those of the column, result 
in binding between the protein and the matrix. By increasing the ionic strength of the 
elution buffer or changing the pH of the solution, the intended protein can be eluted. 
As MonoQ 5/50 GL is an anionic column, negatively-charged molecules would 
strongly bind to the matrix, whereas positively-charged molecules would not bind. In 
this experiment, a shallow salt gradient was obtained by increasing the concentration 
of NaCl to a maximum of 1 M. The resulting protein peaks which absorbed at A280 
nm are illustrated in Figure 3.8 a.  
Three distinct UV peaks were observed, exhibiting a reproducible elution 
pattern, as observed in different purification batches. SDS-PAGE analysis was 
employed to identify whether the fractions correspond to LmiPGAM size (61.8 kDa), 
and it can be seen that all peak fractions had a similar molecular mass (Figure 3.8 b). 
These observations further augmented the possibility that LmiPGAM, may well exist 
in different forms or conformations in solution, causing the charge distribution on the 
surface of the protein molecules to vary, which will be discussed further in chapter 4. 
Nevertheless, further analysis was required, to observe whether the differences were 
due to distinctive charge distributions, and not to incorrectly-folded protein or any 
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post-translational modification events that may have occurred. Further 









Figure 3.8 a) The elution profile of LmiPGAM from MonoQ 5/50 GL column 
resulted in three separate peaks (blue trace) labelled 1, 2 and 3. b) A 
12% SDS-PAGE is shown with 2-4 µg samples of each protein 
fraction corresponding to the three protein peaks (blue trace). The red 
arrow shows the pure proteins corresponding to the size of His-tagged 
LmiPGAM (61.8 kDa). The protein markers are shown as M and 
labelled as kDa. 
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3.5 The expression systems for TbiPGAM 
Similar strategies were involved in the development of expression systems for 
TbiPGAM, as explained for LmiPGAM earlier in section 3.3. An N-terminal His-
tagged TbiPGAM expression plasmid was available in the laboratory, while the un-
tagged TbiPGAM necessitated the construction of a plasmid via molecular cloning. 
The plasmid pET28a containing the TbiPGAM gene with an N-terminal His-tag was 
carried by E. coli strain DH5α. Subsequent molecular cloning techniques were 
employed for the purpose of the insertion of the TbiPGAM gene with the His-tag 
eliminated.  
i) His-tagged TbiPGAM expression system 
As mentioned in the earlier section (see section 3.3 i), the His-tagged TbiPGAM 
expression system was a gift from Prof. Paul Michels and had been developed in 
Brussels research group. In contrast to LmiPGAM, the 6His-tag was present at the N-
terminus of the protein, and the His-tagged TbiPGAM had a calculated molecular 
mass of 62852.1 Da with a theoretical pI of 5.98. However, when the His-tag was not 
included in the calculation, the molecular mass decreased to 60603.5 Da, with a 
theoretical pI of 5.56. The initiator methionine was always included in the 
calculation. The protein parameters, which were calculated using the Expasy 
ProtParam (http://web.expasy.org/cgi-bin/protparam/protparam) are tabulated in 
Table 3.2. Expression trials were conducted for both the His-tagged and un-tagged 








Table 3.2  TbiPGAM parameters which were obtained from the Expasy database. 
Protein Molecular mass 
(Da) 




(M-1 cm-1) * 










*As measured in water at A280 nm  
 
ii) Un-tagged TbiPGAM expression system 
The construction of the un-tagged TbiPGAM expression plasmid began with 
digestion of the original pET28a plasmid containing the TbiPGAM gene with a His-
tag engineered at the N-terminus. This was performed by digesting both NdeI and 
BamHI sites, which were present in the MCS, in the original plasmid. The resulting 
gene fragment was subsequently inserted into the pET30a plasmid, which also 
possesses the corresponding sites (Figure 3.9). The success of the cloning procedure 
was evaluated by digesting the recombinant clone with the same enzymes: NdeI and 
BamHI where DNA fragments corresponding to the size of the vector (5.422 kb) and 
insert (1.653 kb) were observed (Figure 3.10 a). Moreover, PCR analysis confirmed 
the existence of the ~0.7 kb amplified product which corresponds to the size of 
TbiPGAM gene (Figure 3.10 b). The correct sequence was later confirmed by the 
Dundee Sequencing Service, the University of Dundee. The map of the resulting 





Figure 3.9 The cloning strategy for TbiPGAM which involved the insertion of 
TbiPGAM gene from the original pET28a plasmid into the final 





Figure 3.10 Agarose electrophoresis (0.8% (w/v)) of the PCR amplified 
TbiPGAM and the digestion results.  a) a double digested pET30a 
containing TbiPGAM with NdeI and BamHI (well 1); and b) PCR 
amplification of the TbiPGAM gene in the pET30a plasmid. 





Figure 3.11 The plasmid map of the constructed un-tagged TbiPGAM. 
 
3.6 TbiPGAM expression trials 
Various organisms have been manipulated as tools for the production of proteins 
from plasmids. To date, bacterial (Baneyx 1999), yeast (Cregg et al. 2000; Malys et 
al. 2011), insect (Kost et al. 2005) and mammalian cells (Rosser et al. 2005; Lackner 
et al. 2008) have been widely utilised as expression systems for proteins. Among 
these, E. coli is the most extensively used system for the yield of bacterially 
expressed proteins, as it possesses the advantages of economical value and well-
characterised genetics (Ghosh et al. 2004). However, the major downside of the 
system is that the expressed proteins often occur as insoluble aggregates of folding 
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intermediates, known as inclusion bodies. It is hence important to determine the 
optimal expression conditions, in which the solubility of the target protein can be 
increased. In the laboratory, small-scale expression trials were routinely employed, in 
order to obtain the most optimal conditions for subsequent large-scale expression and 
purification. 
The expression of soluble TbiPGAM, as reported in Chevalier et al. 2000, 
was obtained at low production levels, despite various attempts to obtain yields. This 
study, together with Poonperm 2005 reported the requirement of betaine, which was 
proposed to stabililise protein folding within cells, and also sorbitol, which plays a 
functional role in assisting betaine to enter the E. coli cells. Nevertheless, it is 
important to obtain optimal conditions for higher expression levels for this protein, 
and various expression trials were conducted. In the present study, several expression 
parameters were included during the expression trials: temperature, cell lines and 
growth media. In this initial experiment, neither betaine nor sorbitol was included in 
the primary samples. Different conditions are enumerated in Table 3.3. 
Table 3.3 Expression conditions for both the His-tagged and un-tagged 
TbiPGAM. 




18°C, 30°C and 37°C 
BL21 (DE3), Rosetta 2 (DE3) pLysS, BL21 (DE3) Gold, and 
BL21 (DE3) CodonPlus 
LB and 2XYT 
 
Initially, each cell line was included in the expression trials with three distinct 
temperatures and two types of growth media for the His-tagged and un-tagged 
TbiPGAM. As a negative control, samples in the absence of IPTG induction were 
included in each experimental condition. The most optimum condition was 
determined by SDS-PAGE analysis, where protein bands with the greatest intensity 
were carefully observed. The small-scale cell lysis procedure was standardised for all 
samples to ensure uniformity of the results obtained, as was the amount of protein in 
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each sample to be analysed by SDS-PAGE (see chapter 2). The most favourable 
conditions for both the His-tagged and un-tagged TbiPGAM in soluble fractions are 
shown in Figure 3.12, alongside the negative control sample. Prior to this, the 
insoluble and the soluble fractions were separated by the centrifugation step. The 
expression conditions found to be favourable for large-scale purification are tabulated 
in Table 3.4. 
Table 3.4 The optimised expression conditions for TbiPGAM.  





Additional induction regimes 
Shaking speed 
Growth media 








Enzymatic and sonication 
 
The findings showed that the greatest soluble Tb-iPGAM expression for both 
the His-tagged and un-tagged versions were observed at a low temperature (18 °C) 
with longer incubation period (23 hours), as opposed to higher temperatures with 
shorter incubation periods. This may be due to the increment in cell viability at lower 
temperature, as well as the enhancement of the protein folding pathway (Li et al. 
2001). The relative expression of the un-tagged TbiPGAM was better than the His-
tagged version in BL21 (DE3) cells, although in other cells lines (BL21 (DE3) Gold 
and BL21 (DE3) CodonPlus), both versions exhibited similar expression level. 
Nevertheless, the lowest expression level was observed in Rosetta 2 (DE3) pLysS, 
for both the un-tagged and His-tagged versions.  It is noteworthy that a sonication 
step was necessary, as an additional cell lysis procedure alongside lysozyme 
treatment. The use of shaker flasks instead of Falcon tubes and a slower shaking 
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speed also increased the solubility of the proteins. Higher expression levels in the 
soluble fractions for both the His-tagged and un-tagged TbiPGAM were successfully 
obtained, increasing the chances for obtaining higher protein yields during 
purification. 
 
Figure 3.12   TbiPGAM expression trials at 18°C for 23 hours. A 12% SDS-PAGE 
is shown with 2-4 µg samples of IPTG-induced samples containing 
TbiPGAM. Lanes 1 (His-tagged) and 2 (un-tagged) are BL21 (DE3), 
lanes 3 (His-tagged) and 4 (un-tagged) are Rosetta 2 (DE3) pLysS, 
lanes 5 (His-tagged) and 6 (un-tagged) are BL21 (DE3) Gold and 
lanes 7 (His-tagged) and 8 (un-tagged) are BL21 (DE3) Codon Plus. 
The red arrow indicates the over expressed TbiPGAM.  
 
3.7 Purification steps for TbiPGAM 
The high percentage of sequence identity between LmiPGAM and TbiPGAM 
suggested that both proteins may exhibit similar behaviour during purification stages. 
Hence, it was decided that a similar approach should be employed for the latter 
enzyme. In this experiment however, TbiPGAM eluted from IMAC was divided into 
two separate additional purification steps: i) desalting and ion-exchange steps 
analogous to LmiPGAM purification or ii) an additional gel filtration step without the 
other two polishing steps.  
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i) Step one: immobillised metal-affinity chromatography 
As discussed previously in section 3.4 i, the cell lysate containing TbiPGAM was 
applied to a 5 ml Fast Flow IMAC column (GE Healthcare). As intended, the His-
tagged TbiPGAM attached to the matrix, while the unbound proteins were washed 
away in the flow-through in the absence of imidazole. The increase of imidazole 
concentration to 25 mM resulted in weakly-bound proteins being eluted, as shown by 
the small UV peak at A280 nm (Figure 3.13 a). A step-wise increase to 500 mM 
imidazole eluted a sharp UV peak at A280 nm corresponding to essentially pure 
TbiPGAM (Figure 3.13 b). The total protein yield from 1 litre of culture was 





Figure 3.13 a)  The elution profile of TbiPGAM from a 5 ml Fast Flow IMAC 
column resulting in two distinct elution sections (1 and 2) as well as an 
earlier flow-through (F/T) fractions (blue trace). b) A 12% SDS-PAGE 
is shown with 2-4 µg samples of each protein fraction with initial 
extracts (I), flow-through (F/T) and eluates from sections 1 and 2. The 
red arrow shows protein corresponding to the size of His-tagged 
TbiPGAM (62.9 kDa). The protein markers are shown as M and 
labelled as kDa.   
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ii) Step two: desalting 
Pooled fractions of TbiPGAM from the IMAC step were applied to a HiPrep 26/10 
column, a pre-packed Sephadex G-25 Fine column for desalting. As depicted in 
Figure 3.14 a, a large UV peak at A280 nm corresponding to TbiPGAM was observed. 
The subsequent increase in conductivity (brown trace) indicates the elution of salts or 
any other smaller molecules, as also observed in Figure 3.7 for LmiPGAM. Through 
SDS-PAGE analysis (Figure 3.14 b) a conspicuous band corresponding to the size of 
TbiPGAM was observed, indicating the presence of essentially protein suitable for 
the subsequent chromatography step. 
iii) Step three: ion-exchange chromatography 
An identical procedure as LmiPGAM was conducted for TbiPGAM, where a shallow 
gradient elution was performed by increasing the concentration of NaCl to a 
maximum of 1 M. The resulting UV protein peaks are illustrated in Figure 3.15 a, 
where similar elution pattern to that for LmiPGAM was obtained, albeit with poorer 
separation and different relative peak heights. The peak differences from the 
previous LmiPGAM experiment may indicate that both enzymes experienced 
different distribution of conformers or oligomers. Nevertheless, it is also plausible 
that the length of elution has to be increased, to obtain a better peak separation, as the 
resolution of the column is identical to the previous ion-exchange chromatography 
for LmiPGAM. SDS-PAGE analysis exhibited essentially identical protein bands 
corresponding to the TbiPGAM molecular mass in all the fractions (Figure 3.15 b). 
Lower molecular mass bands were also observed, which may well be the 




Figure 3.14  a)The elution profile of TbiPGAM from the HiPrep 26/10 desalting 
column showed a single protein peak (blue trace), and a peak with salt 
and smaller molecules (brown trace). b) A 12% SDS-PAGE is shown 
with 2-4 µg samples of each protein fraction corresponding to the blue 
trace. The red arrow indicates the proteins corresponding to the size of 
His-tagged TbiPGAM (62.9 kDa). The protein marker is shown as M 




Figure 3.15 a) The elution profile of TbiPGAM from the MonoQ 5/50 GL column 
showed three poorly-separated peaks (blue trace), labelled 1, 2 and 3. 
b) A 12% SDS-PAGE is shown with 2-4 µg samples of each protein 
fraction (blue trace). The red arrow shows proteins corresponding to 
the size of His-tagged TbiPGAM (62.9 kDa). The protein markers are 
shown as M and labelled as kDa.   
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iv) Alternative to desalting and ion-exchange steps: Gel filtration  
A portion of essentially pure TbiPGAM from the initial IMAC purification was 
applied to a Superdex 200 10/300 GL column, for post-purification analysis as well 
as for a ‘polishing’ step. As depicted in Figure 3.16 a, two UV peaks could be 
observed, although it is apparent that peak separation was not optimal. Samples 
corresponding to the eluted fractions were analysed individually by SDS-PAGE 
(Figure 3.16 b), and indicated pure protein bands conforming to the molecular mass 
of TbiPGAM. Kinetic measurements of TbiPGAM were carried out using pooled 





Figure 3.16  The elution profile of TbiPGAM from a Superdex 200 10/300 GL 
column showed two overlapping peaks (blue trace) labelled 1 and 2, 
as well as a peak containing salt and smaller molecules (brown trace). 
b) A 12% SDS-PAGE is shown with 2-4 µg samples of each protein 
fraction corresponding to the blue trace. The red arrow shows the pure 
proteins corresponding to the size of His-tagged TbiPGAM (62.9 




As the primary step in any protein characterisation analysis, purification methods 
required careful optimisation in order to yield high purity proteins. The 
chromatography method for macromolecular separation has to be wisely chosen, in 
order to obtain pure and well-separated macromolecules, either in the initial or 
polishing step of purification. An IMAC column provides an excellent tool to obtain 
the initial specific protein of interest, but nevertheless required post-purification steps 
to eliminate similar proteins and to exchange into the correct buffer.  
 Both His-tagged and un-tagged LmiPGAM and TbiPGAM expression 
systems have been developed by the Brussels and Edinburgh research groups, 
respectively. Only the LmiPGAM His-tagged proteins were chosen to be purified, 
because the method was more efficient in yielding high-purity protein samples. 
Despite that the un-tagged TbiPGAM overexpression was better than the His-tagged 
version, the same purification approach as LmiPGAM was adopted, due to the 
efficiency of the protocol and to provide direct comparisons with the former enzyme.       
Ni2+ was selected as the metal ion to interact with the His tags, as opposed to Co2+ in 
the previous single-step purification protocol implemented by Chevalier et al. 2000, 
Guerra et al. 2004 and Poonperm 2005. This modification is vital to avoid any 
residual Co2+ ions to be entrapped in the pure proteins. Subsequently, a desalting step 
was employed to remove imidazole and excess salt, followed by an ion-exchange 
chromatography. SDS-PAGE analysis revealed the presence of high purity 
LmiPGAM and TbiPGAM at each purification stage, indicating the probability of 
obtaining decent structural and biophysical data for both trypanosomatid iPGAMs. It 
is noteworthy that the purity and yield of LmiPGAM which were obtained in this 
study was similar to the previous literature (Poonperm 2005), but the additional ion-
exchange chromatography step provides the possibility of achieving different 
conformations or oligomeric states of the same protein.     
It is indeed interesting to note that ion-exchange chromatography revealed the 
possibility for LmiPGAM to be further separated based on its biochemical and 
biophysical properties, as will be described in chapter 4. The yield of pure 
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LmiPGAM was found to be 20 mg from one litre of cell culture following the 
standard expression method, whereas the TbiPGAM yield was significantly higher 
with 59 mg from a litre of cell culture. The higher TbiPGAM production compared to 
the previous literature (Chevalier et al. 2000; Poonperm 2005) may well be the 



















Chapter 4:  
The Different Forms and Multiple Oligomeric States of Trypanosomatid 
iPGAMS 
4.1 Aims 
The cofactor-independent iPGAM from L. mexicana has been characterised 
extensively, with many observations being related to its dependency for Co2+, as well 
as to structural analyses of the existing closed conformation (Poonperm 2005; Guerra 
et al. 2004; Nowicki et al. 2009). These findings have improved an understanding of 
the structure, function and mechanism of action for the enzyme tremendously, 
thereby providing significant encouragement for trypanosomatid iPGAM as a drug 
target. Nevertheless, from a structural point of view and in relation to drug design, 
knowledge of the open-form structure would be equally beneficial for virtual 
screening. This is particularly true for LmiPGAM because the active site in the 
closed conformation in the presence of substrate and Co2+ is very small, and is poorly 
accessed from the solvent, while the open conformation possesses a wider cleft 
between the two domains (Figure 4.1). It is vital therefore to characterise the 
behaviour of the enzyme biophysically, in order to identify conditions in solution in 
which LmiPGAM adopts the open conformation for the purpose of drug design and 
screening. 
The previous chapter has discussed the three significant well-separated 
fractions eluted from the anion-exchange column, as post purification to Ni2+-IMAC 
and desalting steps. The iPGAM samples in P1, P2 and P3 were indistinguishable by 
SDS-PAGE, so further analysis was required to identify the reasons for the different 
behaviour on the ion-exchange column. The differences in the elution volume may 
well be correlated to the metal binding and content of the enzymes. Apart from this, 
it was also plausible that the differences between each peak were the consequence of 
different oligomeric states or variations in protein folding, where this eventually 
leads to different forms of LmiPGAM. Hence, the main aim for this chapter was to 
characterise the three distinct peaks from the ion-exchange column, which may 










 Figure 4.1 a) The closed form iPGAM with a poorly accessible active site 







Proteins start to fold during the translational process, and may experience 
modifications before, during, or after release from the ribosomes. It has been 
proposed that protein chains, or polypeptides, obtain three-dimensional structure as 
well as altered dynamics during the translational process (Ellis et al. 2009; Gomes 
and Wittung-Stafshede 2011). From the ribosome, the majority of proteins fold into 
their characteristic functional three-dimensional structures with their preferred 
functional shapes or conformations (Alberts et al. 2008). This process is extremely 
important since the three-dimensional structure is essential for a protein’s functional 
role. Nevertheless, conformational transitions can occur and this normally involves 
the relative movement of almost rigid structural elements. In the majority of proteins, 
these domain motions are explicitly vital for protein functions, specifically for 
enzymes in catalysis (Tama and Sanejouand 2001). An example of such phenomena 
has been observed in citrate synthase, which is a two-domain protein. The binding of 
coenzyme A induces an 18° rotation of the small domain around an axis close to 
residue 274 that represents the hinge (Remington et al.1982; Huber and Bennett 
1983; Wiegand and Remington 1986; Tama and Sanejouand 2001). Consequently, 
this triggers the closure of the cleft between the two domains, where the substrate 
binding site lies (Tama and Sanejouand 2001). Moreover, mutations of specific 
residues resulting in amino acid substitutions can also alter the equilibrium between 
the open and closed conformations of some proteins (Nallamsetty and Waugh 2007). 
Often too, these conformational transitions consequently effect the activation and 
inactivation of protein, as observed in some cases (Wu et al. 2009; Olsson and Wolf-
Watz 2010). 
Proteins have also evolved through oligomerisation phenomena, where two or 
more polypeptide chains were associated together (Ali and Imperiali 2005). Various 
factors contributing to dimerisation, as well as the effects on the structure and 
function of proteins have been extensively discussed (Marianayagam et al. 2004; Ali 
and Imperiali 2005). This is mostly related to molecular stabilisation, supporting 
functionality, and sometimes reported to be disadvantageous to the enzyme activity. 
In this chapter, further characterisation of iPGAM will unravel the potential of the 
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previously reported monomeric enzyme to form a dimer, which is a new 
development in understanding the behaviour of iPGAM. 
4.3 Modelling the L. mexicana iPGAM open-form structure 
In the absence of the availability of a crystal structure of the open form of 
trypanosomatid iPGAM, a model had to be generated. This was important to provide 
the basis for molecular interpretations of experimental data. Previously, the closed-
form structure of L. mexicana iPGAM was solved in the presence of the substrate 
3PGA at both high and low Co2+ concentrations (Poonperm 2005; Nowicki et al. 
2009). Nevertheless, as mentioned above, an open-form model of LmiPGAM would 
also be important, to facilitate a preliminary understanding of the structural 
variations of the enzyme, as an outcome of domain movements. Prior to the work 
described in this thesis, the open-form crystal structure of iPGAM from B. anthracis 
(Nukui et al. 2007) had been obtained, and was the best option to generate an 
LmiPGAM model. As described in chapter 1, BaiPGAM has ~33% sequence identity 
to LmiPGAM, and was the closest open-form structure available for the modelling at 
the time. However, more recently, an open-form structure of T. brucei iPGAM (PDB 
ID 3NVL) (Mercaldi et al. 2012) with its ~78% identity to LmiPGAM has been 
reported, which has shed further light on understanding the almost rigid yet flexible 
domain movements of the enzyme. The next section will focus on the modelling of 
open-form LmiPGAM based on the crystal structures of BaiPGAM and TbiPGAM.      
i) Modelling based on B. anthracis open-form structure 
The crystal structure of the open form of BaiPGAM comprises two distinct domains: 
phosphatase and transferase domains, connected by two short peptide linkers: linker 
1 and 2 (Figure 1.5 chapter 1). The crystal structure was solved at 2.40 Å and 
exhibits the occupation of Mn2+ in both metal sites in the presence of a water 
molecule. This structure was shown to be in the open conformation when compared 
to the previous B. stearothermophilus iPGAM structure which was solved in the 
presence of 3PGA (Jedrzejas et al. 2000a) or 2PGA (Jedrzejas et al. 2000b), with two 
Mn2+ ions in each structure.  
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The open-form BaiPGAM structure was used as a template to predict the 
open-form model of LmiPGAM by using Friend for MODELLER, a program used 
for homology and comparative modelling of protein three-dimensional structures by 
using an integrated analytical front-end application for bioinformatics (Abyzov et al. 
2005). The method used to generate the structure has been described in chapter 2. 
Figure 4.2 illustrates the superposition of the model of LmiPGAM with the closed 
form crystal structure (PDB ID 3IGY). The recent publication of the open-form 
structure of TbiPGAM has shown that its structure is substantially different from that 
of open-form BaiPGAM, and it is likely that the more closely related TbiPGAM now 




Figure 4.2  The overlay of the closed-form structure of LmiPGAM (PDB ID 3IGY) 
(blue) with the generated open-form model (red) based on BaiPGAM 




ii) T. brucei iPGAM open-form structure 
It is indeed interesting for LmiPGAM to be compared to the recently reported open-
form monomeric structure of TbiPGAM. It is likely that both enzymes can exist in 
similar forms, either in the closed or open states, since both shares a high percentage 
of sequence identity (78%). As depicted in Figure 4.3, the structure of TbiPGAM 
consists of the two typical phosphatase and transferase domains of iPGAMS. The 
prediction of the hydrodynamic radius of the open form of LmiPGAM will be more 
accurately based on the TbiPGAM structure, rather than on that of BaiPGAM.   
The structural comparisons suggest the possibility that trypanosomatid 
iPGAMs (and possibly plant iPGAMs) belong to one family, while the bacterial 
iPGAMs belong to another different family. A sequence alignment of iPGAMs from 
various organisms (see chapter 1) indicates that the enzyme could be divided into 
two distinct families, where trypanosomatid iPGAMs are grouped together with plant 
iPGAMs, whereas the iPGAMs from bacteria, nematodes, fungi and algae could be 
categorised in another family (Linda Gilmore, unpublished data). This suggestion 
coincidentally fits with the proposed one-metal mechanism (Nowicki et al. 2009), 
which suggests that iPGAMs from trypanosomatids utilise only one metal site during 
catalysis, which is suspected to be similar with plant iPGAMs. The bacterial 
iPGAMs (Jedrzejas et al.2000a; Jedrzejas et al. 2000b) on the hand, function with a 
two-metal mechanism. It is plausible that the bacterial enzymes possess a larger open 
conformation because the two metal sites are involved in catalytic function, whereas 
trypanosomatid iPGAMs perform their function with a further reduced open 





4.4 Hydrodynamic radii of iPGAMs  
i) Closed-form crystal structure of LmiPGAM and open-form crystal 
structure of TbiPGAM 
The hydrodynamic size of the open and closed conformation, as well as the monomer 
and dimer states of the enzyme can be predicted using the solved crystal structures. 
This can be performed by using HYDROPRO software (Garcia de la Torre et al. 
2000; Ortega and Garcia de la Torre 2007; Ortega et al. 2011), which enables the 
measurement to be employed as an indication of the hydrodynamic properties of the 
globular proteins from their atomic level structure. The calculated measurement 
however, relies on a number of geometric assumptions, such as shapes, which can be 
either simple (ellipsoids and cylinders) or more arbitrarily complex (Ortega and 
Figure 4.3 TbiPGAM (PDB ID 3NVL) crystallised in its open conformation 
(Mercaldi et al. 2012). 
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Garcia de la Torre 2007), and may deviate from the experimental values. On the 
other hand, PyMol software (DeLano Scientific 2002) can be used to determine the 
maximum dimension of proteins in the crystal lattice. It is noteworthy that the 
maximum dimensions from the crystal structures of monomeric LmiPGAM, 
TbiPGAM open-form monomeric structure, and BaiPGAM open-form monomeric 
structure using the latter method were performed without standardising specific 
residues in each molecule. Nevertheless, this was done by selecting the widest 
distance that corresponds to the rotational diameter of the proteins.  
Table 4.1 The hydrodynamic properties for the closed-form monomeric 
LmiPGAM, and the open forms of both TbiPGAM and BaiPGAM. 
The values were obtained from the HYDROPRO software, and from 
PyMol representations of the crystal structures. The molecular masses 
used in this analysis correspond to the un-tagged version of the 
proteins.   


































The results from HYDROPRO show that the open-form BaiPGAM is the 
largest molecule, with Stoke’s radius (also known as hydrodynamic radius, Rh) of 
3.61 nm, followed by the open-form TbiPGAM (3.41 nm) and the closed-form 
LmiPGAM (3.21 nm). The radius of gyration (Rg) from the three samples also 
display similar pattern in all samples, where BaiPGAM >TbiPGAM > LmiPGAM 
(Table 4.1). In this case, the apparent differences between the two types of radii are 
due to the consideration of the hydration layer for hydrodynamic radius, which 
includes the effects of both the solvent (hydro) and shapes (dynamic) 
(http://ecoserver.imbb.forth.gr/pdf/hydrodynamic_radius.pdf). The radius of 
gyration, on the other hand, is a measurement of the root mean square radius of the 
molecule from a given axis or its centre of gravity. Both radii are illustrated in Figure 
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4.4. The relationship between Rh and Rg has been discussed by Zif et al. 2008, where 
a simple geometrical calculation exhibits that for a spherical globule, Rg/Rh = √(3/5). 
As mentioned above however, there may be some deviations from the experimental 
results, as also been discussed by Zif et al. 2008. The experimental diffusion 
measurements of globular proteins exhibit larger hydrodynamic radii than the 
calculated values, which is a consequence of the solvation shell (a layer of weakly-
bound water molecules) that is present around folded proteins (Zif et al. 2008). These 
comparisons are found to be similar to iPGAM in the later section (see section 4.5 
iii).  
 
Figure 4.4 The radius of gyration (Rg) and the hydrodynamic radius (Rh) for a 
spherical globule indicated in red and cyan lines. The protein 
molecule is the closed-form LmiPGAM. 
 
A significant observation from the structural comparisons shown in Figure 
4.5 is that the trypanosomatid iPGAM open conformation (Figure 4.5c) is strikingly 
different in shape from the bacterial open form (Figure 4.5b). The open conformation 
of LmiPGAM is predicted to have a very similar hydrodynamic size to that of the 
open conformation of TbiPGAM because of the strong sequence conservation. 
BaiPGAM possesses a more “open” conformation than the TbiPGAM open 
conformation, or the proposed open form of LmiPGAM. On the other hand, the 
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maximum dimension as measured from the crystal lattice for BaiPGAM is ~8.49 nm. 
The open-form structure of TbiPGAM exhibited a rotational diameter of ~8.13 nm, 
followed by the closed form structure of LmiPGAM with ~7.66 nm. Nevertheless, 
the trends of both the calculated hydrodynamic sizes, as well as the maximum 
dimensions from the crystal lattice were very similar, where the open conformation 
of BaiPGAM is larger than that of TbiPGAM, and the closed-form LmiPGAM is the 
smallest molecule.  
Table 4.2 The differences between the calculated hydrodynamic diameter and 
the maximum dimension from the crystal lattice. 
Protein Hydrodynamic diameter from 
HYDROPRO (nm) 
Maximum dimension from 


















Figure 4.5  The maximum dimensions of a) LmiPGAM (PDB ID 3IGY) monomeric 
closed-form structure, b) BaiPGAM (PDB ID 2IFY) monomeric open-
form structure, and c) TbiPGAM (PDB ID 3NVL) monomeric open-








                
Figure 4.5 contd. 
 
4.5 Characterisation of the peaks from ion-exchange chromatography of 
LmiPGAM 
As described in chapter 3, three well-separated LmiPGAM protein peaks were 
obtained from the third-step of purification using the anion-exchange column. It is 
relevant to characterise these peaks using various biochemical and biophysical 
methods, with a view to identify the reasons for their different elution behaviour. The 
differences in the elution positions may indicate different charge distribution on the 
surface of the protein molecules because of distinct structural forms or oligomeric 
states. These observations may be a result of post-translational modifications of the 
proteins to form oligomers (Wang et al. 2008), or may be a consequence of 
conformational transitions of the correctly folded polypeptides to create different 





molecular masses as indicated by SDS-PAGE analysis (see chapter 3). The main 
question would be whether LmiPGAM, previously reported as a monomer of ~60.7 
kDa, has the ability to form oligomers in solution. Hence, in the next sections, the 
biophysical properties of each peak will be discussed in detail.   
i) Specific activity measurement  
It was important to ensure that all peaks were active and did not exhibit a loss of 
activity, which may well be a result of incorrectly folded protein. In this initial 
experiment, a continuous enzyme assay was employed, in which the activity of 
LmiPGAM was monitored by observing the decrease absorbance of NADH at A340 
nm. In this particular experiment, the three samples, P1, P2 and P3 were incubated 
with 0.1 mM Co2+ at 25°C, and the activity measurement was carried out at various 
time of incubation. The initial (time 0) specific activities for all three samples were 
observed to be similar: 20, 19.8 and 15.9 µmol.min-1.mg-1 for P1, P2 and P3, 
respectively. The activities were also measured after 15 min, 1, 3, 6, 9, 18, 24 and 48 
h of incubation.  
The results, as shown in Figure 4.6, provide an interesting observation, where 
the activities of each individual LmiPGAM increased hyperbolically, and displayed 
significant differences in the trend of activity increment. Although the initial 
activities of the three samples were similar, P1 exhibited a substantial increase 
throughout the incubation period, resulting in almost 2-fold to 3-fold higher activity 
compared to P2 and P3. After 48 hours, the activity of P1 has reached a “plateau” or 
stationary phase, where the maximum activity of Ni2+-IMAC purified enzyme has 
almost been obtained. Both P2 and P3 on the other hand, still required longer 
incubation to reach their maximal activities. These observations indicate a distinctive 
regulation of activity for P1, compared to P2 and P3. The variation may well be a 
consequence of the flexibility of the protein around the active site (Fieulaine et al. 
2011), where the catalytic site of LmiPGAM in this case, is located in the cleft 
between two functional domains. This may have resulted in the active and inactive 
states of the enzyme, which coincidentally could be distinguished using the ion-
exchange step. The active state may be correlated to the closed conformation of the 
 
104 
enzyme, which may exist in the presence of the substrate 3PGA, as well as divalent 
metals which occupy the metal sites. The effect of the substrate and metal will be 
discussed in section 4.5 iii. The open-form conformation, on the other hand, may 
well be the inactive state of the enzyme in the absence of ligand, either the substrate 
or the metal. It is too early at this stage to definitively conclude the factors involved 
in contributing to the distinct specific activities, but may well be a direct 
consequence of the conformational differences between the well-separated samples. 
While most enzyme-catalysed reactions occur at a very fast rate, this result showed 
that it is not the case for the LmiPGAM in P2 and P3. This may indicate major 
































Figure 4.6 The specific activities of LmiPGAM P1, P2 and P3 after incubation 
with 0.1 mM Co2+. The specific activity was found to be similar prior 
to incubation, but was significantly enhanced during the incubation 
period, especially for P1. The maximum value for P1 is calculated to 
be 159.8 µmol.min-1.mg-1, whereas P2 and P3 maximum values are 
found to be off-scale. The off-scale refers to the slow pace of activity, 








ii) Gel filtration  
Gel filtration is based on the separation of proteins according to their sizes and 
shapes. This technique is not only utilised for the purpose of purification, but also as 
an analytical method for biophysical characterisation. In this study, a Superdex 200 
10/30 GL chromatography column was utilised for the experiment, and the protocol 
was as explained in detail in chapter 2. This technique was anticipated to provide 
indications of the properties of the three peaks based on their estimated molecular 
masses. Using a calibration standard for molecular mass determination, in which the 
gel phase distribution coefficients (Kav) of the standard proteins were plotted against 
the logarithm of their respective molecular masses, (see Appendix I (c)), the 
molecular masses of the three peaks were estimated. The results indicated variations 
in the oligomeric states of LmiPGAM, and also provided some indications of the 
existence of different conformations.  
As depicted in Figure 4.7, P1 exhibited a single sharp UV elution peak, with 
an estimated molecular mass of 57.7 kDa and an elution volume of 14.14 ml, 
indicating the presence of a single monomeric species in the sample. P2 eluted at a 
slightly earlier volume compared to P1, resulting in elution at 13.98 ml. Interestingly, 
however, the molecular mass of P2, which is estimated to be 60.3 kDa also 
corresponds to a monomeric protein. These results indicate that both P1 and P2 may 
plausibly exist in monomeric states, but may exhibit different conformations, 
resulting in a delayed elution volume for P1. The apparent smaller conformation of 
P1 may indicate that the species exists in the closed form, assuming LmiPGAM is in 
a normal, globular compact shape where the two domains are clasped close together 
resulting in a smaller radius, whereas P2 may well be in the open form. There is also 
a very small shoulder peak in P2 that eluted at 12.32 ml, in which the size may 
correspond to a dimeric LmiPGAM. This observation thus suggests that P2 may well 
have a trace of dimer in the predominately monomeric sample.  
The P3 sample exhibited two major peaks which were eluted at significantly 
different retention volumes. The first peak eluted at 12.16 ml, corresponding to a 
molecular mass of 127.8 kDa, whilst the second much larger peak eluted at around 
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the same retention volume as for P2: 13.95 ml, which corresponds to 63.2 kDa. 
These peaks again correspond to dimeric and monomeric states of LmiPGAM, but 
with a higher proportion of the dimeric form compared to P2. Consequently, this 
observation further supports the idea that LmiPGAM dimerises in solution, despite 
the monomeric nature of the protein obtained from the crystal structure.  
It is therefore suggested that LmiPGAM, by separation through the ion-
exchange column after being initially purified by Ni2+-IMAC, could be distinguished 
into different conformations and oligomeric states. These preliminary observations 
however, could be overestimated since the predicted molecular masses were relative 
to the calibration standards, and also might be concentration dependent. In the next 
few sections, further characterisation of the three peaks will be described, including 
size-exclusion chromatography coupled with multi-angle light scattering (SEC-








Figure 4.7 Gel filtration analysis of LmiPGAM P1, P2 and P3. P1 was eluted as a 
single monomeric peak at 14.14 ml, which corresponds to the size of 
57.7 kDa. P2 was eluted at a slightly earlier volume (13.98 ml) and 
corresponds to the size of 60.3 kDa. Both P1 and P2 are postulated to be 
monomeric proteins with different shapes and conformations. P3 on the 
other hand, was shown to be eluted as double peaks: the earlier peak 
was eluted at 12.16 ml, and estimated to possess a molecular weight of 
127.8 kDa while the latter peak was eluted at 13.95 ml and corresponds 
to 63.2 kDa. P3 was thus predicted to contain a mixture of monomeric 







iii) Dynamic Light Scattering 
Proteins in solution undergo constant random diffusion phenomena known as 
Brownian motion. This type of motion is advantageous for measuring the sizes and 
shapes of particles such as proteins in solution. Dynamic light scattering is one 
available method to measure the hydrodynamic size of proteins based on their 
diffusional properties. The size is frequently expressed in terms of the hydrodynamic 
diameter or the Stoke’s radius (which corresponds to half the hydrodynamic 
diameter). It is important to note that these sizes correspond to the diameter of a hard 
sphere that diffuses at the same rate as the protein. These are inherently more 
extended molecules that are not perfectly spherical, and the hydrodynamic diameter 
of a protein is therefore less than its maximum rotational diameter.  
 In this particular experiment, the hydrodynamic diameters of the three 
LmiPGAM peaks were determined in the absence of additives, and also in the 
presence of 1.5 mM 3PGA as the substrate and low (0.1 mM) and 1 mM (high) Co2+ 
concentrations. These conditions exhibit the highest activity, and are also the 
conditions used for the previous enzyme assay. These measurements were an 
important tool in predicting the characteristics of the three peaks, which interestingly 
differed from one another in terms of specific activity, as was discussed in section 
4.5 i. The protein concentrations of all samples were standardised to 1 mg/ml, the 
measurements were repeated in triplicate, and incubation with additives were carried 
out for 1 hour at 25°C. The mode values of the hydrodynamic diameters of the 
protein molecules in P1, P2 and P3 are tabulated in Table 4.3a and b, and reported as 
both intensity and volume distributions (see below). In Figure 4.8 the hydrodynamic 
diameters (intensity distribution) for these samples in the absence of additives are 
shown. The results exhibit that the hydrodynamic diameters for all measurements by 
intensity distribution are larger than those of the volume distribution. This is because 
the intensity of the scattering is proportional to the diameter to the power of 6 (d6), 
which is based on the Rayleigh approximation. Meanwhile, the hydrodynamic 
diameter by volume distribution is based on the volume of a sphere, which equals to 
4/3π(d/2)3. It is noteworthy that the hydrodynamic diameter by intensity distribution 
is closer to the predicted values from the HYDROPRO software (see Table 4.3c), as 
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well as the measured maximal rotational diameter from the solved crystal structure 
(see section 4.4i). Hence, for the purpose of comparing the experimental and 
calculated values, only the hydrodynamic radius by intensity distribution was taken 
into account. 
The results indicate that P1, which is postulated to be a monomeric closed 
form of LmiPGAM is estimated to have a hydrodynamic diameter of 6.965 ± 0.184 
nm by intensity distribution. The addition of the substrate 3PGA caused a small 
effect on the hydrodynamic size by intensity distribution, showing a decrease of only 
~ 0.063 nm of hydrodynamic diameter, suggesting that this particular sample was not 
altered by the addition of 3PGA. The addition of both the substrate 3PGA and 0.1 
mM Co2+ however, shifted the hydrodynamic size to a larger diameter (Table 4.3a). 
The addition of the substrate 3PGA to P2 resulted in a slight decrease of the 
hydrodynamic diameter by 0.117 nm compared to the native sample, although further 
addition of 0.1 mM Co2+ into the sample provoked a major increase of the 
hydrodynamic size. Peak P3, which had a larger proportion of material eluting at ~12 
ml, showed a substantial shift of hydrodynamic diameter (0.786 nm), also indicating 
a smaller form of iPGAM with the addition of the substrate 3PGA. Nevertheless, in 
the presence of 0.1 mM Co2+, the hydrodynamic diameter shifted to a larger value 
(see Table 4.3a).  
These results suggest that the substrate 3PGA had a relatively small effect on 
the conformation or on the oligomeric state of the three samples. However, Co2+ at a 
concentration of 0.1 mM substantially increased the hydrodynamic size, although the 
mechanism is not totally understood. The hydrodynamic diameter differences 
between the closed-form LmiPGAM and the open-form TbiPGAM from the 
calculated values are ~0.40 nm (Table 4.3c), whereas the experimental closed and 
open-form of LmiPGAM (P1 and P2) the diameter differences are found to be ~0.55 
nm. Both sets of results indicate that the open-form is larger than the closed 
conformation, and agree with the previous crystallisation condition (Poonperm 2005) 
that reported the requirement of 3PGA in obtaining the closed form structure.  
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A second experiment was then conducted, where only P2 and P3 were 
analysed in the presence of 1 mM Co2+. It was assumed that an insignificant effect 
would be observed on P1, as indicated in the first experiment, and was not included 
in this analysis. The results, as shown in Table 4.3b, showed that samples in the 
presence of 1 mM Co2+ exhibited a substantial change when incubated with 1 mM 
Co2+. The reported hydrodynamic diameters were larger than the maximal rotational 
diameter of even a dimeric form of iPGAM, and perhaps correlated with the 
formation of higher order oligomers or of aggregated molecules. 
Table 4.3  a) The estimated hydrodynamic diameters for LmiPGAM P1, P2 and 
P3 in the presence and absence of substrate and low Co2+ 
concentration, incubated for one hour. The one hour incubation was 
performed based on the results from the previous specific activity 
measurement (see section 4.5i), which corresponds to the time to 
reach half of the maximum activity. Results are expressed in both 
intensity and volume distributions. b) Similar results are shown in the 
presence and absence of substrate and high Co2+ concentration. c) The 
comparison between the calculated values from HYDROPRO 
software and the experimental values.  
 
Experiment 1 – low Co2+ (0.1 mM) 
 
Samples  
Mode value of 
hydrodynamic diameter 
(nm) by intensity 
distribution 
Mode value of 
hydrodynamic 
diameter (nm) by 
volume distribution 
P1 native 
P1 with 1.5 mM 3PGA 
P1 with 1.5 mM 3PGA and 0.1 mM Co 
P2 native 
P2 with 1.5 mM 3PGA 
P2 with 1.5 mM 3PGA and 0.1 mM Co 
P3 native 
P3 with 1.5 mM 3PGA 
P3 with 1.5 mM 3PGA and 0.1 mM Co 
6.965 ± 0.184 
6.902 ± 0.95 
7.239 ± 0.132 
7.523 ± 0.202 
7.406 ± 0 
8.531 ± 0.787 
8.787 ±  0.613 
8.001 ±  0.212 
9.77 ± 0.45 
5.44 ± 0.147 
5.613 ± 0 
5.117 ± 0 
5.882 ± 0.272 
5.975 ± 0.314 
6.452 ± 0.298 
6.359 ± 0.444 
6.368 ± 0.624 






Experiment 2 – high Co2+ (1 mM) 
Samples 
Mode value of 
hydrodynamic diameter 
(nm) by intensity 
distribution 
Mode value of 
hydrodynamic 
diameter (nm) by 
volume distribution 
P2 native 
P2 with 1 mM Co 
P2 with 1.5 mM 3PGA and 1 mM Co 
P3 native 
P3 with 1 mM Co 
P3 with 1.5 mM 3PGA and 1 mM Co 
8.251 ± 0.22 
29.17 ± 0.77 
19.02 ± 2.08 
9.569 ± 1.027 
29.68 ± 2.321 
19.73 ± 1.328 
6.452 ± 0.29 
20.48 ± 0.945 
10.85 ± 3.602 
6.563 ± 0.49 
20.53 ± 1.896 
13.67 ± 1.234 
 
 
Conformations Experimental values (nm) 
(LmiPGAM) by intensity 
distribution 




Difference between open and closed 
conformations 
6.97 ± 0.184 


























      







         
Figure 4.8: The hydrodynamic sizes of LmiPGAM a) P1, b) P2 and c) P3 by 
intensity distribution, which is based on the relative intensity of the 
scattered light from the protein molecules in the samples been 
measured. All experiments were conducted in triplicate, and individual 
measurements are shown in red (replicate 1), green (replicate 2) and 













































iv) Native-PAGE analysis 
Polyacrylamide gel electrophoresis (PAGE) is a convenient technique for protein 
analysis, and is based on the uniform pore size of the gel. While SDS-PAGE is a 
technique used to separate proteins by molecular mass after treatment with SDS (see 
chapter 2), native-PAGE has the ability to separate proteins in the absence of SDS 
into their different conformations and surface net charges. However, it is often 
challenging to interpret the results unambiguously since the mobility of a protein 
may reflect both its conformation and surface net charge. Moreover, the success of 
the analysis also depends on the pI of the protein. Proteins with pI above the pH of 
the PAGE running buffer migrate backward or "retro-phorese" into the upper buffer 
chamber (http://www.nationaldiagnostics.com/article_info.php/articles_id/60). 
Hence, it is vital to ensure that the conditions for such analysis are appropriate for a 
particular protein. 
The pI of His-tagged LmiPGAM is 5.62, and the pH of the PAGE running 
buffer is 8.3, indicating that native PAGE could appropriately be employed to 
analyse the differences in the conformational or oligomeric states of the three 
samples: P1, P2 and P3. It is relevant to recall that all three samples were 
indistinguishable by SDS-PAGE (see chapter 3). Each peak, together with a sample 
of desalted protein without the ion-exchange step as a control (C) was loaded 
separately, with a protein amount of 5-10 µg per individual well. The protocol was 
explained in detail in chapter 2. The results, as indicated in Figure 4.9, showed that 
P1 is observed as a single prominent band, in contrast to P2 and P3 with additional 
multiple upper bands. P3 had a further additional band compared to P2. The upper 
bands in P2 and P3 may correspond to i) different conformations as a result of 
distinct charge distribution on the surface of the protein molecules, and/or ii) higher 
molecular masses due to different oligomeric states. It is indeed relevant to correlate 
the results with multiple conformations and/or oligomeric states of LmiPGAM. The 
control (C) also showed the presence of multiple bands, in a pattern similar to that of 
P3, which indicates that the ion-exchange step was crucial for separating the 
LmiPGAM into its different conformations and oligomeric states. In the next section, 
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SEC-MALS analysis will be discussed, as an additional powerful and 
complementary technique to characterise the samples.  
 
 
Figure 4.9   Native-PAGE analysis of LmiPGAM P1, P2 and P3. A 9% native-
PAGE is shown with 5 -10µg samples of each protein fraction. C is a 
control sample of pure LmiPGAM without an additional ion-exchange 
step.  
 
4.6 Size-Exclusion Chromatography coupled with Multi-Angle Light 
Scattering (SEC-MALS) 
i) Different oligomeric states are confirmed by SEC-MALS 
The downside of molecular mass determination from a conventional gel-filtration 
analysis is the reliance of the technique on calibration curves, in which relative 
comparisons are being made with a series of globular protein standards. By 
combining size-exclusion chromatography (SEC) to static multi-angle light 
scattering (MALS) or Rayleigh scattering, calibration standards are not required, and 
a direct measurement of the molecular mass can be independently employed. 
Following the earlier molecular mass determination by gel filtration, it was relevant 
to determine the absolute molecular mass of the three peaks: P1, P2 and P3 in order 
to confirm the presence of different conformations and/or oligomeric states of 
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LmiPGAM in solution. The experiment was conducted for the three samples, with a 
standardised concentration of 0.4 mg/ml for each peak (Figure 4.10). P1 exhibited a 
single peak eluting at ~13.9 ml with a calculated molecular mass of 58.23 kDa, 
which corresponds to monomeric LmiPGAM, and is smaller than the mass calculated 
from the sequence, 61.8 kDa. The peak was shown to be homogenous, and 
monodispersity was observed, indicating the presence of a single species in the 
solution. The peak was predicted to be in the closed conformation, and will be 
discussed in section 4.6iii.  
P2 exhibited a major peak eluting at ~13.4 ml, corresponding to a monomer 
at 59.1 kDa. In addition, the small peak eluting at ~11.6 ml had a molecular mass of 
114.9 kDa, indicating the presence of a dimeric form of the enzyme. The 
heterogeneous protein eluting before 11 ml may correspond to a mixture of higher 
order oligomers and aggregated proteins. The major peak was slightly asymmetric 
with a right-hand edge, indicating that the LmiPGAM in this peak might contain a 
small amount of the closed form in addition to the predominantly open form. P3 
clearly contained multiple forms of iPGAM, with a peak at ~11.6 ml, another peak at 
13.4 ml and a shoulder at 13.9 ml, in addition to heterogeneous protein eluting at 
~9.7 ml. The LmiPGAM molecules eluting at 13.4 ml and 13.9 ml were monomeric 
(56.88 kDa), presumably in the open and closed forms, respectively. The LmiPGAM 
eluting at 11.6 ml had a mass of 113.7 kDa, corresponding to a dimer, and the protein 
eluting at ~9.7 ml correspond to a tetramer (265.5 kDa). However, the vertical line 
corresponds to the molecular mass was broad, which may indicate that apart from a 
higher order oligomer, it may also contain aggregates (see Figure 4.10).  
Strong justification for the existence of multiple conformations and 
oligomeric states of LmiPGAM has been obtained, and this interestingly, correlates 
well with the earlier gel filtration and native-PAGE experiments. The results from 
SEC-MALS analysis are useful to determine more accurately the absolute molecular 
masses, and the results tally with the gel filtration results. Although the 
concentrations of the samples were dissimilar in these two analyses, they exhibit 
comparable results, in which the molecular mass in the gel filtration analysis was 
determined relative to protein calibration standards. This observation strongly 
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suggests that trypanosomatid iPGAM, although previously reported as a monomer, 
can also be present in a dimeric state in solution, as indicated by the properties of  P2 
and P3. These data also equated with the native PAGE results, which display the 
presence of upper bands in both samples, with P3 having more bands compared to 
P2. The additional upper bands may well be the consequences of sample aggregation, 
as also observed from the SEC-MALS analysis.    
The phenomenon of dimer formation from monomeric proteins has 
previously been discussed (Park and Raines 2000; Marianayagam et al. 2004; Ali and 
Imperiali 2005). The occurrence of such observations can be related to a domain 
swapping mechanism, where a monomeric protein reciprocates one of its domains 
with another segment of a monomer to form a homodimer (Figure 4.11), before 
residues been replaced to stabilise the dimeric form (Park and Raines 2000). 
LmiPGAM in this case however, exhibits the ability to exist both as a monomer and 
dimer in solution. This appearance has also been reported for some proteins that are 
known to exist in both the monomeric and oligomeric states, in which the 
interdomain interactions can occur either within a sole monomer or between 
monomer units (Liu and Eisenberg 2002; Ali and Imperiali 2005). A significant 
presence of polar and charged residues at protein intersubunit interfaces, which 
contributes to distinct surface charges in the two domains, may also encourage the 
formation of a dimer in monomeric proteins (D’Alessio et al. 1999). In this case, 
STP, a program which possesses the ability to predict protein-protein or protein-
ligand interactions by the molecule surface properties (Mehio et al. 2010) has been 
utilised for the purpose of predicting the most likely region to be involved in the 
interactions. The results, as shown in Figure 4.12, indicate the regions which are 
most likely to interact with other biomolecules (red), whereas the blue- coloured 
regions are less likely to form interactions. Nevertheless, the areas which are prone to 
form protein-protein interactions with another LmiPGAM molecule may well be 
spread out through the whole top and bottom regions of both the phosphatase and 
transferase domains. This may result in instability of the dimer molecule if it 
involves weaker interactions, as coloured in green or blue. Intriguingly, from the 
SEC-MALS data, there seems to be a dynamic equilibrium between a monomer and 
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dimer in LmiPGAM, where the presence of both states could be observed in P2 and 
P3 (Figure 4.10). It is indeed relevant to investigate this phenomenon in the presence 
of divalent metal ions in each sample, as this may contribute to the shift of 
equilibrium towards either a monomer or dimer. It is noteworthy also, that it is 
unlikely for the dimer formation to be mediated by disulfide bridges, because the five 











Figure 4.10   SEC-MALS analysis of LmiPGAM P1, P2 and P3, where the 
presence of monomeric species was indicated in the major peaks 
eluting between 13-15 ml. P2 and P3 also exhibited the presence of 
dimeric species in the peaks eluting at ~11.6 ml. A tetramer was 
observed in P3 in the peak eluting at ~9.7 ml. The molecular masses 
are shown as the horizontal lines corresponding to the colours of each 
peak. The essentially horizontal lines for the peaks at 13-15 ml 
indicate that the masses are consistent throughout the elution peak. 
However the lines for the peaks at 11.6 ml and 9.7 ml have vertical 
components indicating changes in molecular mass across the elution 
peak. The peak eluting at ~9.7 ml may contain a mixture of tetramer 
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Figure 4.12 STP analysis on the closed-form LmiPGAM (PDB ID 3IGY). The 
red regions represent the most likely areas for interactions with 
another molecule, whereas the blue regions are the least likely to 
form any inter-molecular interactions. The red circle represents the 
top of the phosphatase and transferase domains from one 
LmiPGAM molecule, which is likely to interact with the bottom of 
another LmiPGAM molecule (indicated with the black box). The 
formation of dimer may involve weaker interactions in the protein 






(ii)   The effects of Co2+ on LmiPGAM oligomeric states 
The presence of a dimeric form of iPGAM, in addition to the monomeric form has 
been determined in both P2 and P3 samples, as discussed in detail in the previous 
section. P1 however, consistently displayed the presence of only a single monomeric 
state in the sample. In the previous DLS experiment, the effect of 1 mM Co2+ was 
analysed in both P2 and P3, where the hydrodynamic diameter shifted into much 
larger sizes, which may indicate the presence of aggregated material in the sample. 
Although a similar treatment was not tested on P1, it would be interesting to observe 
if the presence of metal could prove likewise for P1. Hence, in the next SEC-MALS 
experiment, the three samples were incubated with 1 mM Co2+ for 1 h, before being 
analysed sequentially for reproducibility.  
 Figure 4.13 shows that P1 eluted predominantly as a monomeric peak at 14.3 
ml, with perhaps surprisingly a trace of dimer (not present in the absence of added 
Co2+) at 12.3 ml. The molecular mass of the monomeric form of the enzyme 
corresponds to 65.8 kDa, and the molecular mass of the dimeric form was found to 
be 126.4 kDa. The molecular mass of the monomeric P1 in the absence of Co2+ (see 
earlier section) was found to be 58.6 kDa, which was 7.2 kDa smaller than the value 
after incubation with 1 mM Co2+. P2 and P3, by contrast, each exhibited single 
peaks, which corresponded to monomeric species of 64.6 kDa and 71.4 kDa, 
respectively, although the quality of the P3 data had become poorer.  
It can be seen in summary that the incubation with 1 mM Co2+ has caused all 
three samples to adopt monomeric forms. It is also a striking observation that in the 
presence of Co2+, the molecular masses of all the monomeric peaks have increased, 
and the elution volumes were shifted to be slightly delayed, thus suggesting that it is 
possible that Co2+ caused iPGAM to become more compact. It is noteworthy 
however, that the sizes of the peaks which were eluted from the column in the 
monomer position (see Figure 4.13) were diminished for P2 and P3, compared with 
the result in the absence of Co2+ in Figure 4.10. This might be due to a large amount 
of aggregated material, which was eluted near the void volume (8 ml). Nevertheless, 
all samples exhibited similar molecular masses, although it is apparent that the 
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molecular mass of P3 was slightly inconsistent throughout the peak, indicating the 
heterogeneity of the sample. The formation of a small amount of dimer in P1 
however, is yet to be further analysed in the future. Nevertheless, the phenomenon of 
dimer formation caused by divalent metal ions has been discussed in other enzymes, 
such as β-Lactamases from Pseudomonas aeruginosa. It was reported that the 
dimeric form of this enzyme has been stabilised by a number of divalent metal ions 
(Danel et al. 2001). It is noteworthy that a similar experiment was attempted in the 
presence of Mg2+ and Zn2+ separately for LmiPGAM P2, but the protein precipitated 










Figure 4.13 SEC-MALS analysis of LmiPGAM P1, P2 and P3 in the presence of 1 
mM Co2+, where the presence of monomeric species was indicated in 
the distinct major peak. P1 surprisingly exhibited the presence of 
































































(iii) SEC-MALS analysis provides strong indications of the different 
conformational states of LmiPGAM in solution 
With regard to understanding the potential conformational differences displayed by 
LmiPGAM, significant clarification has been obtained by comparing the SEC-MALS 
elution volumes of the three samples, thus giving an indication of contrasting 
macromolecular sizes or shapes. This had been observed earlier in the gel filtration 
experiment, where the elution volume of P1 was delayed compared to the other two 
peaks, presumably corresponding to a smaller hydrodynamic size of the protein 
molecule. Based on this hypothesis, SEC-MALS analysis was employed and 
repeated in triplicate, to provide reproducible observations regarding the elution 
volume of the peaks.  
In the first run of the experiment (black lines in Figure 4.14), which was 
carried out 24 h after protein purification, the elution volume of P1 was 13.95 ml 
(Figure 4.14a). A symmetrical peak was observed, with no apparent leading or 
trailing edges. The major peak of P2 that corresponds to a monomer, on the other 
hand, was eluted at 13.38 ml (Figure 4.14 b), indicating that the molecule has a larger 
hydrodynamic size, and hence resulting in an earlier elution volume. This sample 
however, showed a distinct right-hand edge towards the elution volume of P1. The 
third sample (P3) exhibited a similar elution volume to P2 (13.39 ml) for the 
monomeric protein, but interestingly, the presence of the right-hand edge of the 
shoulder peak was more apparent (Figure 4.14 c).  
 The second run of the experiment was conducted 43 h after purification, 
where similar patterns of elution were observed. A single symmetrical peak was 
observed for P1 with no apparent leading or trailing edges. However, the shoulder 
peak of the monomeric P2 became more discernible, and an apparent shift was 
observed towards the elution volume of P1. A similar observation was seen for the 
monomeric P3, where the distinct shoulder peak became much clearer compared to 
the sample that had been analysed in the first batch.  
After 50 h, the last run of the experiment was conducted, and as observed in 
Figure 4.14 a, a single peak was observed for P1, this time with a slight left-hand 
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edge. The shoulder peak of monomeric P2 was observed to be very similar to the 
shape of the monomeric P3 from the previous two batches. By this time, the 
monomeric P3 exhibited two distinguishable monomeric peaks, where the elution 
volume of the first distinct peak corresponds to the elution volume of P2 and P3 
(13.42 ml), and the second peak corresponds to that of P1 (13.92 ml). One of the 
most important observations from this analysis is the consistency of the elution 
volume of P1 and the monomeric peaks in P2 and P3. The difference in the elution 
volumes was ~0.5 ml for the two monomeric peaks (P1 and P2/P3, ignoring the 
existence of shoulder peaks). This was also observed in the earlier gel filtration 
experiment, which showed that the open and closed conformations can be well-
separated by ~0.5 ml difference in the elution volume.   
It was postulated at the beginning of this chapter, that trypanosomatid 
iPGAM can either be in the closed, or the open conformation. A direct understanding 
from the SEC-MALS data is that LmiPGAM, as a globular protein, exists in both 
conformational states, and this can be seen from the difference in the elution volumes 
of the monomeric peaks of all samples. P1 may well be entirely in the closed 
monomeric form, whereas P2 and P3 can be a mixture of populations: a dimer as 
well as a monomer with an open conformation. Interestingly, the monomeric peaks 
of P2 and P3 both have right-hand edges towards the elution volume of P1, which 
became more apparent when left longer in solution. This observation may indicate 
the presence of both the open and closed conformations in P2 and P3, and thus 
suggests that the change of conformation is time-dependent and could attain 
equilibrium after having been left for a certain period of time. This may well be the 
reason for the slow increase in reaching maximal activity of P2 and P3, compared to 
P1 that has been discussed in an earlier section (see section 4.5i). Nevertheless, both 
samples also exhibit a tendency to form aggregates, especially P3, where the 
intensity of the scattered light detected larger macromolecules in the earlier elution 
volume, corresponding to the void volume (8 ml). Interestingly, the formation of 
tetramer was detected in the first batch of P3 at around ~9.7 ml, which suggests that 
the peak probably contained not just denatured protein, but also higher order 
oligomers. These may also explain the difficulties in obtaining crystals for both P2 
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and P3, because of the presence of multiple species, as well as the formation of 
aggregated materials.      
Open and closed conformations of the same protein have been widely 
reported (Ruzheinikov et al. 2004; Nallamsetty and Waugh 2007; Kumar et al. 2010). 
It is predicted that the open conformation of LmiPGAM may be very similar to the 
open conformation of TbiPGAM, as discussed previously (see section 4.3ii), since 
both enzymes share ~78% sequence identity. It is also relevant to postulate that the 
enzyme can possibly exist in a mixture of both the open and closed conformations 
(Bucher et al. 2011). In this case, the presence of ligands which induced the closed 
conformation would play a more important role in shifting the equilibrium towards 
the closed conformation. This mechanism is known as the ‘conformational selection’ 
or ‘population shift’ phenomenon (Boehr et al. 2009; Bucher et al. 2011). It has been 
proposed as well (Bucher et al. 2011) that the transformation between the forms may 
well be the consequence of solvation and would be assisted by the packing of non-
polar side chains. If the conformation is different, and the surface charge of the 
macromolecule consists of more non-polar residues, it may well affect the hinge 
region, which is important in allowing the opening and closing motion to occur 
(Hayward 1999). It is thus suggested that the presence of alternative conformations 
in LmiPGAM may well be related to the difference in surface charge of the 
molecules, and can change occasionally from one conformation to the other, as 
observed in P2 and P3. Structural changes of LmiPGAM are postulated to be 
important in balancing the conformational dynamic equilibrium for protein integrity 










































Figure 4.14 SEC-MALS analysis in all LmiPGAM samples as observed in three 
separate runs: a) P1, b) P2 and c) P3. The mixture of aggregated 
materials and higher order oligomers were observed in all samples, but 



































































































4.7 Different forms and different oligomeric states can be separated by ion-
exchange chromatography  
A significant outcome from the SEC-MALS analysis, as well as the earlier 
experiments, is the demonstration that an ion-exchange step is capable of separating 
and consequently capturing different conformational and oligomeric states of 
LmiPGAM. This can be explained by the anionic nature of the column used, MonoQ 
5/50 GL (GE Healthcare). The positively charged column will strongly interact with 
negatively charged groups distributed on the surface of the LmiPGAM. Different 
conformations or oligomeric states of the same protein possess different surface 
charges which affect the elution of each state as it goes through the column. 
Molecules with more positive surface charges will have weaker interaction with the 
column, and hence will be eluted first. The more negatively charged the molecule, 
the stronger the interaction with the column. A schematic diagram showing the 
interaction between the surface charges of the column and LmiPGAM is illustrated in 
Figure 4.15.  
In the case of LmiPGAM, it is apparent that P1 has more positive charges on 
the surface of the protein, and this resulted in an earlier elution volume, compared to 
the other two peaks (see chapter 3). Subsequently, P2 was eluted, followed by P3, 
which indicates that the binding between the protein molecules and the column is 
tighter than P1. Factors that contribute to this observation may well be a) the 
differences in conformation and oligomeric states, which result in different surface 
charges, and/or b) the presence of additional positively charged molecules, such as 
metal ions, in the early eluting fractions. Nevertheless, the different elution volumes 
of the three distinct peaks P1, P2 and P3 have clearly correlated with significant 
differences in the conformational and oligomerisation states of LmiPGAM, and ion-
exchange has been found to be a useful method in separating the distinct protein 






Figure 4.15 The interactions of various forms of LmiPGAM with the anion-
exchange column resulting in different elution volumes for each form. 
 
4.8 Metal binding and metal content in LmiPGAM  
The previous section has discussed the utilisation of an anion-exchange column, 
MonoQ 5/50 GL in separating LmiPGAM based on its different conformations and 
oligomeric states. It is also relevant to note that the presence of different positively 
charged ligands such as metal ions could also be in accordance with the different 
elution volumes from the anion-exchange column. Hence, the three samples P1, P2 
and P3 were analysed using matrix-assisted laser desorption ionisation time-of-flight 





i) MALDI-TOF mass spectrometry of ion-exchange peaks from LmiPGAM 
Differences between P1, P2 and P3 of LmiPGAM were further characterised by 
MALDI-TOF mass spectrometry of each individual sample. Samples of 0.5 µl of 1 
mg/ml protein were used in this experiment, in the presence of 20 mM TEA pH 7.6 
and 50 mM NaCl. Since this analysis was employed to analyse the whole protein 
molecule, and iPGAM is catagorised as a large protein molecule (~60.7 kDa), it 
would be challenging to differentiate the contributions of bound ligands to the exact 
mass of each peak. Nevertheless, the MALDI-TOF analysis could provide an 
indication if there are more metal ions or other ligands bound to one sample than 
another. 
The results in Figure 4.16 a, b and c show MALDI-TOF spectra with a 
distinct major peak in all samples, indicating the presence of a monomeric molecular 
ion corresponding to LmiPGAM. The masses of the peaks were found to be very 
similar to the calculated theoretical value of 61788.5 Da, including the His-tag and 
the initiator methionine. P1 was shown to be 61817.16 Da, whereas P2 and P3 were 
estimated to possess masses of 61762.81 Da and 61802.58 Da, respectively (Table 
4.4). The augmented masses of P1 and P3 are postulated to be the consequences of 
Na+ (molecular mass of 22) or Mg2+ (molecular mass of 23) bound to iPGAM (a Na+ 
and Mg2+ ion in place of H+ in positive ion mode resulted in the increase in 
molecular masses). The small differences of the molecular mass however, may be 
overestimated, since the size of iPGAM is too large to be accurately determined by 
MALDI-TOF analysis. It is also noteworthy that apart from the main peaks that 
correspond to a monomeric protein, smaller peaks with masses of 30864.36, 
30863.23, and 30858.90 Da were also observed in samples P1, P2 and P3, 
respectively. The identity of the smaller peak may well be of the doubly-charged 





Table 4.4 The theoretical and experimental values of LmiPGAM P1, P2 and P3 
molecular masses 














































Figure 4.16 MALDI-TOF mass spectrometry of LmiPGAM (a) P1, (b) P2 and (c) 
P3. P1 was shown to be 61817.16 Da, and P2 and P3 were estimated 
to possess masses of 61762.81 Da and 61802.58 Da, respectively. The 
augmented masses of P1 and P3 are postulated to be the consequences 
of Na+ (molecular mass of 22) or Mg2+ (molecular mass of 23) bound 
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ii) ICP-MS of ion-exchange peaks from LmiPGAM  
The effects of divalent metal ions to LmiPGAM has been discussed in earlier 
publications (Guerra et al. 2004; Poonperm 2005; Nowicki et al. 2009), where metal 
ions were reported to be essential for enzyme activity. However, the issue of which 
divalent metal ions that can support trypanosomatid iPGAM activity has always been 
controversial, for which the determination of metal concentrations in the protein 
samples are vital. In this case, ICP-MS analysis is one of the most appropriate 
methods for metal determination in purified protein samples, where the results will 
provide the concentrations of the divalent metals, thus providing clues of which 
metals are present at sufficient concentration to support enzyme activity, either in 
vivo or in vitro. This technique however, can not distinguish between free or bound 
metals. This interesting topic will be discussed in chapter 5. 
Following on from the MALDI-TOF mass spectrometry analysis, which 
showed an apparent increase in the molecular mass of P1 and P3 of LmiPGAM, ICP-
MS was employed to measure the concentrations of divalent metal ions in the three 
samples P1, P2 and P3. This result, apart from being able to provide knowledge 
about the individual metal concentrations in each sample, would also indicate 
samples that had acquired more metal ions than the others. In this analysis, each 
sample of LmiPGAM was normalised to 1 mg/ml, and seven metals (Co2+, Cu2+, 
Fe2+, Mg2+, Mn2+, Ni2+ and Zn2+) were measured, following the experimental 
procedure that has been described in chapter 2. As mentioned in chapter 2 and 
chapter 5, elemental standards were prepared and provided linear concentration-
response curves in both water and in enzyme storage buffer (20 mM TEA-HCl, pH 
7.6 and 50 mM NaCl) (see Appendix I (e)). The LOD for each individual metal has 
also been determined, in both water and the enzyme storage buffer.   
The results are shown in Figure 4.17 a and b, where the metal concentrations in 
the three samples were divided into two categories: the more abundant and less 
abundant metals. Mg2+ was shown to be the most abundant metal in P1 (7.55 µM), 
whereas the concentrations of Mg2+ in P2 (0.55 µM) and P3 (0.52 µM) are ~14-fold 
lower. Zn2+ was also present at significant concentrations, with a concentration of 
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5.55, 0.8 and 3.26 µM in P1, P2 and P3, respectively. Fe2+ exhibited lower 
concentrations in all three samples compared to the other two abundant metals, 
nevertheless displaying a higher concentration in P1, rather than the other two peaks. 
The least abundant metals: Co2+, Cu2+, Mn2+ and Ni2+ are shown in Figure 4.13b, 
where for P1, the concentrations of metals were in following descending order: 
Mn2+>Ni2+>Cu2+> Co2+. On the other hand, the order of metal concentrations in P2 
and P3 was: Ni2+> Cu2+> Mn2+> Co2+. The trends of metal content in these two peaks 
were very similar, albeit the Ni2+ concentration in P3 was significantly higher than 
P2 by two-fold. The concentrations of Cu2+ and Mn2+ in P2 however, are 
significantly more than in P3 by two- and three-fold. The most interesting 
observation is the concentration of Co2+, which is dangerously near to the detection 
limit in all samples.  
It is indeed interesting to observe that Zn2+ was the most abundant metal in P3, 
and was substantially higher than the amount of Zn2+ measured in P2. This could be 
one of the reasons contributing to the dimer formation, and also may well be related 
to the slower pace of P3 to reach maximum activity, compared to the other peaks 
(see section 4.5 i). In this case, Zn2+ ions that are possibly occupying the metal sites 
in P3 may have to be displaced by Co2+ in order to be catalytically active. Although 
the Zn2+ concentration in P1 was almost two-fold higher than in P3, it is relevant to 
note that P1 possesses substantially more Mg2+ than P3. The latter metal was 
measured to be at a higher concentration than Zn2+, and thus may contribute to a 
faster pace to reach the maximum activity. Mg2+ and Zn2+ concentrations in P2 
however, were inherently similar, and may well reflect the slightly slower pace, 
compared to P1.      
Another main observation in this analysis is that the overall metal content of 
P1 is substantially higher than the other two peaks, and hence provides a logical 
explanation for the earlier elution from the ion-exchange column. The metal content 
of P3 was shown to be higher for Zn2+ and Ni2+ compared to P2, although the rest of 
the metals were shown to be in equal amounts or slightly higher in P2. The apparent 
later elution volume of P2 and P3 from the ion-exchange column could well be the 
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consequences of lower metal content, where in this case, both samples displayed 




















































Figure 4.17  ICP-MS analysis of ion-exchange fractions P1, P2 and P3 of 
LmiPGAM. The relative molar concentrations of metals and purified 
LmiPGAM are shown. (a) Abundant metals, Fe2+, Mg2+, and Zn2+, with 
the y axis scale 0 - 8. (b) Low abundance metals, with the y axis scale 0 
– 0.25. The following limit of detection values (all µM) was obtained: 
Fe2+, 0.0313; Mg2+, 0.195; Zn2+, 0.00652; Co2+, 0.000238; Cu2+, 






It was hypothesised in an earlier chapter that the difference in the elution volumes of 
the three peaks from the ion-exchange column may be due to distinct protein 
conformational and oligomeric states. Various biochemical and biophysical 
techniques have been employed in order to investigate whether LmiPGAM does 
indeed exist in different structural states. The first analysis to be performed was the 
measurement of the activation of LmiPGAM by Co2+, which showed that in the 
presence of low Co2+ concentration (0.1 mM), the reaction was a slow process, 
which is possibly due to major conformational change during catalysis. DLS 
measurements then showed that the trend of hydrodynamic size for LmiPGAM 
resembled the calculated values, indicating that P1 corresponds to the smaller 
monomeric closed-form structure, while P2 and P3 most probably correspond to the 
larger open conformation. The biophysical dimensions however, are slightly different 
from the crystal values, which may reflect the comparison between proteins in 
solution and in the crystal lattice. It is noteworthy that from these comparisons, the 
trypanosomatid and bacterial iPGAMs are divided into two families, which can also 
be clearly seen from the sequence similarity analysis and the distinct metal-
mechanisms for the catalytic function of the two families, apart from the differences 
in the domain movement of the open-form structures.  
Further indication of the existence of multiple species of LmiPGAM was 
observed in native-PAGE, where multiple bands were observed in P2 and P3, in 
contrast to the results from SDS-PAGE that exhibited a single prominent band in all 
the fractions corresponding to the theoretical size of LmiPGAM. Subsequently, the 
results from gel filtration and SEC-MALS analyses concluded that it was possible to 
separate the enzyme conformational states by ion-exchange chromatography and by 
gel filtration. The SEC-MALS analysis, independent of any protein molecular weight 
standards, also conclusively identified the presence of dimeric iPGAM in both the P2 
and P3 samples. Interestingly however, the formation of a dimeric iPGAM in the P1 
sample only occurred in the presence of 1 mM Co2+. Nevertheless, the formation of 
dimer in the presence of metal ions has also been reported in other enzymes, such as 
β-Lactamases from Pseudomonas aeruginosa (Danel et al. 2001). 
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The metal content from ICP-MS indeed showed that the metal content of P1 
is mostly dominated by Mg2+, while P3 is strikingly occupied by Zn2+. The presence 
of both metals in P2 however, was shown to be at equal very low concentrations. 
These observations could be related to the different rates of activity for all samples 
after the addition of Co2+, where P3 exhibits a lower pace to reach maximum 
activity, compared to P1 and P2. Zn2+ was shown to possess an inhibitory effect on 
iPGAM, as discussed later in chapter 6, whereas Mg2+ could substantially enhance 
iPGAM activity, albeit to a lower extent than Co2+. Moreover, the techniques that 
have been employed in this study indeed confirmed that ion-exchange 
chromatography possesses the ability to separate LmiPGAM into different 














Chapter 5:  
Hyperactivation of Trypanosomatid iPGAM is Observed in Vitro, But Not in 
Vivo 
5.1 Aims 
Over the years, the regulation of numerous proteins by metal ions has been explored 
extensively. The requirement of metal ions for the structural and functional integrity 
of proteins, especially enzymes, is a fascinating aspect of the biochemistry of living 
cells. Interestingly, over one-third of known proteins are metalloproteins (Ibers and 
Holm 1980; Tainer et al. 1992; Castagnetto et al. 2002; Page and Di Cera 2006), and 
such protein-metal complexes tend to favour divalent metals (Page and Di Cera 
2006). The alkaline phosphatase superfamily, with trypanosomatid iPGAM as one of 
its members, has also been typified as requiring divalent metals for its catalytic 
function. Co2+, as described in chapter 1, plays a vital role in regulating 
trypanosomatid iPGAM activity, and indeed is the metal that supports the maximum 
activity of LmiPGAM (Nowicki et al. 2009) and TbiPGAM (Chevalier et al. 2000).  
However, looking at the typical metal concentrations in eukaryotic cells 
(Maret 2010), it is plausible that different scenarios may occur in vivo, where the 
concentrations of Co2+ will be much lower than in activity assays and in 
crystallisation conditions (Nowicki et al. 2009). It is also possible that in vitro 
experimental condition may favour the binding of different metal ions, rather than 
the native one (Maret 2010).  
Taking the previous literature into consideration, this chapter will describe 
the concentrations of seven transition metal ions in the periodic table (Co2+, Cu2+, 
Fe2+, Mg2+, Mn2+, Ni2+ and Zn2+) in the cytosol of T. brucei, where iPGAM is 
located, and also in the purified LmiPGAM. In addition, the specific activities of both 
the in vitro and in vivo iPGAMs will be compared, and hyperactivation of the 
purified enzyme with Co2+ will also be discussed in detail. Furthermore, this chapter 
will discuss the possibilities of whether Mg2+ and/or Zn2+ play roles as the native 




The majority of metalloproteins have been structurally characterised by analysing 
ligand preferences and geometries of the divalent metals in vitro. It is often difficult 
however, to determine the correct metal that is involved in regulating the enzyme 
activity in vivo, without understanding the natural environment of the organism from 
which the protein was isolated (Maret 2010). Over the years, numerous studies have 
shown that there could be misleading information on the “correct” metal ions thus 
giving biased understanding of the proteins at the molecular and structural levels. In 
some cases, non-native metals could be incorporated into the proteins during 
expression in the culture medium or in the purification process. This phenomenon 
has been demonstrated for instance, by the incorporation of cobalt instead of zinc in 
alcohol dehydrogenase when yeast was grown in cobalt (II) enriched medium 
(Curdel and Iwatsubo 1968). Metal substitution has often been observed to occur in 
vitro, thereby causing hyperactivation with the non-native metals, as exemplified by 
the incorporation of copper instead of zinc in amino peptidase (Prescott et al. 1985). 
In vivo substitution of divalent metals also has been reported, as in the case of the 
substitution of zinc by cobalt in carbonic anhydrase in marine diatoms. By contrast 
however, this particular example demonstrated that the substitution of cobalt is 
reportedly causing the enzyme to be less active than the native zinc form (Lane and 
Morel 2000).  
Determination of the biologically relevant and correct metals for the catalytic 
function of a protein normally requires various careful measurements. These include 
the knowledge of the natural metal bioavailability in the native environment, the 
suitability of a metal to coordinate in the metal site of a particular protein structure, 
and also, any significant effects on the activation or loss of protein activities by 
certain metals. These factors will be discussed in this chapter, where the 
concentrations of seven biologically relevant metals (Figure 5.1) in the cytosol of T. 
brucei and the purified LmiPGAM, the hyperactivation of LmiPGAM with Co2+, and 
also the possibilities for other metals to occupy both metal sites in LmiPGAM will be 
considered. It is noteworthy however, that both metal analyses performed in this 
study are capable to measure the total metal content in the samples, thus do not 
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possess the ability to distinguish free metals from any bound metals. Hence, the ICP-
OES results for the cytosolic fractions are based on the total (free + bound) metal 
concentrations in the biological samples. However, since the ICP-MS analysis was 
performed on the purified LmiPGAM, only metals which are associated with the 
protein would be quantified, thus provides information on the bound-metal 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































5.3 Low enzymatic activity of iPGAM observed from the cytosolic fractions 
of T. brucei 
The first seven enzymes in the glycolytic pathway of trypanosomatids are 
sequestered in a unique subcellular organelle, the glycosome, with multiple copies in 
each cell. Interestingly however, iPGAM, together with ENO and PYK is located in 
the cytosol (Oduro et al. 1980; Chevalier et al. 2000; Guerra et al. 2004). Hence, 
cytosolic samples were prepared following the method by Misset and Opperdoes 
1984, at the Université catholique de Louvain, Brussels, Belgium from both 
procyclic and bloodstream stages of T. brucei.  The former stage refers to the form of 
the parasite when it lives in the midgut of the fly, whereas the latter stage 
corresponds to the pathogenic form found in mammalian blood.  
The integrity of the samples was analysed by SDS PAGE (Figure 5.2), and 
indicated the absence of proteolytic degradation. S1, S2 and S3 are the procyclic 
forms, whereas S4 and S7 are the bloodstream forms. The patterns of bands are 
broadly similar across all the fractions, with the exception of a prominent band with a 
mass of ~50 kDa in sample S4. The identity of this protein, however, is not known. 
The concentrations of each sample were determined by Bradford assay, as described 
in chapter 2. Variations were observed across the samples, from 2.8 to 8.1 mg/mL, 
hence the results for specific activity and for metal contents were all normalised to 1 
mg of protein. The protein concentrations, iPGAM specific activities and estimated 
iPGAM concentrations of the fractions are as indicated in Table 5.1. No additional 
Co2+ was added into the samples so as to obtain conditions similar to the native 
catalytic state of iPGAM. It can be seen that the specific activities of iPGAM in the 
procyclic cytosolic fractions were higher than in the bloodstream-form cytosolic 
fractions. Similar trends of results were reported by the Brussels research group, 
where iPGAM activity in both T. brucei procyclic and L. mexicana promastigote 
forms are 10 fold higher than the bloodstream form (Paul Michels, unpublished data) 
(Fuad et al. 2011). 
Low specific activities have also been reported in the literature for iPGAM in 
the absence of added Co2+ (Guerra et al. 2004; Albert et al. 2005), and interestingly, 
this particular enzyme exhibited the lowest activity in the cell lysate, compared to the 
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other glycolytic enzymes. It is fascinating to observe that trypanosomes expressed 
their enzymes differentially during different stages of the life-cycle. Although at 
present, the reason behind this observation is unknown, the results clearly augmented 
the value of iPGAM as a drug target. 
 
 
Figure 5.2  SDS-PAGE analysis of the T.brucei cytosolic fractions. A 12% SDS-
PAGE is shown with 5 µl samples of each cytosolic fraction. The 
masses (in kDa) of standard marker proteins are indicated in lane M. 
Abbreviations: M, marker proteins; S1-S3, cytosolic fractions from 
procyclic T. brucei; S4 and S7, cytosolic fractions from bloodstream-










Table 5.1 iPGAM molar concentration in T. brucei cytosolic fractions 
 S1a S2 S3 S4 S7 
protein concentration (mg/ml) 4.0 3.9 2.8 8.1 5.4 
specific activity (nmol.min-1.mg-1 protein) 16.0 19.7 6.29 1.12 5.80 
iPGAM concentration in cytosolic fractions 
(µmoles/L)b 
50.1 60.3 13.8 7.12 24.5 
aSamples: S1, S2 and S3 are procyclic fractions; S4 and S7 are from bloodstream 
parasites.  
bThe calculation was made using the assumption that pure iPGAM has a specific 
activity of 21 µmol.min-1.mg-1 protein (under the same assay conditions as those used 
to measure the activity of iPGAM in the cytosol).  
 
5.4 ICP-OES analysis of the cytosol of T. brucei 
Metal requirements of iPGAMs have been discussed in great detail for 
trypanosomatids (Chevalier et al. 2000; Guerra et al. 2004, Poonperm 2005) as well 
as for other organisms (Jedrzejas et al. 2000; Nukui, et al. 2007; Raverdy et al. 
2007). However, very little was known about the biologically relevant metal 
concentrations in the natural environment where the iPGAM was located. It was 
therefore decided to measure the concentrations of relevant divalent metal ions in 
cytosolic samples of T. brucei, in order to provide or eliminate possible native metal 
ion candidates in vivo.   
ICP-OES analysis was employed to measure the concentrations of seven 
metal ions (Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+ and Zn2+) in cytosolic fractions from 
both procyclic and bloodstream-form T. brucei. It is important to keep in mind that it 
is indeed the total metal concentrations which were obtained by this analysis, where 
metals bound to macromolecules or to EDTA could not be distinguished from free 
metal ions. As described in chapter 2, elemental standards were prepared, and gave 
linear concentration-response plots in both water and in cytosol buffer (see Appendix 
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I (d)). Any background readings or noise signals collected from the control data were 
deducted from the readings of the samples. The LOD was determined for each metal 
ion, as described in the legend for Figure 5.3.   
The results from the analysis revealed an interesting trend of metal 
concentrations, yet provided patterns similar to those observed in other eukaryotic 
cells (Maret 2010). Mg2+, Zn2+ and Fe2+ were found to be the most abundant metals 
(~200, 30 and 15 µM, respectively (Figure 5.3), while Co2+, Cu2+, Mn2+ and Ni2+ 
concentrations were determined to be below 1 µM. Interestingly, Co2+ was found to 
be below the limit of detection (<0.035 µM), in which the signals may well be from 
the background noise of the instrument. It can be seen that the samples from the two 
different life stages of T. brucei gave similar results, which shows that different 
environmental conditions do not substantially affect the metal content. 
The cytosolic concentrations of TbiPGAM may be estimated from the specific 
activity of the pure enzyme compared to the specific activities within the cytosolic 
fractions, and give a value of approximately 10-50 µM (Table 5.1). It is clear from 
the ICP-OES results that the Co2+ concentrations in the cytosolic fractions are <0.03 








Figure 5.3  ICP-OES of cytosolic fractions from procyclic and bloodstream-form T. 
brucei. The blue bars correspond to the procyclic cytosolic fractions S1, 
S2 and S3, whereas the pink bars indicate bloodstream cytosolic 
fractions S4 and S7. (a) Results for the relatively abundant metals, Fe2+, 
Mg2+ and Zn2+, with the y axis scale 0-200 µM. (b) Results for the less 
abundant metals, Co2+, Cu2+, Mn2+ and Ni2+, with the y axis scale 0-1.0 
µΜ. The values for Co2+ (0.0130-0.0296 µM) are below the limit of 
detection (<0.0352 µM). The following limit of detection values (all 
µM) were obtained: Fe2+, 0.0819; Mg2+, 0.495; Zn2+, 0.122; Co2+, 
0.0352; Cu2+, 0.116; Mn2+, 0.0920; Ni2+, 0.104. The figure is taken from 




5.5 Addition of cobalt in vitro can enhance the activity of bacterially expressed 
LmiPGAM  
It is known that the specific activity of LmiPGAM purified in the presence of 10 µM 
Co2+ is ~400 µmol.min-1.mg-1 protein (Poonperm 2005). It also has been discussed in 
chapter 4 that LmiPGAM purified on a Ni2+ column required a long period of time 
(up to 48 hours for P1 and longer for both P2 and P3) to reach its maximal activity 
after the addition of 0.1 mM Co2+. In this section, similar experiment was conducted 
on the purified LmiPGAM, but the incubation was performed for one hour, in the 
presence of higher concentration of Co2+ (1 mM). The one hour incubation with 1 
mM Co2+ was performed based on the results from the previous specific activity 
measurement (see section 4.5i), which corresponds to the time to reach half of the 
maximum activity. The initial specific activity for P1, P2 and P3 were calculated to 
be 19, 18 and 16 µmol.min-1.mg-1 protein for the conversion of 3PGA to 2PGA, and 
when assayed after one hour incubation with 1 mM Co2+, the specific activities of the 
three samples were increased to 137, 120 and 119 µmol.min-1.mg-1 protein, 
respectively (Figure 5.4). The initial value is similar to the value of 26 µmol.min-
1.mg-1 protein obtained for pure bacterially expressed TbiPGAM that had also been 
purified on a Ni2+-IMAC column without the addition of any divalent metals (Collet 
et al. 2001). This clearly shows that Co2+ can strongly stimulate the activity of 
iPGAM, and indicates that the specific activity in vivo would never reach the high 
specific activity exhibited in vitro, taking into account the low concentration of Co2+ 





























Figure 5.4 The specific activity of the three peaks of LmiPGAM, before and after 
one hour incubation with 1 mM Co2+. One unit corresponds to the 
conversion of 1 µmol of substrate min-1 mg-1 protein under standard 
conditions. 
 
5.6 ICP-MS analysis of bacterially expressed LmiPGAM 
Although the concentrations of metals in the cytosol of the parasite have been 
determined, it is also important to measure the metal content in the bacterially 
expressed protein. An important reason for this analysis to be performed is that the 
sample analysed contains only pure iPGAM, where essentially all other 
macromolecules must have been washed away during the chromatography steps. 
Thus, the metal concentrations in the sample would be specific for metals bound only 
to iPGAM, instead of to other molecules, as in the cytosol. The results would provide 
a control experiment to the earlier ICP-OES analysis, in order to observe whether the 
metal concentration trend would be similar to that in the cytosol. In this particular 
analysis, the metal content of the essentially homogenous purified bacterially 
expressed LmiPGAM was analysed by the more sensitive ICP-MS technique. Metal 
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content in the well separated samples from the ion-exchange column: P1, P2 and P3 
were analysed, as described in chapter 4. Following similar experimental procedure 
as ICP-OES, the concentrations of seven different metals (Co2+, Cu2+, Fe2+, Mg2+, 
Mn2+, Ni2+ and Zn2+) were measured. Elemental standards were prepared as 
described in chapter 2, and gave linear concentration-response curves in both water 
and in enzyme storage buffer (20 mM TEA-HCl, pH 7.6 and 50 mM NaCl) (see 
Appendix I (e)). Similar to ICP-OES, the LOD has been determined for each metal 
ion, in both water and the enzyme storage buffer.   
In this section, only the metal content of P1 is shown, as a comparison to the 
ICP-OES results from analysis of the cytosol samples, and exhibited a similar trend 
of metal content as measured in the cytosol. The metal content of P2 and P3 has been 
discussed earlier in section 4.8 ii, and showed slight differences to the metal content 
in P1 and the T. brucei cytosolic fractions. Mg2+ was identified as the most abundant 
metal (as it was in the cytosolic fractions), but the concentration of Zn2+ was 
substantially enhanced, and approached the concentration of Mg2+ (Figure 5.5). This 
would indicate that Zn2+ is being selectively bound to iPGAM. The high 
concentrations indicate that iPGAM selectively binds these two metals.  The 
concentration of Co2+ was 0.01 µM, above the limit of detection (<0.0002 µM), but 
very low compared to the concentration of iPGAM (0.99 µM).  
Interesting and clear observations have been obtained from both the ICP-MS 
and ICP-OES analyses. Co2+, despite being the only metal that enables the bacterially 
expressed TbiPGAM and LmiPGAM to be maximally active, is not present in the 
enzyme in cytosolic fractions or in enzyme purified in the absence of added Co2+. 
Two of the most abundant metals, Mg2+ and Zn2+ exhibited molar ratios of ~8 and ~6 
µmol of metal to 1 µmol of LmiPGAM, respectively, indicating the possibility that 
either or both of these metals are the preferred metal(s) in vivo. It is observed from 
this analysis that the Zn2+ concentration has substantially increased and approaches 
the concentration of Mg2+, which reflects that there is possibility that Zn2+ binds 
specifically to iPGAM during purification. It is also important to note that any metals 
that are present in E. coli cells, where the protein was expressed, may bind to 
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iPGAM too. Meanwhile, Mn2+ that is known to be the preferred metal for bacterial 
iPGAMs (Kuhn et al. 1995; Jedrzejas et al. 2000a; Jedrzejas et al. 2000b) was 
present in the purified LmiPGAM at a molar ratio of less than 0.3. It is noteworthy 
that the concentration of Ni2+ was low, despite the purification being done on an 
IMAC column charged with Ni2+. 
 
 
Figure 5.5  ICP-MS analysis of purified LmiPGAM. The relative molar 
concentrations of metals and purified LmiPGAM are shown. (a) 
Abundant metals, Fe2+, Mg2+ and Zn2+, with the y axis scale 0 - 8. (b) 
Low abundance metals, with the y axis scale 0 – 0.25. The following 
limit of detection values (all µM) were obtained: Fe2+, 0.0313; Mg2+, 
0.195; Zn2+, 0.00652; Co2+, 0.000238; Cu2+, 0.000936; Mn2+, 
0.00128; Ni2+, 0.000803. The figure is taken from Fuad et al. 2011. 
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5.7 Mg2+ and Zn2+ could be the native metals required to regulate iPGAM 
activity in vivo 
Enzymes are molecules that are present in cells which play important roles in 
assisting biochemical reactions at the cellular level. It is known that enzymes have 
often evolved by natural selection to attain a state of optimal catalytic activity, often 
with adaptation to a particular biological environment. For instance, the activity of 
the glycolytic enzyme triose phosphate isomerase is limited only by diffusion of 
substrate onto, and product off, the enzyme, and is therefore thought to have evolved 
to almost catalytic perfection (Albery and Knowles 1976). There is thus an 
understandable tendency to correlate the highest specific activity of an enzyme in 
vitro with its ‘native’ state in vivo. This is clearly not the case for trypanosomatid 
iPGAMs where the maximal activity (by a factor of ten or more) is obtained with 
Co2+, but the concentration of this metal is essentially undetectable in the parasite 
cytosol. In this respect, iPGAM is not alone, and carboxypeptidase A (Behnke and 
Vallee 1972), aminopeptidase (Prescott et al. 1985), alcohol dehydrogenase 
(Cavaletto et al. 2000), 5’-nucleotidase (McMillen et al. 2003) and catechol 
dioxygenase (Fielding et al. 2010) are just some among many examples of Zn2+-
containing enzymes in vivo that are hyperactive when Co2+ replaces the Zn2+ in vitro 
(Fuad et al. 2011). 
The results of ICP-OES indicate that potentially only Mg2+ and Zn2+ are 
sufficiently abundant in the parasite cytosol to support the activity of a significant 
proportion of the iPGAM present (Figure 5.3), whereas Cu2+, Mn2+ and Ni2+ were all 
well below the concentration of iPGAM. A similar trend is observed with the ICP-
MS analysis of purified LmiPGAM in which only Mg2+ and Zn2+ are sufficiently 
abundant to support the activity of the enzyme (Figure 5.5). However, as mentioned 
earlier, not all metals which are measured in ICP-OES are freely available for 
iPGAM, although the result is more significant with the ICP-MS analysis. However, 
the rest of the other metals, especially Co2+, Cu2+, Mn2+ and Ni2+ can be eliminated 
from being the native metal supporting iPGAM activity in vivo, since the measured 
concentrations for these metals are insufficient for iPGAM. It thus seems that the 
biologically relevant metal for this enzyme is likely to be either Mg2+ or Zn2+, or 
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both. As mentioned previously, iPGAM belongs to the metal-dependent alkaline 
phosphatase superfamily (Galperin et al. 1998) most of whose members require two 
divalent metals at the active site. Three enzymes are particularly well characterised 
structurally: E. coli alkaline phosphatase (Kim and Wyckoff 1991), BsiPGAM 
(Jedrzejas et al. 2000; Nukui et al. 2007) and LmiPGAM (Nowicki et al. 2009). 
Alkaline phosphatase uses two Zn2+ ions, BsiPGAM utilises two Mn2+ ions, but 
LmiPGAM by contrast, appears to function with a one-metal mechanism. Of the two 
metal sites of LmiPGAM, as shown in Figure 1.6 of chapter 1, only site M1 shows 
high occupancy, with site M2 having only low occupancy (6%) even at 4 mM Co2+. 
Moreover, when site M2 is occupied, the side chain of Ser75 that is phosphorylated 
during catalysis adopts a position unfavourable for phospho transfer (Nowicki et al. 
2009) (Fuad et al. 2011). 
The evaluation of the probability that Mg2+ and Zn2+ regulate iPGAM activity 
in vivo also requires structural information for the interaction of metals with the 
neighbouring residues of the metal binding sites. This is important for the 
identification of possible metals that could be replaced by Co2+ when the protein was 
expressed in vitro. Generally, metal cations in proteins prefer to form interactions 
with donor atoms in the functional groups of certain amino acid side chains, 
preferably sulphur from cysteine, imidazole nitrogen from histidine, carboxylate 
oxygen from aspartic or glutamic acid, or oxygen from threonine or serine (Harding 
et al. 2010). These interactions, which involve a number of atoms within chemical 
bonding distance (coordination number), would result in the most ideal 
stereochemistry for each coordination number.  
In LmiPGAM specifically, distorted octahedral geometry is observed when 
Co2+ occupying metal site M1, coordinates with the first carboxylate oxygen from 
Asp425, the second nitrogen from His429, the second nitrogen from His496 and a 
phospho group oxygen from 2PGA or 3PGA. Apart from these, longer interactions 
were observed with the second carboxylate oxygen from Asp425 and the bridge 
oxygen from 2PGA or 3PGA (Figure 5.6a). The second metal site (M2) when 
occupied with Co2+ has tetrahedral geometry with interactions to the following 
neighbouring atoms: the first carboxylate oxygen from Asp23, oxygen from the 
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second rotamer of Ser75, first carboxylate oxygen from Asp466 and second nitrogen 
from His467 (Figure 5.6a) (Nowicki et al. 2009). Based on the interactions 
mentioned above, it is plausible that the octahedrally coordinated M1 has a 
preference for Mg2+ and Co2+, with coordination number 6 (MESPEUS database, 
http://mespeus.bch.ed.ac.uk/MESPEUS/_1.jsp). The poorly occupied site M2, on the 
other hand, has tetrahedral geometry with a preference for Zn2+, and less so for Co2+, 
with coordination number 4.  
The normal coordination number and requirement of donor atoms for Co2+ 
and Mg2+ is 6 (Figure 5.7), thus satisfying the preference for regular octahedral 
geometry. Comparing the possibilities of Mg2+ to be in the M1 site instead of Co2+, 
similar interactions could occur with the neighbouring atoms (Figure 5.6b). 
However, some possible interactions are rare, for instance, the unusual occurrence of 
coordination by bidentate carboxylate, or histidine as donor atoms (Harding et al. 
2010). This is not impossible however, as the structure of bovine beta-1,4-
galactosyltransferase (Ramakrishnan et al. 2004) has illustrated that both interactions 
could occur when Mg2+ occupied the metal sites 
(http://mespeus.bch.ed.ac.uk/MESPEUS/_1.jsp). Although Ni2+ and Mn2+ have 
similar probability to occupy the M1 site with similar coordination geometry in the 
crystal, the concentrations of the metals as measured by ICP-OES are too small, and 
hence insufficient to satisfy a 1:1 stoichemistry of metal: protein. Fe2+ however, by 
being the third highest concentration in vivo and in vitro, has a better chance to 
occupy the M1 site, as it has very similar requirements for donor atoms, compared to 
Co2+. Nevertheless, the concentration of Fe2+ in the parasite cytosol is only just 
sufficient to satisfy the binding requirements of iPGAM, even if all of the Fe2+ is 
freely available. By contrast, the total Mg2+ content is present in excess concentration 
and could support the activity of a significant proportion of the iPGAM in the cell. 
Total Zn2+ is also present at a relatively high concentration, and could be able to 
down-regulate the enzyme activity by occupying site M2, but the extent of this 
regulation is difficult to evaluate without knowing the concentration of Zn2+ freely 
available. However, it is relevant to note that Zn2+ in the purified iPGAM exists at 
sufficient concentration to be bound to iPGAM, and hence provides a strong 
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indication of the availability of the metal to regulate iPGAM activity. The effects of 




























Figure 5.6 Putative metal-binding partners of LmiPGAM. a) Co2+ coordinated by 
neighbouring atoms in both M1 and M2 sites, as observed in the crystal 
structure of LmiPGAM in the presence of 4 mM Co2+. b) Mg2+ and Zn2+ 
modelled into sites M1 and M2, respectively, can readily coordinate the 





Zn2+, compared to most of the other divalent metal ions, is much more 
promiscuous in its choice of donor atoms and coordination group geometry. A 
detailed guide of the requirement of donor atoms by Zn2+ has been discussed 
previously (Harding et al. 2010). The usual coordination number for Zn2+ is 4 (Figure 
5.7), although it has been observed to be coordinated by 5 or 6 donor atoms. In the 
M2 site of LmiPGAM however, Zn2+ is very likely to be tetrahedrally coordinated. 
Coordination by both monodentate and bidentate carboxylates, and any intermediate 
patterns are possible with Zn2+, while aspartate, glutamate and histidine are the 
commonest donor amino acid residues in the catalytic sites. The possible Zn2+ 







Figure 5.7 The preferred coordination geometries of Co2+, Mg2+ (octahedral) and 
Zn2+ (tetrahedral).  
 
It has been suggested that LmiPGAM has a one metal mechanism, instead of 
two (Nowicki et al. 2009). This is based on the observation in the crystal structure 
that the side chain of Ser75 can assume three different positions, one of which adopts 
an unfavourable position for catalysis, when the M2 site is occupied by Co2+. Two 
hypotheses for the occupation of the metal sites of trypanosomatid iPGAMs by Zn2+ 
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or Mg2+ may be proposed: i) Mg2+ or Zn2+ occupy the M1 site, and site M2 is empty 
with a one metal mechanism and ii) Mg2+ or Zn2+ occupies the M1 site, while Zn2+ 
occupies the second site. The geometrical coordination for both metal sites suits the 
usual preference for both metal atoms, although the interaction of Mg2+ with N from 
histidine, and bidentate carboxylate in M1 is relatively rare, as described previously. 
It is possible too, that the geometrical coordination might change, as discussed by 
Poonperm 2005, when both metal sites are occupied by Mn2+ or Zn2+.  
The potential binding of Mg2+ and Zn2+ to trypanosomatid iPGAMs was 
considered further by analysing available published structures of enzymes with Mg2+ 
and Zn2+ occupying the catalytic site which form interactions with bidentate 
carboxylate oxygen from aspartate. This is one of the important interactions to 
consider in the M1 site, as Co2+ interacts with both carboxylate oxygens from 
Asp425. The MESPEUS database (http://mespeus.bch.ed.ac.uk/MESPEUS/_1.jsp) 
was used for this purpose, where the metal-bidentate carboxylate interactions were 
searched for both Mg2+ and Zn2+. For Mg2+, 137 hits of PDB structures with 
resolution 1.6 Å or better were obtained for the interactions with bidentate 
carboxylate oxygen. However, there are some difficulties in bidentate definitions, as 
there are three possibilities of interactions: i) both O atoms from one carboxylate 
group bind to one metal ion: ii) one O atom from the carboxylate group binds to two 
metal ions iii) both O atoms from one carboxylate group bind to two different metals 
(Dr. Marjorie Harding, personal communication). In the case of possible interactions 
in the M1 site, only the first possibility was taken into account, where five pairs of O 
atoms (ten altogether) were obtained from the initial 137 hits. Zn2+, on the other 
hand, exhibited more common interactions with bidentate carboxylates, exhibiting 23 
pairs of O atoms (46 altogether) out of 73 initial hits. It should be noted that the 
coordination number for the search was fixed at six, assuming that similar 
geometrical coordination was obtained when Mg2+ or Zn2+ occupy the M1 site. 
These results suggest that both Mg2+ and Zn2+ have the ability to bind to the 
two O atoms of the carboxylate from Asp425, although the interaction was found 
rare for Mg2+, compared to Zn2+. Meanwhile, it is also plausible that Mg2+ forms an 
interaction to monodentate carboxylate from Asp425, with an additional interaction 
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with an O atom from a water molecule. Dudev and Lim 2004 have described that in 
such cases, water molecules have a crucial role in stabilising the monodentate 
carboxylate-binding mode of water-rich Mg2+ complexes. Nevertheless, the key 
factor in determining the carboxylate-binding mode is the availability and type of 
interactions between the metal-free carboxylate O atom and its neighbours (Dudev 
and Lim 2004). In the case of Zn2+ however, as mentioned above, the latter metal 
prefers coordination number 4 for the interaction, thus the coordination geometry 
might change too if the M1 site is occupied by Zn2+.  
The metal-donor atom distances observed in protein crystal structures are 
2.07±0.10 Å for the interaction between Mg2+-O from monodentate carboxylate, 
while the value for Zn2+-O is 1.99±0.05 Å (Harding et al. 2010). Although these 
values are estimated for the interaction of metals with monodentate carboxylate, the 
metal-distances for Mg2+ and Zn2+-bidentate carboxylate also fall within the same 
range (Figure 5.8). The mean value for O-metal distances is 2.14±0.16 Å and 





Figure 5.8 Possible metal-bidentate carboxylate coordination. a) Examples of 
Mg2+-bidentate carboxylate coordination (inositol 1,3,4-trisphosphate 
5/6-kinase, PDB ID 1Z2O) b) Examples of Zn2+- bidentate 
carboxylate coordination (aminopeptidase from Aeromonas 




























































Figure 5.9 Distribution for observed distances for metal-bidentate carboxylate 
oxygen in Mg2+ and Zn2+. The observation corresponds to the number 
of proteins showing the various metal-bidentate carboxylate distances. 
The data were obtained from the MESPEUS database. 
Possible effects on the catalytic mechanism are anticipated with changes in 
the interactions of the neighbouring atoms with the different metals. Poonperm 
(2005) reported that the substitution of Mn2+ and Zn2+ into both metal sites by crystal 
soaking led to differences in metal coordination geometries and protein-ligand 
binding at the active site of LmiPGAM, which caused the activity of iPGAM to be 
decreased. In the presence of 1 mM Mn2+ and 0.01 mM Co2+, the coordination 
geometry of both the M1 and M2 sites changed to trigonal bipyramidal. Zn2+ on the 
other hand, when present at 0.5 mM concentration together with 0.01 mM Co2+, 
exhibited a tetrahedral coordination in M1, while forming five tight interactions in 
M2, causing the geometry to change to trigonal bipyramidal. While Mn2+ prefers the 
latter coordination, this is not the case with Zn2+, as it is observed to be less preferred 
compared to four-coordination. Nevertheless, both findings observed that Ser75, 
which becomes phosphorylated during catalysis, had moved towards the phospho 
group of the phosphoglycerate, thereby being in a favourable position to form a 
phosphoserine intermediate, and explaining the inhibitory effect of both metals. It 
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was suggested by this study that Mn2+- and Zn2+-bound proteins represent iPGAM 
trapped in a non-productive intermediate stage during catalytic activity, in contrast to 
Co2+-bound iPGAM, which represents an early or final stage of the catalytic reaction. 
In another experiment, in the presence of a higher concentration of Ni2+ (4 mM) and 
similar concentration of Co2+ (0.01 mM), no significant changes could be observed 
with lower occupancy of the metal in M2 site. This observation indicated that Ni2+ 
was not required, and had a low preference for metal coordination in the active site 
of iPGAM (Poonperm 2005).  
The major problem in observing the effects of these metals on the activity of 
iPGAM is the intolerance of the coupling enzymes in the activity assay to higher 
concentrations of metals. Hence, an assay system which can be carried out in the 
presence of different divalent metal ions with minimal interference on the coupling 
enzymes was developed, as described in chapter 6.  
The loss of activity, with metal substitution in the metal sites has been 
reported in other enzymes. Human carbonic anhydrase II is one of the enzymes that 
display negligible activity when the native metal Zn2+, which was tetrahedrally 
coordinated by three histidine residues and a water molecule was replaced by other 
divalent trace metals: Cu2+, Mn2+ and Ni2+. The coordination number around the 
metal was increased, to penta-coordinated with Cu2+, and hexa-coordinated with both 
Mn2+ and Ni2+ (Håkansson and Wehnert 1992). Interestingly, the tetrahedral 
geometry was restored when Co2+ occupied the metal site. Nevertheless, the reaction 
of Co2+-substituted enzyme was slowed down, thus proposing that Zn2+, with its 
natural abundance and coordination geometry, is the native metal that supports 
enzyme activity in vivo. This might be the case for LmiPGAM too, where Co2+ 
conversely, activated the enzyme much better than the native metals in vivo. It is not 
possible at this stage to decide definitively which metal is the biologically relevant 
one, and indeed it may be that both metals can support trypanosomatid iPGAM 
activity. Hence, it is crucial to measure iPGAM activity in the present of these 
significant metal ions, to indicate which metals may support or inhibit the enzyme 




The findings in this chapter have culminated in a better understanding of the hyper 
activation of trypanosomatid iPGAM with Co2+. The bacterially expressed protein 
purified with a Ni2+ column would never reach the maximum activity observed with 
samples purified in the presence of Co2+, unless additional Co2+ was added into the 
samples. A comparison of the specific activities for both samples remarkably showed 
an almost 20-fold difference, indicating that Co2+, unlike other metals, could activate 
iPGAM to a much higher extent. This observation however, is only anticipated with 
samples purified in vitro, since Co2+ concentrations in vivo were found to be much 
lower than in Co2+-purified samples and in the crystal structure. 
Through ICP-MS and ICP-OES analysis, it is clear that Co2+ concentrations 
are much lower than the other biologically relevant metal ions. Both the bacterially 
expressed protein and the cytosol of the parasites exhibited low concentrations of 
Co2+, which indicates that it is not sufficient to support iPGAM to a maximal 
activity. By comparing the concentrations of TbiPGAM in the cytosolic fractions 
(~10-50 µM), to Co2+ concentrations in vivo which are less than 0.03 µM, it is clear 
that the stoichiometry is insufficient to satisfy even a small proportion of the iPGAM 
present. A similar observation was reported by ICP-MS for the bacterially expressed 
protein, where the concentration of Co2+ was only 0.01 µM. Although the value is 
above the limit of detection (<0.0002 µM), it is still exceptionally low compared to 
the concentration of the bacterially expressed iPGAM in the same sample (0.99 µM). 
Mg2+ and Zn2+ were found to be at higher concentrations compared to the 
other divalent metal ions. Both metals exist at concentrations that are more than 
sufficient to satisfy a significant proportion of iPGAM either in vivo or in vitro. 
However, as mentioned earlier, the concentrations of metals that are freely available 
to bind to iPGAM may be overestimated, since these analyses do not distinguish free 
metals from bound ones. Nevertheless, the results from ICP-MS analysis provide 
strong indications for this hypothesis, since the sample analysed is purified iPGAM. 
In this respect, any metals present, in theory should be specifically bound to iPGAM. 
Moreover, the low activity observed from the bacterially expressed protein (~21 
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U/mg) may also be supported by Mg2+ and/or Zn2+. The M1 and M2 metal sites in 
iPGAM exhibited structural preferences for Mg2+ and Zn2+, respectively, based on 
coordination geometry and the possibilities of interactions with the neighbouring 
atoms. In the next chapter, further analysis on the activities of iPGAM in the 
presence of these two significant metal ions, and also with the other relevant divalent 

















Chapter 6:  
The Development of an Assay System for Trypanosomatid iPGAM in The 
Presence of Metal Ions 
6.1 Aims 
The previous chapter has discussed metal concentrations in the cytosol of T. brucei, 
and also in the bacterially expressed protein from L. mexicana in great detail. There 
are similarities in the trends of metal concentrations in both samples, where Mg2+, 
Zn2+ and Fe2+ are in greatest abundance, compared to the least abundant metals; 
Mn2+, Ni2+, Cu2+ and Co2+. In particular, Co2+ is present below the limit of detection, 
which suggested that in vivo cellular conditions lacking Co2+ are unable to support 
the maximal activity of iPGAM, and Mg2+ and/or Zn2+ may assume this role. The 
significance of these findings required further analysis on the activities of iPGAM in 
the presence of various metal ions, which could be carried out initially on the in vitro 
conditions from the bacterially expressed protein in the laboratory. As detailed in 
chapter 2, the assay system used to measure the activity of iPGAM is based on the 
oxidation of NADH, by coupling iPGAM with ENO, PYK and LDH. The well 
known intolerance of enolase towards divalent metal ions (Lee and Nowak 1992; 
Poonperm 2005), and the requirement of Mg2+ by both enolase and PYK (Ainsworth 
and Macfarlane 1975; Brewer 1981) provide challenges in assaying the activity of 
iPGAM in the presence of a series of divalent metals. Hence, the aim for this chapter 
is to develop an assay system which could be carried out at minimal metal 
interference to the latter coupling enzymes using a more modern, fast and cost saving 
multimode plate reader technique, and hence, could provide indications of the 







In 1988, Johnson and Price had reported that iPGAM activity could be monitored 
using an assay system called the ‘coupled-quenched’ procedure, or also known as 
‘stop and sample’ assay. In this experiment, a portion of iPGAM and the substrate 
3PGA was incubated together before disruption of the enzyme activity. A small 
amount of the enzyme catalysed reaction which contained a mixture of 3PGA and 
2PGA was added into a mixture containing the rest of the enzyme components, 
including the other three coupling enzymes. The end absorbance reading after 
absorbance decrease at A340 nm was recorded and compared to calibration curves to 
obtain the amount of 2PGA produced in the initial reaction. The rationale behind the 
development of the assay is to avoid the interference of a range of divalent metals to 
be tested on iPGAM, with the rest of the coupling enzymes in the whole system. This 
type of assay corresponds to a discontinuous assay, where iPGAM as a reversible 
enzyme acted to convert 3PGA to 2PGA and vice versa before the next reaction in 
the presence of the latter coupling enzymes takes place. By contrast, the standard 
continuous assay is a non-reversible way of monitoring the enzyme activity, purely 
because the presence of the rest of the coupling enzymes includes the essentially 
irreversible step catalysed by PYK. Figure 6.1 showed the differences between the 
two types of assays.  
Our novel assay utilises the recent advancement in micro plate reader format, 
which exhibits dissimilarities from the traditional cuvette approach described in 
Johnson and Price (1988), and also from the continuous assay system that has 
routinely been implemented in the laboratory. Considering the volume in the cuvette 
system is 10 fold higher than the micro plate wells, the consumption of the reagent in 
the latter instrument could be brought down which is more sufficient to carry out 
large scale analysis. The micro plate with 96 wells also made it feasible to perform 
multiple samples for an analysis in a much shorter period of time. 
This chapter will describe the recent progress in optimising the micro plate 
reader technique to measure the absorbance of NADH at A340 nm, which is directly 
involved in measuring iPGAM activity. Subsequently, the chapter will discuss the 
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details of the discontinuous assay which was implemented in the newly developed 
multimode plate reader technique. The effects of a series of divalent metals will also 
be described in this section.  
 
Figure 6.1  The steps in the discontinuous and continuous assays for measuring 




6.3 Optimisation of the plate reader format for assaying phosphoglycerate 
mutase enzymatic activity 
a) Determination of the parameters for the assay components. 
i) NADH concentration 
The standard coupling enzyme assay was monitored by the oxidation of NADH to 
NAD+, which occurred during the conversion of pyruvate to lactate by lactate 
dehydrogenase. In this section, a stock concentration of 6.4 mM NADH was diluted 
two-fold to get a series of different concentrations: 1.6 mM, 0.8 mM, 0.4 mM, 0.2 
mM, and 0.1 mM.  The rest of the enzyme components were specified at the standard 
concentrations in the normal continuous assay, as described in chapter 2. The starting 

























Figure 6.2 Determination of the optimal NADH concentration in the LmiPGAM 
assay mix. 0.8 mM to 1.6 mM NADH concentrations provided sufficient 
signal for the analysis. Lower NADH concentrations exhibited inadequate 
signal as monitored in the spectrophotometer. Errors were calculated but 





The results indicated that NADH concentrations from 0.8 mM to 1.6 mM are 
sufficient to obtain good starting absorbance for the reaction. On the other hand, 
lower concentrations of NADH (0.4, 0.2 and 0.1 mM) did not provide adequate 
signal for the starting absorbance. It was therefore decided that future experiments 
would be employed in the presence of 0.8-1.6 mM NADH. 
ii) Enzyme concentration 
Different enzyme concentrations were tested to obtain the optimal velocity in 
determining the rate of the reaction. A range of protein concentration was tested: 
0.00125, 0.0025, 0.005, 0.01, 0.02 and 0.04 mg/ml as the final concentrations in the 
well. The results, as depicted in Figure 6.3, demonstrated a linear correlation 
between the amount of enzyme used, and the velocity. In this initial experiment, the 
reaction was conducted for 30 min, which means that the enzyme concentration 
required would be low. It was later determined that an enzyme concentration in the 
range of 0.0025 to 0.005 mg/ml was found to be sufficient for the multimode plate 
























Figure 6.3  Determination of the LmiPGAM concentration required for the  
multimode plate reader assay. Errors were calculated but the values 
are too small to show up. 
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b) Specific activity determination of LmiPGAM and TbiPGAM 
In chapter 4, the difference in the specific activities of LmiPGAM was explained in 
detail, with regard to the different forms and oligomerisation status of each peak 
eluted from the ion-exchange column. In the optimisation steps for the multimode 
plate reader however, determination of the specific activity was carried out only by 
using P1 from the ion-exchange step for LmiPGAM and purified protein from the gel 
filtration step for TbiPGAM. Both samples were treated with 1 mM Co2+ for 45 min 
at 25°C, and samples without added Co2+ were used as controls. The specific activity 
of LmiPGAM without the presence of Co2+ was determined to be 21 U/mg, and 
increased to 183 U/mg after incubation with Co2+ for 45 min. TbiPGAM provided 
similar observation with 33 U/mg of specific activities before the addition of Co2+, 
and 190 U/mg after incubation for 45 min (Figure 6.4). 
As anticipated, these two set of results are very similar to the results obtained 
using the standard spectrophotometric cuvette assay (chapter 4), and also suggested 
that TbiPGAM, as LmiPGAM, is hyperactivated by Co2+ at standard conditions. 
These results also supported the previous findings in chapter 5, where Co2+, when 
present at very low concentrations in the cytosol of T. brucei, could not sustain the 
activity of iPGAM at a high level. Alternatively, the activity may have been 
maintained at a low level by the presence of different metal ions. It is also 
noteworthy that the specific activity before the addition of Co2+ in TbiPGAM 
(33U/mg) is similar to the value obtained by Collet (2001), which is 26 U/mg. The 

























Figure 6.4  Specific activities of LmiPGAM and TbiPGAM before and after the 
incubation with 1 mM Co2+ for 45 min. One unit corresponds to the 
conversion of 1 µmol of substrate min-1 mg-1 protein under standard 
conditions. 
 
i) Kinetic values: Vmax and Km values for LmiPGAM and TbiPGAM 
Following the determination of the specific activities for both LmiPGAM and 
TbiPGAM, the kinetic values Vmax and Km were determined. Varying concentrations 
of substrate 3PGA was added into the reaction mixture at a final concentrations of 
1.5 mM, 0.75 mM, 0.375 mM, 0.1875 mM, 0.09 mM, 0.05 mM and 0.02 mM. The 
Km values for LmiPGAM were determined for the three peaks from ion-exchange 
chromatography, and from the gel filtration column for TbiPGAM.  To note, 1 mM 
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Figure 6.5   Michaelis Menten plot for the determination of the Km values for 3PGA 
in a) LmiPGAM and b) TbiPGAM. The plots were generated using the 
program Kaleidagraph. Errors were calculated but the values are too 





The Km values for 3PGA for the three peaks from ion-exchange column are 
tabulated in Table 6.1, and similar to each other, with 0.45 ± 0.03 mM for P1, 0.33 ± 
0. 03 mM for P2, and 0.39 ± 0.03 mM for P3 (Figure 6.5a). For TbiPGAM, the Km 
value was determined to be 0.43 ± 0.04 mM (Figure 6.5b). Nevertheless, these values 
were higher than LmiPGAM that has been purified by a Co2+-IMAC column, which 
were 0.18 ± 0.01 mM (Poonperm 2005) and 0.27 ± 0.02 mM (Guerra et al. 2004) 
(Table 6.1). Meanwhile, the Km values that have been reported for Co2+-TALON 
purified TbiPGAM and EDTA-treated TbiPGAM purified by Ni2+-NTA agarose 
column after reactivation with Co2+ were 0.15 ± 0.02 mM (Chevalier et al. 2000) and 
0.1 mM (Collet et al. 2001), respectively. Tighter bindings of 3PGA to the active site 
in the present of higher concentrations of Co2+ in Chevalier et al. 2000; Poonperm 
2005 and Guerra et al. 2004, or in the absence of other metals reported in Collet et al. 
2001 was expected since the specific activities and the Vmax values are higher with 
enzyme that has been purified in the presence of Co2+. Since this study is focusing on 
the activity using the forward reaction, the Km value for 2PGA is not determined. The 
observation of the hyperactivity of trypanosomatid iPGAM with Co2+ and how other 
metals could support the enzyme activity at lower levels will be discussed in detail in 
section 6.4. 
Table 6.1   The Km values for LmiPGAM and TbiPGAM from this study, and the 
previously reported values.   
Proteins Km values (mM) from this study Km values (mM) from other study 
LmiPGAM 
 
P1 0.45 ± 0.03                               
P2 0.33 ± 0.03                                
P3 0.39 ± 0.03 
0.27 ± 0.02 (Guerra et al. 2004)               
0.18 ± 0.01 (Poonperm 2005)       
TbiPGAM 0.43 ± 0.04 0.15 ± 0.02 (Chevalier et al. 2000)    







c) Metal tolerances of the coupling enzymes: lactate dehydrogenase, 
pyruvate kinase and enolase. 
i) Tolerance of LDH to divalent metal ions 
In order to observe the effects of metals on iPGAM, the tolerances of the coupling 
enzymes to divalent metals have to be determined. These results are important to 
draw borderlines of the amount of metals which could be tested on iPGAM, without 
significant interference to the other coupling enzymes. Lactate dehydrogenase is the 
last enzyme in the coupling enzyme assay, converting pyruvate, the ultimate product 
in glycolysis, to lactate. In the assay mixture, LDH from rabbit muscle was utilised 
for the reaction. Since this is the first trial that was employed to observe the 
tolerances of the coupling enzyme towards divalent metal ions, only Co2+ was 
included in the experiment. Hence, using pyruvate as the substrate without the 
presence of the other coupling enzymes, the activity of LDH was measured in the 
presence of Co2+ ion. Concentrations of Co2+ ranging from 0, 0.1, 1, 1.5, 2, 3, 4, 5 
and 10 mM were tested to observe their effects to LDH.  
The results (Figure 6.6) concluded that the activity of LDH is decreased by 
Co2+, with the remaining activity ~60% at higher concentrations of Co2+. Mg2+ 
however, was always present in the assay buffer at 5 mM concentration. It was 
therefore decided that the next enzyme, which is PYK, would be tested together with 























Figure 6.6 Effect of Co2+ on the activity of LDH. The reaction was started with 
pyruvate as the substrate, in the presence of 5 mM Mg2+. Errors were 
calculated but the values are too small to show up. 
 
ii) Tolerances of PYK and LDH to divalent metal ions 
PYK catalyses the conversion of phosphoenolpyruvate (PEP) to pyruvate, and plays 
a role as the final enzyme in glycolysis. In this study, the activity of PYK from rabbit 
muscle was tested in the presence of Mg2+, Mn2+, Fe2+, Co2+, Ni2+, Cu2+ and Zn2+, in 
concentrations ranging from 0, 0.1, 1, 1.5, 2, 3, 4 and 5 mM. It is important to note 
that the initial activity was assayed in the absence of any divalent metals, and for the 
purpose of testing the effects of Mg2+, this metal was omitted from the assay mixture. 
Activation of rabbit muscle PYK by Co2+, Mn2+ and Ni2+ had been reported 
previously (Mildvan and Cohn 1965; Bygrave 1966; Ainsworth and Macfarlane 
1975). Meanwhile, it is well-known that rabbit muscle pyruvate kinase requires Mg2+ 
and a monovalent cation, preferably K+ for the reaction between 
phosphoenolpyruvate and ADP is to occur (Kachmar and Boyer 1953; Ainsworth 
and Macfarlane 1975). The initial reaction (in the absence of metal ions) exhibited 
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almost no activities of the enzymes in the absence of the divalent metal ions. It is 
clearly shown in Figure 6.7 that Co2+ and Mn2+ activated the enzymes, even up to 
two-fold more strongly than Mg2+. The rest of the metals (Cu2+, Fe2+, Ni2+ and Zn2+) 






























Figure 6.7 Effects of various divalent metals on the activities of PYK and LDH. 
The reaction was started with phosphoenolpyruvate as the substrate, 
in the absence of Mg2+ in the assay buffer.Errors were calculated but 
some of the values are too small to show up.  
 
iii) Tolerances of ENO, PYK and LDH to divalent metal ions 
In the glycolytic pathway, ENO utilises 2PGA as substrate, producing PEP as the 
ninth and penultimate metabolite in the pathway. The poor tolerance of yeast ENO 
towards a number of divalent metals such as Mn2+ and Zn2+ has been discussed 
previously (Lee and Nowak 1992). These observations however, contradict older 
reports by Parisi and Vallee (1969) and Brewer (1981) which reported that transition 
metal ions such as Mg2+, Mn2+, Ni2+, Co2+ and Zn2+ are activators of yeast ENO. In 
the present study, two sets of analysis were conducted, where in the first experiment 
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the activity of the coupling enzymes was assayed in the presence of Mg2+ in the 
assay buffer (Figure 6.8a). For the purpose of assaying the effects of Mg2+ to the 
enolase, the second experiment was performed in the absence of the metal. The 
experimental condition employed was the standard condition for PYK, except that 
the activity was started by 2PGA, which is the substrate of ENO. 
In the first experiment (Figure 6.8a), significant depletion of the enzyme 
activity was observed as the concentration of Zn2+ and Ni2+ increased. The enzymes 
exhibited better tolerance to Co2+, although the activity gradually decreased as the 
concentration of the metal rose. Mn2+ however, maintained the enzyme activity 
almost at 100% remaining activity at the whole range of concentrations. With Zn2+, 
the 100% inhibitory effect was observed as the concentration increased to 0.1 mM, 
while the enzymes exhibited better tolerance to Ni2+, with 100% inhibitory effect at 5 
mM.   
The second experiment (Figure 6.8b) was conducted only in the presence of 
Co2+, Mn2+ and Mg2+. The initial activity was nearly zero when Mg2+ was omitted 
from the assay mixture, exhibiting similar observations as the previous experiment 
where PEP started the reaction in the absence of ENO.  It is clear that Mn2+ and Mg2+ 
are able to support the activities of the coupling enzymes, with Mg2+ being the more 
active. Co2+, on the other hand, exhibited a smaller activating effect than Mg2+ or 
Mn2+.   
 The preliminary test for assaying the tolerances of the coupling enzymes 
towards the divalent metals concluded that LmiPGAM activity has to be assayed in a 
condition where the presence of metals concentrations would have none or minimal 
effects towards the coupling enzymes. Considering the fact that any significant 
observations would be masked by the effects of metals towards PYK or ENO, either 
as inhibitor or activator, iPGAM activity has to be determined prior to the addition of 
the other coupling enzymes. Therefore, in the next section, the development of the 



















































Figure 6.8 a) Effects of Co2+, Mn2+, Ni2+ and Zn2+ on the activities of the coupling 
enzymes (enolase, PYK and LDH). The reaction was started with 2PGA 
as the substrate in the presence of 5 mM Mg2+ b) A separate experiment 
of effects of Co2+, Mg2+ and Mn2+ on enolase, PYK and LDH. This 
analysis was done in the absence of Mg2+ in the assay buffer. Errors were 





6.4 The development of the multimode-plate reader discontinuous assay  
A discontinuous assay measurement is one of the best methods of testing iPGAM 
activity in the presence of metal ions, without interference of metals on the activity 
of coupling enzymes. Apart from minimising the poor tolerance of ENO towards 
Zn2+, the assay may limit the possibility of “false” activation of the enzyme by Mg2+, 
by separating iPGAM activity from the rest of the coupling enzymes. These 
advantages however, were challenged by the limitations of conducting the end-point 
assay in which only small amounts of 2PGA are present. Moreover, iPGAM is 
inherently difficult to assay because neither the substrate nor product can be readily 
measured directly. Hence, the activity measurements required not only iPGAM, but 
the other three coupling enzymes: ENO, PYK and LDH to obtain convenient 
spectroscopic signals in which changes due to iPGAM activity could be observed. 
Traditionally, using the non-reversible continuous assay, the product (2PGA) would 
be taken away by the next enzyme (ENO) and thus favour the forward direction. In 
the discontinuous assay however, the scenario is different. iPGAM, in the absence of 
the other coupling enzymes, not only would convert 3PGA to 2PGA, but would 
catalyse the reverse reaction, until the equilibrium between 3PGA and 2PGA is 
attained. The ratio of 3PGA to 2PGA at equilibrium was not known prior to these 
measurements, but was initially assumed to be of the order of 1 to 1. It was later 
found to be 1 to 0.08 (see section 6.5a). This situation is often the major difficulty in 
optimising this type of assay, in which the length of incubation for iPGAM and 
3PGA, together with the amount of enzyme and substrate used become the major 
challenge in obtaining sufficient product for measurement. These are all factors that 
have to be considered to determine the time to reach equilibrium. Figure 6.9 




   
Figure 6.9 The reactions catalysed by iPGAM. a) Reversible reaction in the 
presence of iPGAM alone. b) Essentially non-reversible reaction in 
the presence of iPGAM, along with the rest of the coupling enzymes: 
ENO, PYK and LDH.   
The principle of the discontinuous assay method involves the reaction of 
iPGAM with its substrate 3PGA in the presence of divalent metal ions in the first 
tube, before being deactivated (for example by rapid heating, changes in pH or in 
some conditions by adding trichloroacetic acid that denatures and precipitates almost 
all proteins (Price and Nairn 2009)). The 2PGA which is present in the first tube is 
the substrate used to start the next reaction containing the rest of the coupling 
enzymes and the assay components, preferably in the plate reader wells. The reaction 
was monitored by the decreased absorbance of NADH at A340 nm, and the 
concentration of 2PGA was determined by comparing the end absorbance of NADH 
to the standard curves, which were generated with known concentrations of 2PGA. 
This concentration of 2PGA would correspond to 1/20 of the concentration in tube 1 
because of the 20-fold dilution from tube 1 to the plate reader well. The 
discontinuous assay method proved to be convenient for monitoring the activity of 





a) The generation of the standard curves in the presence of various metal 
ions 
As mentioned above, iPGAM activity is assessed by the concentration of 2PGA in 
the first tube. Hence, the calibration standards are vital to ensure the validity of the 
concentration of 2PGA, which reflects the activity of iPGAM. In this particular step 
of assay development, 2PGA at known concentrations were prepared (0.63 mM, 0.31 
mM, 0.16 mM, 0.08 mM and 0 mM) and added to the reaction mix in the well of the 
plate reader containing the rest of the enzyme components (chapter 2), excluding 
iPGAM and 3PGA. Prior to the analysis, the 2PGA had been heated at 100°C for 2 
min and showed that the metabolite is stable to boiling, reflecting the suitability of 
the method of quenching in this analysis.  
A further step in assay development concerned the tolerance of the coupling 
enzymes to divalent metals at different concentrations, bearing in mind the 20-fold 
dilution from tube 1 to the plate reader well. Thus, three different concentrations of 
metals (0.05, 0.1 and 0.5 mM) for each Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+ and 
Zn2+ were added separately to individual reactions (in the presence of the usual 5 
mM Mg2+ and 50 mM K). Although Ca2+ was not included previously in the ICP-
OES or ICP-MS analysis, the presence of this metal in the cytosol of T. cruzi 
(Docampo et al. 1993; Scott et al. 1997) and T. brucei (Xiong and Ruben 1998) made 
it an interesting candidate to test, along with the other metal ions. Taking into 
account the 20-fold dilutions made up upon adding 5 µl from the original reaction 
mix into 100 µl total volume of final reaction, the effects of up to 1, 5 and 10 mM 
metals could be tested on iPGAM activity in tube 1. Altogether, 25 calibration 
standards were constructed, at three different concentrations for all eight metals, with 
a control in the absence of added metal ions, except for 5 mM Mg2+ and 50 mM K+ 
in the assay buffer (see Appendix I (f)). Many of the standard curves were generated 
using linear fit; y=mx + c, where m is the slope and c is the y-intercept, and some 
others were plotted using a polynomial regression with the formula y=ax2 – bx + c. 
The R2 values for these curves were >0.99, indicating the goodness of the fit.  
As observed in the standard curves (see Figure 6.10 and Appendix I (f)), no 
significant effects on the activity of the coupling enzymes could be observed even at 
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the highest concentration tested, which was 0.5 mM for some metals, such as Ca2+, 
Co2+ (Figure 6.10a), Mg2+, Mn2+ and Ni2+. Fe2+ started to show a decrease in the 
activity of the coupling enzymes at 0.5 mM, albeit no significant effects could be 
seen at 0.05 and 0.1 mM (Figure 6.10b). Zn2+ and Cu2+ were the two metals which 
showed the greatest effect on enzyme activity. Decreased activity in the presence of 
these metal ions could be observed with increasing metal concentrations, starting 
from the lowest concentrations: 0.05 mM and up to 0.1 mM and 0.5 mM, and hence, 
resulting in a non-linear regression (see Appendix I (f)).Considering these results, 
and for the purpose of mimicking the in vivo condition as in the cells, while keeping 
the concentration biologically relevant, the highest concentration that would be tested 
in tube 1 containing iPGAM, metals and 3PGA was standardised to be 1 mM. Hence, 
all the end absorbance values for the activities of iPGAM in the presence of specific 
metal ions could be compared to standard curves in the presence of 0.05 mM metals, 






           





























































Figure 6.10  Calibration standards in the presence of different concentrations of a) 
Co2+ and b) Fe2+ for the coupling enzymes. The rest of the calibration 
standards are shown in the Appendix I (f). The curve fit and R2 value 
were only shown for the 0.05 mM concentration, as this is the 





b) Assay optimisation: Enzyme concentrations, substrate concentrations 
and time of incubation 
Development of the new coupled discontinuous enzyme assay required a number of 
preliminary experiments in which three important parameters had to be validated: 
enzyme concentrations, substrate concentrations and length of incubation for the 
reaction of the enzyme and the substrate to occur. It is often difficult to standardise 
all the parameters at the same time, hence every single one of them required a ‘try 
and error’ test to select the best condition for the assay. Enzyme concentration, in 
any type of assay, is crucial to be determined. Often adding too much enzyme would 
lead to very swift attainment of equilibrium, even before the cuvette or plate is 
placed in the spectrophotometer, resulting in samples all having the same 
concentration of 2PGA. On the contrary, adding too little enzyme would result in 
concentrations of 2PGA that would be too small to be measured accurately (Price 
and Nairn 2009). Although the discontinuous assay is not an absolute quantitation, 
and is relative to the standard curves generated, it is necessary to ensure that the 
concentration of the enzyme is optimal to provide meaningful results from the 
analysis. Reliable measurements also depend on the amount of substrate and the time 
of incubation for the reaction to occur. In this section, some preliminary experiments 
which were carried out in the presence of a range of enzyme and substrate 
concentrations, and at variable time of incubation will be discussed. It is necessary to 
note that this analysis was carried out using iPGAM from P1 from the ion-exchange 
column, in the absence of EDTA or any metal chelating agents.   
Initially, the reaction was carried out in the presence of 0.1 mg/ml, 0.2 
mg/ml, 0.5 mg/ml and 1 mg/ml of iPGAM in the presence of 1 mM Co2+, with 10 
mM 3PGA as the original concentration in the first tube (Johnson and Price 1988). 
The starting absorbance in the plate reader well was standardised to be ~0.7 by 
adjusting the NADH concentration. As shown in Figure 6.11, the absorbance values 
of all the samples were very similar to 0.7, thus indicating that the concentration of 
2PGA in tube 1 was insufficient. It was learnt later (see section 6.5a) that the 
concentration of 2PGA from an initial concentration of 10 mM 3PGA was too low to 
measure reproducibly. The 2PGA concentration at equilibrium was only 7.56% from 
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the original 3PGA concentration, which means only 0.756 mM 2PGA was present in 
the original mixture in tube 1. Taking into account the 20-fold dilution made after 
quenching, only 0.038 mM 2PGA was present in the well during the absorbance 
measurement. Although this value is still in the range that could be determined from 
the calibration standards (see Figure 6.10), it is too low to show any significant 
changes at the different enzyme concentrations.  
The binding of a substrate to an enzyme, followed by a catalytic step 
correspond to two major stages in an enzyme reaction (Figure 6.12). The principle of 
the reaction lies in the concentrations of substrate and product, which would only 
change as the reaction progresses, until equilibrium is attained. In this initial 
experiment, the amount of 2PGA formed was obtained in the presence of 1 mM 
Co2+, which is known to maximally activate iPGAM in the continuous assay (see 
section 6.3b) and later found to speed up the time to reach the equilibrium (see 
section 6.5b). If the time of incubation is too long, all samples, regardless of the 
metal present, would exhibit similar 2PGA concentrations, as the reaction attained 
equilibrium. In this respect, besides the enzyme concentration, it is vital to determine 
the time required for the reaction to be measured before the equilibrium is attained, 
so that the concentration of 2PGA in all samples could be distinguished. In addition, 
a sufficient initial 3PGA concentration has to be determined, to ensure an adequate 
signal that could be monitored using the calibration standards. It is noteworthy that 































Figure 6.11 Effect of LmiPGAM concentrations on iPGAM activity in the 
discontinuous assay. Absorbance reading at A340 nm exhibited 
insufficient concentration of 2PGA in the reaction mixture, indicating 




Figure 6.12 The mechanism of an enzyme catalysed reaction. The substrate (S) 





Subsequently, the effect of 3PGA concentration was studied in an attempt to 
observe changes in the absorbance. The experiment was conducted in a similar 
manner, albeit with different initial concentrations of 3PGA; 30 mM, 50 mM, 70 mM 
and 100 mM with a fixed enzyme concentration of 0.2 mg/ml. The protocol for the 
activity measurement was as described in chapter 2. As depicted in Figure 6.13, 
increased initial concentrations of 3PGA resulted in decreased absorbance of NADH. 
Since 50 mM 3PGA exhibited sufficient signal for the analysis, the next experiments 
were conducted with 50 mM 3PGA as the initial concentration. The method of 
quenching was also validated by heating iPGAM at 100°C for 2 min prior to 
equilibration with 3PGA, whereby no decrease in absorbance was observed, 





















Figure 6.13 Effect of 3PGA concentrations on LmiPGAM activity in the 
discontinuous assay. Absorbance reading at A340 nm showing 
significant effect of different 3PGA concentrations on the assay 
system. Errors were calculated but some of the values are too small to 




With the purpose of determining the optimum incubation time before the 
reaction attained equilibrium, a control experiment was set up with iPGAM in the 
absence and presence of 1 mM Co2+, and the reaction was started with the addition of 
50 mM 3PGA. An aliquot of sample was taken at 5, 10, 15, 20, 30, 60 and 120 min 
after the start of the reaction and quenched with rapid heating for 2 min at 100°C. 
The differences of the absorbance reading between the two samples are depicted in 
Figure 6.14. The striking observations are that the decrease in absorbance of NADH 
is more rapid in the presence of 1 mM Co2+, and levelled off after 30 min incubation. 
This reflects the ability of Co2+, as determined in the continuous coupled assay 
system, to hyperactivate the enzyme. While it was essential in this experiment to stop 
the reaction at different time points to observe the rate of production of 2PGA which 
is clearly different in the two samples, the concentration of the product would be 
similar once equilibrium had been reached. An equilibrium level, indicating similar 
2PGA concentrations formed, was attained in both samples after approximately 30 
min incubation, irrespective of the amount of enzyme activity. In a different albeit 
similar conditions, Johnson and Price 1988 reported that the final concentrations of 
2PGA formed from wheat germ and Aspergillus nidulans iPGAMs, and surprisingly 
rabbit muscle dPGAM were also similar in all cases, after more than 20 min of 
incubation. Therefore, it is crucial to “catch” the reaction after an appropriate 
incubation time, to ensure that the enzyme activity is distinguishable between the 
different samples before the reaction completes. The hyperbolic rate of the reaction 
within the time interval before the equilibrium phase indicated the suitability of this 
assay. Consequently, a 15 min incubation time was selected as the time of incubation 


























Absence of added metals
 
Figure 6.14 Effect of incubation time on LmiPGAM activity in the discontinuous 
assay. Absorbance reading at A340 nm showing significant effect of 
different times of incubation for iPGAM with the substrate 3PGA.  
The experiment was conducted in the presence and absence of 1 mM 
Co2+. 
6.5 Enzymatic activities in the presence of different metal ions 
The requirement for divalent metal ions by iPGAMs from a range of different 
organisms has been elucidated previously (Watabe and Freese 1979; Chevalier et al. 
2000; Guerra et al. 2004; Raverdy et al. 2007). The metal ions required for each of 
these iPGAMs however, varies from one organism to another as discussed in the next 
section. Trypanosomatid iPGAMs have been shown to possess a great affinity for 
Co2+, as elucidated in chapter 5. Nevertheless, it is plausible that iPGAM, in the 
presence of Co2+, experiences hyperactivation and the phenomenon observed in vitro 
is not a true reflection of the condition in vivo. The optimisation of the activity assay 
in a discontinuous fashion made it possible to assay iPGAM activity with minimal 
metal interference on the coupling enzymes. The next section will focus on the 
activities of iPGAM in the presence of a range of divalent metal ions, as measured by 
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the concentration of 2PGA. This may be analysed in two ways: (i) the effects of 
metals at different concentrations on iPGAM activity after 15 min reaction with 
3PGA, and (ii) the time required to reach half of the 2PGA concentration at 
equilibrium in the presence of different metals. 
a) Effects of metals at different concentrations towards LmiPGAM activity 
As a member of the metal-dependent alkaline phosphatase superfamily, iPGAM 
evolved as an enzyme that requires metals at the active site. Other members of the 
family that have been well characterised such as E. coli alkaline phosphatase (Kim 
and Wyckoff 1991), Bacillus iPGAM (Kuhn et al. 1995; Nukui et al. 2007) and 
nematode iPGAM (Raverdy et al. 2007) require Zn2+, Mn2+ and Mg2+, respectively. 
LmiPGAM and other trypanosomatid iPGAMs however appear to function with a 
one-metal mechanism (Nowicki et al. 2009) in which Co2+ performs well as the 
proposed required metal. As shown in Figure 1.6 (chapter 1), LmiPGAM possesses 
two metal sites, with metal site 1 (M1) having a greater affinity for Co2+, while M2 
by contrast, exhibited poor affinity for the metal. Moreover, Ser75 that is coordinated 
with the M2 site and involved in catalysis adopts an unfavourable position for 
phospho transfer if site M2 is occupied by metal. Based on these observations, it is 
plausible that M1 site occupation is essential for iPGAM activity, while M2 might 
play a role as a metal regulatory site for LmiPGAM. Nevertheless, with the low 
affinity for Co2+ (or the biologically relevant metal) of the M2 site, the inhibition 
could only be observed at relatively high metal concentrations. As elucidated in 
chapter 5, the highest concentration measured in the cytosol of the parasite is Mg2+ 
with 0.2 mM, hence the effects of metals should be tested in conditions close to those 
resembling the in vivo surroundings.  
In this section, iPGAM activity was monitored in the presence of biologically 
relevant concentrations of divalent metals, ranging from 0.01 mM to 1 mM. 
Altogether, eight metals were tested; Ca2+, Co2+, Cu2+, Fe2+, Mg2+, Mn2+, Ni2+ and 
Zn2+, following the protocol as described in chapter 2. The incubation time for 
iPGAM with the metals is 1 h, prior to the reaction between the enzyme and 
substrate 3PGA, which was executed for 15 min. It is noteworthy that the metals 
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were not removed from the iPGAM samples, hence some residual effects of the 
metals could still be observed from the control experiment. These conditions would 
provide better mimicking of the in vivo surroundings, where divalent metals would 
































Figure 6.15  Effects of divalent metal ions at different concentrations on LmiPGAM 
activity. The concentrations of 2PGA formed are those in the plate 
reader well before correction of the 20-fold dilution. 
As mentioned previously, the activity of iPGAM was monitored by the 
concentration of 2PGA in the original reaction in tube 1. Figure 6.15 depicts the 
concentration of 2PGA in each sample containing individual metals at different 
concentrations. All metals at low concentrations, except for Ca2+ and Ni2+, stimulated 
the concentration of 2PGA compared to the native sample in the absence of added 
metals (red dot), which acted as the control experiment. The trends however, varied 
greatly among the different metals. Co2+ exhibited the strongest activation effects on 
iPGAM, increasing the activity until 0.5 mM, before decreasing the activity when it 
reached 1 mM. This observation, in line with the previous hypothesis, suggested that 
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Co2+ activated iPGAM to a certain concentration, approximately 0.5 mM, where 
primarily metal site 1 is occupied by Co2+. Since M2, as suggested from Nowicki et 
al. 2009, is the regulatory site albeit a weaker binding site for Co2+, the inhibitory 
effects would not have been seen until 1 mM concentration, as observed in Figure 
6.15. It is anticipated that the activity would decrease as the concentration of Co2+ 
increased. It is noteworthy that the activation of LmiPGAM by Co2+ in the 
discontinuous assay is comparable to the previous continuous assay, although the 
activation was observed to be less than the former analysis.  
A direct observation that could be seen in this experiment is the concentration 
of 2PGA in the samples, which interestingly is much lower than the initial substrate 
concentration (50 mM). This is an unexpected result for LmiPGAM, where in the 
crystal structure, 3PGA and 2PGA are present at equal occupancies (Poonperm 2005; 
Nowicki et al. 2009). Nevertheless, Johnson and Price 1988 reported that the 
concentration of 2PGA in the A. nidulans iPGAM reaction was only 0.8 mM from 
the original concentration of 10 mM 3PGA. A similar observation was obtained from 
the present study, where 3.78 mM 2PGA was measured (after correction of dilution) 
from the original concentration of 50 mM 3PGA, in the presence of 0.5 mM Co2+. 
While in the older report, the equilibrium mixture contained 8% 2PGA, the latter 
experiment resulted in 7.56% 2PGA. It is clear from this result that in solution, the 
substrate: product ratio at equilibrium is far from 1:1, and in fact is 12:1. The Km 
value for 2PGA, which is two-fold lower than 3PGA (Guerra et al. 2004) might 
explain this observation, as the continuously formed 2PGA with tighter binding to 
the active site reacted in situ with iPGAM to produce more 3PGA.  
Among all metals, Mg2+ showed a slight activation of iPGAM, across the 
whole range of concentrations. It is noteworthy that Mg2+ is found at the highest 
concentration of any divalent metal in the protein sample (8 µM), and might 
contribute to the residual activity found in the sample in the absence of added metals. 
A similar trend of Mg2+ concentration is also observed in vivo in the parasite cytosol. 
It is postulated that Mg2+, by being the most abundant metal in the cell, can maintain 
the activity of iPGAM at a low level, albeit less than Co2+ in vitro. This is clearly 
seen by the regulation of the activity of iPGAM by Mg2+ (Figure 6.15), which was 
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maintained at the same level over a range of Mg2+ concentrations up to 1 mM (five 
times the cytosol concentration of ~200 mM (see chapter 5). Mn2+ showed a similar 
effect, albeit at a lower level of iPGAM activity. Ca2+, Cu2+ and Fe2+ showed 
decreased iPGAM activity at higher concentrations. Ni2+ and Zn2+, on the other hand, 
inhibited the enzyme even at low concentrations. Zn2+ moreover, showed significant 
inhibition of the enzyme activity with almost no 2PGA formed when the Zn2+ 
concentration increased to 1 mM.  
b) Divalent metals that are activators, inhibitors or have no effect on 
LmiPGAM 
A second experiment was conducted in the presence of various divalent metal ions. 
This analysis however, was employed in the presence of fixed concentrations of 
metals at 1 mM. A similar protocol was conducted for all experiments, and a portion 
of the enzyme catalysed reaction was quenched at 5, 10, 15, 30, 60 and 120 min. It 
was anticipated that the data would fit a hyperbolic curve, where the exponential 
phase can estimate the rate of activity in the presence of each metal. This could be 
performed by determining the time to reach half equilibrium 2PGA concentration, 
separately for each individual metal. The analysis was similar to the determination of 































































































Figure 6.16 Effects of metals towards LmiPGAM activity is shown, and the types 
of metals are grouped as follows: a) Strongly activating and inhibiting 







Table 6.2 The time required to produce half of the equilibrium 2PGA 
concentration in the presence of different divalent metal ions at 1 mM. 






















The results (Figure 6.16) showed that most of the data fit the hyperbolic 
curves very well, and all the plots were acquired by using the Modified Hyperbola 3 
curve fit (Sigma Plot). The original equation; y = a-b/(1+cx)1/d, was derived to 
obtain the time (x) value to obtain the half maximum 2PGA concentration at 
equilibrium (y). The results from this experiment categorised the divalent metals into 
specific groups, based on their effects towards the enzyme activity. Figure 6.16a 
illustrates the effects of the iPGAM activator Co2+, and the inhibitors Ni2+ and Zn2+, 
compared to the sample in the absence of added metals. The calculated value from 
the equation showed that samples in the presence of Co2+ reached half of the 
maximum 2PGA concentration at equilibrium almost three-fold faster than in the 
absence of added metals (see Table 6.2). On the contrary, Ni2+ slowed the rate of the 
reaction by a factor of ~2, and Zn2+ slowed the reaction beyond a measurable value. 
Interestingly, the addition of Mg2+ into the samples in the presence of Zn2+ did not 
restore the activity of iPGAM, which remained unambiguously the same as the 
sample with Zn2+ alone. Relating this result to in vivo conditions, it is important to 
note that the total Zn2+ concentration in the cytosol is ~6-fold lower than the total 
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Mg2+ concentration, and many of these metal ions might be tightly bound to other 
macromolecules which are present in the cytosol. Unfortunately, the method used to 
determine the divalent metal concentrations as explained in chapter 5 does not 
distinguished between bound or free metals in the analysed sample and hence, the 
actual concentrations of free metals in the cytosol are not known.  
Some of the other divalent metals fell into the slightly activating metals 
category, specifically Fe2+, Mn2+ and Mg2+ (Figure 6.16b). These three metals 
required 12.1, 12.6 and 13.8 min respectively, to reach the half maximum 2PGA 
equilibrium concentration, compared to the sample in the absence of added metal 
which required 16.2 min (see Table 6.2). Interestingly, Fe2+ and Mg2+ (as well as 
Zn2+) were among the three metals that were found to be abundant in the parasite 
cytosol (chapter 5). On the other hand, Ca2+ and Cu2+ do not exhibit significant 
activating effects on iPGAM activity (Figure 6.16c), and had values close to the 
control sample, requiring 18.5 min and 18.8 min (Table 6.2) to produce half of the 
maximum 2PGA equilibrium concentration, respectively. 
In summary, it is clear that the selectivity of metals for iPGAM to employ its 
function is different from one metal, to another. Co2+ at all concentrations tested, has 
greater activating effects on iPGAM, compared to the rest of the metals. 
Interestingly, Mg2+, being the most abundant metal in vivo, could sustain the activity 
of iPGAM throughout the range of concentrations, albeit to a lower level than Co2+. 
This result supports the preference of the octahedral geometry of the M1 site for Co2+ 
and Mg2+, and provides the possibility that Co2+ in vitro could replace Mg2+ by 
occupying the M1 site. Zn2+, on the other hand, is inhibitory toward iPGAM. It may 
be postulated that Zn2+ coordinates the M2 site that possesses tetrahedral geometry, 
and thereby contributes to the inhibitory effect. A mechanism for the regulation of 
the activity of iPGAM in the trypanosomatid cytosol is modelled in Figure 6.17. 
Although the mechanism of the enzyme in vivo is still poorly understood, it is 
plausible that the activation and inhibition of iPGAM are regulated by divalent 
metals, resulting in the relatively low specific activity as measured in the cytosol of 





Figure 6.17 The potential for the occupation of the metal sites of trypanosomatid 
iPGAM in the cytosol of the parasites with Mg2+ and Zn2+. Other 
divalent metals are present at significantly lower concentrations than 
either Mg2+ or Zn2+. However, the concentration of the free metals in 







c) Enzymatic activities in the presence of higher concentrations of 
monovalent cations Na+ and K+ 
Monovalent cations, Na+ and K+ have been shown to be essential for regulating the 
activity or maintaining the structural integrity of enzymes (Page and Di Cera 2006). 
The crystal structure of LmiPGAM (Nowicki et al. 2009) revealed the presence of a 
Na+ ion in the phosphatase domain, although the occupied location is distant from 
the active site (Figure 1.6 chapter 1). The main role of Na+ is unclear, but believed to 
be required for structural integrity. In addition, Na+ is required to activate a number 
of enzymes such as fructose 1,6-bisphosphate aldolase (Hall et al. 1999), an enzyme 
that plays a role in both glycolysis and gluconeogenesis, and tagatose 1,6-
bisphosphate aldolase (Hall et al. 2002), which is involved in galactose metabolism. 
These enzymes however, displayed the pairing of Na+- Zn2+ rather than K+-Mg2+ 
typical configuration observed in most phosphoryl transfer enzymes (Page and Di 
Cera 2006). A vital role for K+ has been identified in a number of phosphoryl 
transfer enzymes such as pyruvate kinase (Larsen et al. 1998), pyruvate 
dehydrogenase kinase (Kato et al. 2005), and ribokinase (Andersson and Mowbray 
2002; Zhang et al. 2004), which interestingly also have absolute requirements for the 
divalent metal cation, Mg2+ (Page and Di Cera 2006).  
Taking into account the requirement for K+ by pyruvate kinase, this 
monovalent cation has always been present in excess in the assay buffer, at 50 mM. 
Na+ on the other hand, is included throughout the purification procedure and kept in 
the storage buffer for iPGAM structural integrity, also at 50 mM. Hence, in order to 
observe potential significant effects of these monovalent cations towards iPGAM 
activity, the concentrations were increased to be in the range of 100 to 200 mM. The 





























Figure 6.18   The formation of 2PGA in the presence of different concentrations of 
monovalent cations. 
The results indicated that slight activation of the enzyme could be observed 
with increasing concentrations of K+, while fluctuation is observed with higher 
concentrations of Na+ (Figure 6.18). It is not possible however, at this stage to 
determine whether these monovalent cation metals are required for iPGAM activity. 
The slight activation may well be the direct effect of K+ on pyruvate kinase activity 
in the second reaction of the discontinuous assay.     
6.6 Conclusion 
An assay system that could be employed in the presence of metal ions, with minimal 
metal interference to the other coupling enzymes has been successfully developed. 
As expected, greater activation was observed in the presence of Co2+, although the 
activity of iPGAM decreased when the concentration of Co2+ exceeded 0.5 mM. The 
time required for iPGAM in the presence of Co2+ to produce half of the maximum 
2PGA equilibrium concentration is three-fold faster than in the control experiment 
(in the absence of added metal), supporting the previous findings that the enzyme 
could be hyper activated in vitro. At equilibrium the concentration of 2PGA was 
7.56% of the 3PGA concentration, implying that the reversible mechanism of the 
enzyme is favouring the reverse reaction. In addressing the “correct” metal in vivo, 
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Fe2+, Mg2+ and Mn2+ exhibit slight activation of iPGAM, albeit less than Co2+. Mg2+ 
was shown to activate iPGAM across a 100-fold range of concentrations, suggesting 
that it may continuously support iPGAM activity at a relatively low level in vivo. The 
relative concentrations of these three divalent metal ions in the cytosol were in the 
order Mg2+>Fe2+>Mn2+. A similar trend of metal concentrations was also observed in 
the bacterially expressed LmiPGAM.  
By contrast, Ni2+ and Zn2+ exerted inhibitory effects on iPGAM activity. 
While the concentration of Ni2+ in the cytosol is insignificant to satisfy a 1:1 
stoichiometry of metal: iPGAM, Zn2+ appeared to be present in excess concentration 
to fulfil the stoichiometry. Interestingly, the M1 site in the active site of iPGAM has 
octahedral geometry, indicating its preferences for Co2+ or Mg2+, while the M2 site 
possesses tetrahedral geometry, with a tendency to be occupied by Zn2+. Taken 
together, it is plausible that Mg2+ and Zn2+ are the native metals which regulate 
iPGAM activity in vivo, albeit keeping it functioning at a relatively low level. 
However, it is noteworthy that if all Zn2+ which is present in the cytosol is free, the 
activity of iPGAM would be inhibited, which is believed to be proven otherwise. 
Some of Zn2+ might be bound tightly to other macromolecules, which means that it, 
with ~6-fold lower concentration than Mg2+, may play a role in regulating the 
activity of iPGAM. The mechanism and behaviour of iPGAM in its in vivo 
surroundings is yet to be explored in detail, but it may well turn out to have the 
potential to be a key modulator in controlling the glycolytic flux in trypanosomes 








Chapter 7:  
Preliminary Inhibitor Screens for LmiPGAM 
7.1 Aims 
The search for drug candidates in order to inhibit target proteins has been one of the 
focal points in many trypanosomatid parasite studies (Albert et al. 2005; Wiese et al. 
2009; Cavalli et al. 2010; Gupta et al. 2011). This is particularly highlighted for 
glycolytic enzymes, as a number of them have been validated as promising drug 
targets, including iPGAM (Albert et al. 2005). At present, a robust high-throughput 
screening programme of trypanosomatid glycolytic enzymes including LmiPGAM is 
being conducted in the NIH, Bethesda, USA to identify potent inhibitors. While 
high-throughput screens provide an exceptional method for identifying drug 
candidates (Taylor et al. 2008; Agresti et al. 2010), a complementary in silico 
approach with similar objectives can also be employed by using virtual screening 
programs. Both analyses, which currently are being employed simultaneously by the 
NIH and Edinburgh research groups, are aimed at elucidating the ability of specific 
compounds to inhibit enzyme activity in vitro. It will be in subsequent stages, where 
the potency of inhibitors on cultured parasites and on parasite/animal models will be 
determined.  
While the LmiPGAM closed-form structure is available from structural studies, 
the poorly accessible catalytic site (see chapter 4) made it difficult to perform 
structure-based drug design experiments. Since the open-form T. brucei structure has 
only recently become available (Mercaldi et al. 2012), the virtual screening analysis 
had to be carried out with either: i) a model of the open-form based on BaiPGAM 
open conformation, or ii) based on the known ligands. Attempts to use the model 
were unsuccessful because the open-form model was too large, and this may well be 
the consequence of the unfavourable conformation of the open-form BaiPGAM 
(Mercaldi et al. 2012). Hence, the second approach is a better choice. This approach 
was employed by initialising similar compounds that resemble the original ligands 
(substrate 3PGA and/or product 2PGA) which occupy the catalytic site before 
performing any docking and scoring experiments. In this chapter, some preliminary 
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results based on this screening approach, as well as high-throughput screening and 
inhibitory analysis will be discussed.     
7.2 Introduction 
The interactions between proteins and ligands have always been the basis of any drug 
design implementation. In this case, the fundamental principle involving explicit 
biochemical interactions between the amino acid side chains and the binding 
molecules were manipulated for the purpose of altering the activity of the protein. 
Enzymes in particular, in a normal biochemical reaction, interact with the substrate 
which acts as a reactant. These interactions however, may be disrupted by 
introducing another molecule which possesses the ability to inhibit the binding of the 
substrate to the enzyme, either by competing or altering the enzyme’s mechanism 
(Klebe 2009). iPGAM in particular, is folded into two domains and competitive 
inhibitions may occur in a reversible or irreversible fashion, in which non-covalent 
(hydrogen, ionic or hydrophobic) or covalent (specific interactions between reactive 
functional groups with amino acid side chains) interactions between the molecule 
and the residues in the active are involved. For reversible inhibition, the inhibitor 
may also be competing with the substrate to bind to the active site. Another 
possibility of inhibition is the presence of any molecules that may not be present in 
the active site, but lie close enough to the hinge regions and thus affect the 
movement of the two domains. This is known as non-competitive inhibition. The 
possible inhibition mechanism for iPGAM is pictured in Figure 7.1. Often too, an 
activator, which increases the activity of the enzyme, is also taken into consideration 















Non-competitive and reversible 




Figure 7.1 The possibilities for iPGAM inhibition. a) Competitive inhibition which 
may occur either in a reversible or irreversible fashion in the active site 
and b) Non-competitive inhibition which may occur in a reversible 
fashion, notably in the hinge regions that control the movement of the 





Over the years, the majority of drug design strategies have involved two 
possible routes: high-throughput or virtual screens. The first possibility allows 
experimentally-determined analyses to be conducted through biochemical and 
pharmacological laboratory tests. The outcome would be the basis for subsequent 
analyses to find specific interactions between the proteins and the compounds, 
through another round of biophysical and structural studies. The latter alternative, on 
the other hand, involves fast and rapid searches of chemical structures in large 
compound libraries, where the most likely molecules are evaluated to determine their 
possibility of binding to the target protein (Rester 2008; Rollinger et al. 2008). This 
can be related to the majority of drugs showing pharmacological effects by explicit 
interactions with the target proteins, which is often understood based on a variety of 
models: lock-and-key (Fischer 1894), induced-fit (Koshland 1958), and 
conformational selection or population shift (Kumar et al. 2000; Boehr et al. 2009). 
By analysing the chemical structure and dynamic conformational properties of these 
molecules, the effects on the receptor protein could be predicted (Shim and 
Mackerell 2011). Subsequently, a series of laboratory experiments would be 
employed to obtain the experimental outcome for the predicted interactions. Both the 
high-throughput and virtual screening approaches are shown in Figure 7.2. It is 
noteworthy that at present, iPGAM inhibitors are still being sought, with no well-
established inhibitors except for the non-specific metal chelators reported for the 
enzyme. As mentioned above, both strategies are being used to search for potent 









7.3 In silico virtual screening strategy 
Since virtual screens provide fast, convenient and economical strategies for selecting 
possible drug candidates, this approach was considered for the initial LmiPGAM 
drug discovery analysis. However, as discussed in the earlier section, the major 
obstacle of this approach for LmiPGAM is its poorly-accessible catalytic site. For 
this reason, the experimental approach has to be designed based on the chemical and 
structural characteristics of the substrate or product. This is the common route in 
virtual screening analysis, in cases where the structure of the target molecule is 
unavailable or suffers poor accessibility to the active site. As this is the case for 
LmiPGAM, the screening was initially employed following the ligand-based method, 
before a subsequent round of docking and scoring experiments was conducted with 
the structure-based method. Both the ligand-based and structure-based drug design 










a) Ligand-based screens: UFSRAT for identifying small molecule mimics of 
the substrate and/or product  
The ligand-based virtual screen method hinges on the similarities of the query 
molecule to the compounds that are stored in any compound library or database. The 
similarities are often regarded as a preamble to the capability of the compounds to 
mimic the structure and activity of the query molecule. This is particularly interesting 
for LmiPGAM, as the small and poorly accessible active site results in difficulties for 
predicting the interactions with any drug-like compounds. It is hence important to 
find molecules which are similar to the substrate 3PGA or product 2PGA to be 
inserted into the active site prior to conducting any docking and scoring experiments. 
For the purpose of identifying the potential candidates, UFSRAT (Ultra Fast Shape 
Recognition with Atom Types) (Shave 2010) algorithm was employed, utilising both 
3PGA and 2PGA as the query molecules (Figure 7.4).    
 
 
Figure 7.4   The query molecules which were used for UFSRAT: a) 3PGA and b) 
2PGA molecules. The red atom refers to oxygen (O), the green refers 






The UFSRAT algorithm is based not only on overall shape similarities, but 
also considers the types and molecular topology of the existing atoms. In this case, 
the geometrical distribution of atoms was divided into four categories in which 
consider: all atom types, hydrophobic, hydrogen acceptor or hydrogen donor atoms 
(Adie 2010; Shave 2010). Taken these descriptors into consideration, a search was 
employed through a large multi conformer library comprising 4,853,000 molecules 
from various suppliers: Chembridge, Asinex, Maybridge, Enamine, LifeChemicals 
(InfLab) Specs, InterBioScreen and ChemDiv, to identify candidates similar to the 
query molecule. Evaluation was performed based on the scoring function, where a 
molecule with a score of 0 is the least similar to the query molecule, and a score near 
to 1 suggests a closer resemblance. The top five most similar candidates for 2PGA 
and 3PGA are shown in Figure 7.5a and b, respectively, and the complete results are 
listed in the Appendix II sections. For the subsequent docking experiment, the most 
favourable compounds which were similar to 2PGA were utilised. This was 
performed due to the experimentally determined Km value for 2PGA 
(0.11 ± 0.03 mM) which was lower than 3PGA (0.27 ± 0.02 mM) (Guerra et al. 









                           
                               
 
                          
        
Figure 7.5 The top five highest-scored compounds which were similar to a) 
2PGA and b) 3PGA. The atom colourings are identical to Figure 7.4, 
with the addition of the cyan colouring for fluorine (F) and the blue 













b) Structure-based screens: Docking and scoring algorithms  
Docking and scoring functions are widely applied in virtual screening for three 
important purposes: i) to envision the binding mode of a known ligand for the target 
molecule, ii) to pinpoint new binding candidates for protein-ligand interactions and, 
iii) to predict the binding affinities of the candidates (Leach et al. 2006). Often a 
particular interest for enzymatic analysis is to observe possible interactions between 
the receptor protein and small molecules which could possibly modify the catalytic 
functions. Nowadays, most programs enable ligand flexibility during docking 
experiments, with rigid or almost rigid protein structure (Leach et al. 2006), before 
the docking results were evaluated through a scoring function. A few docking 
programs such as GLIDE, Gold, and ICM (Perola et al. 2004), and scoring 
algorithms (GlideScore and ChemScore), as well as virtual screening with 
combination of both, such as AutoDock4 (Morris et al. 1998; Huey et al. 2007; 
Morris et al. 2009), AutoDock Vina (Trott and Olson 2010), and LIDAEUS (Taylor 
et al. 2008) are some of the programs available for predicting protein-ligand 
interactions. In this study, virtual screening programs combining both algorithms 
were used: AutoDock4 and AutoDock Vina using the outcome from UFSRAT, as 
well as a combination of a few virtual screens programs performed iteratively: 
AutoDock 4, AutoDock Vina, and LIDAEUS (LIgand Discovery At Edinburgh 
UniverSity) based on the in-house relational small-molecule database EDULISS 
(EDinburgh University LIgand Selection System) (Hsin et al. 2011). 
i) AutoDock4 and AutoDock Vina 
AutoDock4 is a computational docking program which is performed on the basis of 
two important methods: i) exploration of the conformational spaces available in the 
targeted region and ii) empirical and semi-empirical force fields to evaluate the 
energetics of the conformations (Huey et al. 2007). Two main approaches are 
included in the program: i) AutoDock employs ligand docking to a set of grids 
representing the target receptor and ii) Autogrid which pre-calculates the grids. 
Meanwhile, AutoDock Vina is the updated version of the program, which surpasses 
the previous functions of AutoDock4 in atom type selection and grid-map 
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calculations. In the Vina version, the grid maps are automatically calculated, thereby 
showing the results transparently to the users (Trott and Olson 2010). This further 
improves the accuracy and speed of the binding-mode prediction.  
Both AutoDock and Vina analyses were carried out for LmiPGAM, utilising 
the closed-form structure as the target receptor, against the UFSRAT results for 
2PGA (Figure 7.6). The hits were listed based on individual scores, and the top five 
compounds are shown in Table 7.1a and b. The full list is shown in the Appendix II 
section. The majority of results possess the criteria that are commonly accepted by 
Lipinski’s rule of 5 for molecules’ drug-likeliness (Lipinski et al. 1997), where: i) the 
molecular mass ≤ 500 Da, ii) ≤ 5 hydrogen bond donors, iii) ≤ 10 hydrogen bond 
acceptors and iv) MLogP (the octanol-water partition coefficient that measures the 
hydrophobicity of compounds) that is ≤ 4.15 (Moriguchi et al. 1992) (Taylor et al. 
2008). Both the AutoDock and Vina results were individually assessed by the scores, 
where the lower the values, the better the scores. A small number of compounds was 
purchased (see section 7.5) for the subsequent inhibition analysis.  
 






Table 7.1 The top five hit molecules from a) AutoDock and b) AutoDock Vina 
Compound 
dockposes  






























































































































































































































































Table 7.1 contd. 
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ii) COmbining Docking And Similarity Search (CODASS)  
The in-house high-throughput virtual screening program, LIDAEUS is a screening 
approach based on the generation of site points (categorised into hydrogen bond 
donor, hydrogen bond acceptor or hydrophobic) around the pocket of a target protein 
(Taylor et al. 2008). Molecules selected from a database are docked individually and 
matched to the generated site points in the binding pocket based on the preferred 
interactions. The predicted interactions are therefore scored by two methods: i) force 
field-based energy function combining both van der Waals and hydrogen bond 
energies and ii) pose interaction profile which is specific to a particular type of 
interactions (Taylor et al. 2008), and expressed by the energy scores (kcal/mol). 
While a number of publicly-accessed small molecule databases are available for 
data-mining, EDULISS, the in-house relational small molecule database provides a 
collection of over four million commercially available compounds from 28 different 
suppliers (Hsin et al. 2011). This allows high-throughput searching capabilities, and 
thus provides many possibilities for specific protein-ligand interactions to be 
explored.    
In order to obtain comparable and accurate results from virtual screens, a 
group of screening programs were combined to provide a consensus prediction of 
possible molecular interactions. This involved a cycle of parallelised fast flexible 
docking and similarity search algorithms comprising AutoDock, AutoDock Vina and 
LIDAEUS, which were employed against the EDULISS database. The analysis was 
performed by Dr. Douglas Houston, using LmiPGAM as the target molecule and 
3PGA as the original ligand, in the presence of Zn2+ atoms. The scores from all three 
programs were compared and ranked based on “consensus score”, which indicates 
the agreement of each algorithm, where the lower the number, the better. The full 
results are shown in the Appendix II section, while the top five hits, ranked based on 
the “consensus scores” are illustrated in Table 7.2. Selected candidates from the 
screen, together with the previous AutoDock and AutoDock Vina results, were 
pooled and compared before compounds were purchased for inhibition analysis. The 
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7.4 Quantitative high-throughput screening strategy 
As a complement to the in silico virtual screening approach, quantitative high-
throughput screening (qHTS) for LmiPGAM is currently being conducted by the NIH 
research group. The methodology relies on large-scale automated titration-based 
screening against a large number of compounds from a comprehensive chemical 
library (Inglese et al. 2006; Inglese et al. 2007a; Inglese et al 2007b). The major 
advantage of this approach is the ability to screen compounds at multiple 
concentrations, thus minimising false positive and false negative hits, as well as 
extensive follow-up testing (Inglese et al. 2006). 
With a microtiter-plate based platform, a molecular target end-point assay for 
LmiPGAM was performed in the presence of the biochemical components involved 
in the reaction. Figure 7.7 depicts both the forward and reverse reactions involved in 
assaying LmiPGAM activity, where the enzyme luciferase is utilised for the 
generation of luminescence as a detection method. In this case, the Kinase-Glo® 
Luminescent Kinase assay (Promega) method was utilised to quantify the amount of 
ATP remaining in the sample, after a kinase reaction. As discussed in chapter 6, the 
activity of iPGAM is not readily measured, hence coupling enzymes are required to 
be included. For the forward reaction, both enolase (ENO) and PYK are involved, 
whereas in the reverse reaction, both GAPDH and PGK are essential for the 
biochemical reaction. It is noteworthy that the generated luminescent signal is 
inversely proportional to the amount of kinase activity, and correlated with the 
production of ATP in the reaction (http://www.promega.com/products/cell-





Figure 7.7   A schematic diagram showing the forward and reverse reactions for 




It is typical in high-throughput screening experiments for an analysis of the 
concentration response curve (CRC) to be conducted and classified. This is vital to 
identify any activators or inhibitors from the primary screen with desirable potencies 
for subsequent investigation of structure-activity relationships (Inglese et al. 2006). 
The CRCs can be divided into four main categories based on the quality of the curve 
fit (r2), the efficacy (magnitude of response) and the number of asymptotes to the 
calculated curve: i) class 1 with an r2 value > 0.9, with both lower and upper 
asymptotes shown in the complete CRCs, ii) class 2 with incomplete CRCs lacking 
lower asymptote and r2 value > 0.9, iii) class 3 with compounds only exhibiting 
activity at the highest concentration tested, and iv) class 4 which contains compounds 






Figure 7.8 Concentration response curves (CRCs) are classified into four types.  
Examples of curves fitting the following classification criteria:  Class 
1 curves display two asymptotes, an inflection point, and r2 ≥0.9; 
subclasses 1a vs. 1b are differentiated by full (>80%) vs. partial (≤ 
80%) response.  Class 2 curves display a single left-hand asymptote 
and inflection point; subclasses 2a and 2b are differentiated by a max 
response and r2, >80% and >0.9 or <80% and <0.9, respectively.  
Class 3 curves have a single left-hand asymptote, no inflection point, 
and a response >3SD the mean activity of the sample field.  Class 4 
defines those samples showing no activity across the concentration 
range.  The figure and the table were obtained from a presentation by 
















Table 7.3 The main characteristics of the four different classes of the CRCs, as 
described above in the legend for Figure 7.8.  
Description 1 Complete 
response 






Assymptotes 2 1 1 0 
Inflection Yes Yes No No 
Efficacy magnitude 
of response 
1  >80% 
2  ≤80% 
1  >80% 
2  <80% 
>3 SD from 




r2 ≥0.9 1   >0.9 
2  <0.9 
NA NA 
 
The primary qHTS screen for LmiPGAM was conducted initially with the 
Library Of Pharmacologically Active Compounds (LOPAC®), which contains 
pharmaceutically diverse compounds with known drug or drug-like activity (Sigma-
Aldrich). The results are shown in Figure 7.9, where the hit rate of iPGAM was very 
low, probably as a consequence of its poor accessibility to the active site. Only 
0.08% from the hits was typified as Class 1 and another 0.47% was classified as 
Class 2 inhibitors. Out of the hits, seven active compounds were obtained, as shown 
in Figure 7.10, where only three compounds were suitable for further testing in 
secondary screens. The rest of the hits were a known luciferase inhibitor, a common 
false positive, or exhibited some cross activity (Dr. Linda Gilmore, personal 
communication). The three hit compounds with IC50 values between 13-26 µM were 














Figure 7.9 The percentage of LmiPGAM LOPAC® hits classified as Class 1 and 
Class 2 inhibitors (0.08% and 0.47%), respectively. The remaining 
99.45% compounds were classified as inactives. The figure was 






Figure 7.10 Seven active compounds from the initial LOPAC® screen. Only three 
compounds were considered as potential hits, whereas the rest were 
either known as a luciferase inhibitor, a common false positive or 
exhibited some cross-activity. The figure was adapted from a 




7.5 Preliminary inhibition analysis with novel compounds  
It has always been a challenge to find appropriate drug candidates which exhibit not 
only possibilities to bind to the target protein, but also show significant effects on the 
protein’s activity. While the in silico virtual screens provide successful prediction of 
the binding affinities of the compounds and the target protein, and the qHTS enables 
the assessment of binding affinities and initial inhibitory effects on the target 
molecule, secondary analyses are also necessary to confirm the specificity of the 
inhibitors. It is therefore important to perform an additional inhibitor screening with 
the standard enzyme assays that are routinely implemented in the laboratory. In this 
case, both the continuous and discontinuous coupling enzyme assay approaches (see 
chapters 2 and 6) were employed to screen the potential compounds. 
 Based on the initial LOPAC® screen, three compounds emerged as potential 
candidates to inhibit LmiPGAM activity. Compound C1 and C3 (6-bromoindirubin-
3′-oxime (BIO) (Table 7.4) resembled ‘potential hit 3’ in Figure 7.10, and was 
obtained from Enamine and Sigma-Aldrich, respectively. Compound C2 
rabromobenzimidazole (TBBz) corresponds to ’potential hit 2’ in Figure 7.10, and 
was from Sigma-Aldrich. In addition to these two selected compounds, a number of 
virtual screen ‘hits’ were also included for the activity assays. Four compounds (C4-
C7) were selected from Enamine, while four others (C8-C11) were obtained from 
Interbioscreen. The compounds were chosen by Dr. Douglas Houston and were 
considered for the subsequent inhibitory analysis since they covered a range of 
chemical classes, were inexpensive and readily available. Some of these compounds 
contained specific chemical groups which may resemble the properties of the 
substrate and product, phosphate mimics or carboxylic acid groups. They were also 
chosen based on their solubility and binding energy. The structures and molecular 
properties of the selected compounds are shown in Table 7.4.  
A number of amino acids with different functional groups were also included 
in the inhibition analysis, and were divided into two main classes: i) polar and 
hydrophilics (L-aspartate, L-glutamate, L-serine), and ii) non-polar or hydrophobics 
(L-valine, L-cysteine, L-leucine and L-isoleucine). L-isoleucine, which has 
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previously been shown to be an inhibitor of LmiPGAM (Poonperm 2005) was 
included as a positive control. For the purpose of observing whether molecules in 
other metabolic pathways can also affect iPGAM activity, α-ketoglutarate, a key 
intermediate in the Krebs cycle, and malonate, a well-known competitive inhibitor of 



















Table 7.4 Selected compounds from LOPAC® and virtual screens for the 
inhibition analysis. In C4, only the right hand molecule was involved 
in the docking experiment, while the left hand molecule was present 
in the compound, and most probably included as a counter ion. The 
presence of the left hand molecule may affect the molecular weight of 
the compound, thus also affecting the concentration calculations.   
 
Molecule ID number Molecular weight Supplier 
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Table 7.5 Selected amino acids and metabolites for the inhibition analysis.All 
compounds were purchased from Sigma-Aldrich.  
Molecule Molecule name  Molecular weight 
 





































Table 7.5 contd.   
















































 Since dimethyl sulfoxide (DMSO) (Figure 7.11a) was utilised for the purpose 
of dissolving the compounds, it is therefore important to determine the tolerances of 
the coupling enzymes and LmiPGAM towards the organosulfur compound. Figure 
7.11b depicts the effect of DMSO on the coupling enzymes (ENO, PYK and LDH) 
and on LmiPGAM, where the range of DMSO concentrations tested was from 1-
10%. Enzyme samples in the absence of DMSO were included as negative controls. 
It is apparent from the results that LmiPGAM is more susceptible to higher 
concentrations of DMSO, where substantial effects on the activity could be observed 
when the concentration exceeded 2%. The remaining activity decreased as the 
concentration of DMSO rose. Interestingly however, the coupling enzymes exhibited 
better tolerances to DMSO, which became more apparent when compared to iPGAM 
at the maximum concentrations tested (9% and 10% DMSO). This intriguingly 
suggested that LmiPGAM is specifically inhibited by DMSO, and therefore the 
maximum final concentration of DMSO that was present in the sample during the 







































Figure 7.11 a) The chemical structure of DMSO and b) DMSO tolerance test for the 
coupling enzymes (ENO, PYK and LDH) and for LmiPGAM. 
 The inhibition analysis was performed by incubating 0.162 µM P2 
LmiPGAM from the ion-exchange column with a final concentration of 1 mM Co2+ 
at 25°C for 1 h, before adding a final concentration of 1 mM compounds individually 
with further incubation for another hour. P2 was chosen for the inhibition analysis 
because it is in the open conformation, and this may provide better access to the 
active site. It is noteworthy that a relatively high concentration of buffer was chosen 
in the experiment, in order to minimise the effects of compounds to pH. The cobalt 
incubation was employed to activate the enzyme to its maximum activity (see 
chapter 5 and 6) before observing the effects of the compounds. The results are 





the coupling enzymes in the continuous assay. The discontinuous assay (Figure 7.13) 
however, carried an advantage since the inhibitor concentrations would be 20-fold 
lower in the well containing the coupling enzymes. The methods for both analyses 
can be found in chapter 2 and specifically in chapter 6 for the discontinuous assay. 
The basis of the reaction was similar to the metal studies (see chapter 6), hence the 
effects on the coupling enzymes were minimised. In both cases, enzymes in the 
absence of the compounds were included as negative controls, and the analyses were 
conducted in duplicate. The samples were tested in the presence of 1% DMSO, 
except for C5 and C10, which were done in the presence of 2% DMSO. This is due 
to the insolubility of the compounds that required to be dissolved at a higher 
concentration of DMSO. Nevertheless, the effect of DMSO at 1% and 2% were 
insignificant, thus the results could be equally compared. 
 The efficacy of some inhibitors could be observed in the continuous assay 
(Figure 7.12), where the activity of LmiPGAM was specifically inhibited by α-
ketoglutarate, malonate, C1 and C2 from the LOPAC® screen, and some of the 
virtual screen hits: C4, C5, C7 and C11. The efficacy of some compounds however, 
was observed to be better than others by showing more than 50% inhibition, for 
example C7 (49% remaining activity) and C2 with 14% remaining activity, when 
compared to the control sample. C1, C4, C5 and C11 exerted an effect by causing 
remaining activity to be in the range of 87% to 96% respectively. C3 on the other 
hand, showed a tremendous effect not only on LmiPGAM, but on the coupling 
enzymes as well, thus suggesting a non-specific inhibition. By contrast, C6, C8 and 
C10 did not show any specific inhibition of LmiPGAM, and C9 peculiarly, did not 
show any signal from the absorbance measurement, and thus suggested to be a strong 
activator for the coupling enzymes. The Krebs cycle intermediate α-ketoglutarate 
exhibits partial inhibition with a remaining activity of 89%, while malonate did not 
cause a significant effect on LmiPGAM. The rest of the compounds exhibit an 
activating effect and this was apparent in the samples containing amino acids, 
particularly L-aspartate and L-cysteine. L-isoleucine, which was previously reported 




 By contrast, the outcome from the discontinuous assay (Figure 7.13) exhibits 
relatively small effects of the compounds on LmiPGAM activity. With minimal 
interference on the coupling enzymes, the results (expressed as the concentrations of 
2PGA after 15 min incubation) indicate that the activity of LmiPGAM remained 
essentially the same, with the formation of 0.111 to 0.157 mM 2PGA in the tested 
samples, compared to the control in the absence of inhibitor (0.154 mM). By contrast 
to the continuous assay however, there seems to be no obvious activating effects of 
these compounds on LmiPGAM, and malonate, C4 and C10 in particular, exhibited 
~20% inhibition of LmiPGAM. This thus suggested that the compounds may prevent 
iPGAM from reaching its equilibrium when compared to the control sample, which 
reached equilibrium within the incubation period. The trend of inhibition may well 
be due to the specific chemical properties of the compounds, such as the presence of 
carboxylic acid group in most of the compounds from virtual screens and in the 
amino acids, or specific functional groups that may interact with the residues in the 
active site. The different results obtained from both analyses may indicate the 
involvement of the coupling enzymes in affecting iPGAM activities in the 
continuous assay. Further trials are required to be conducted to provide significant 
understanding of the effects of the inhibitors on LmiPGAM activity. Apart from that, 
it is noteworthy that a piperazine analogue: 4-(2-hydroxyethyl)-1-piperazine 
ethanesulfonic acid has been crystallised with BaiPGAM strain Sterne (Chang et al. 
2011, PDB ID 3R7A) (Figure 7.14a and b). Piperazine, which is a six-membered ring 
containing two opposing nitrogen atoms has been widely used as anthelmintic 
(Holden-Dye and Walker 2007) and antileishmanial agents (Mayence et al. 2004). 
The effect of piperazine derivative on BsiPGAM is yet under development, but may 
well be a potential candidate that explicitly affects the transferase domain for future 

































































Figure 7.12 Inhibition analysis (see Tables 7.4 and 7.5) for the coupling enzymes 
and LmiPGAM. 2PGA or 3PGA were used as the starting reagents for 
the coupling enzymes (ENO, PYK and LDH) or LmiPGAM, 
respectively. The assay was carried out in a continuous fashion with 




























































































Figure 7.13 Inhibition analysis (see Tables 7.4 and 7.5) using the discontinuous 
assay. The results are expressed as the concentration of 2PGA after 15 





Figure 7.14 a) The crystal structure of the transferase domain of BaiPGAM strain 
Sterne (Chang et al. 2011, PDB ID 3R7A) complexed with 4-(2-








Two different approaches for LmiPGAM drug development have been employed. 
The qHTS which is currently being conducted in the NIH, Bethesda, US primarily 
yielded a low number of hit candidates from the small-scale (LOPAC®) screen, and 
this is potentially due to the small buried active site between the two domains. 
Nevertheless, there were three promising inhibitor candidates with relatively low 
IC50 values, and two of them were selected for secondary screening. The second 
approach was conducted via the in silico virtual screening method, and was primarily 
employed by the ligand-based strategy. This is a direct consequence of the 
inaccessibility of the active site, which required the analysis to be conducted based 
on the structural and molecular properties of the substrate/product. A series of 
structure-based screens through a similarity search, as well as multiple docking and 
scoring algorithms were later employed. While virtual screens provide a higher 
number of potential binding candidates for the protein, high-throughput screens have 
the advantage of primary inhibition analysis prior to a secondary screen. 
Nevertheless, the outcome from both approaches was compared and nine compounds 
with distinct molecular properties from different chemical classes were selected for 
secondary screens.  
Subsequent secondary analysis using the continuous and discontinuous 
coupling enzyme assays were performed for 11 selected compounds. Seven amino 
acids with different molecular properties, together with α-ketoglutarate and malonate 
were also included in the inhibition analysis, giving a total of 20 compounds tested. 
Through the continuous assay, two potential inhibitors were obtained, with less than 
50% remaining activities (C2 NIH with 14% remaining activity) and C7 (49% 
remaining activity). The discontinuous assay however, showed only modest effects 
of the inhibitors on the activity of LmiPGAM. The 2PGA concentrations were in the 
range of 0.111 to 0.157 mM, as compared to the 0.154 mM 2PGA in the control 
sample at equilibrium. The differences between the two experimental approaches 




Concluding Remarks and Future Directions 
8.1 General conclusions 
An understanding of protein biochemistry is fundamental in drug design and 
discovery. Without comprehending the nature of the target molecule, the efficacy of 
the chosen therapeutic approach may well be illusory. While current molecular 
approaches tend to use in vitro technology and have been successful in mimicking in 
vivo cellular conditions, there are also experimental flaws that contribute to data 
inaccuracy. In addressing this issue, experiments have to be carefully designed with a 
preference for biologically relevant conditions which have to be taken into account. 
The aims of this study, as discussed earlier in chapter 1, are focussed on two main 
biochemical and structural aspects of the enzyme phosphoglycerate mutase from 
trypanosomatids, and concern: i) The biologically relevant metal ions that support 
the enzyme activity and ii) Characterisation of the enzymes to obtain druggable 
states, which are important for designing and discovering potential inhibitors. This 
study is therefore performed on the basis of understanding the behaviour of the 
enzyme under conditions that closely resemble the in vivo situation, when the 
parasite is infecting a human.    
Trypanosomatid iPGAMs are drug targets. Trypanosomatid iPGAMs, particularly 
from T. brucei have been genetically validated as potential drug targets. This has 
been shown through RNAi experiments (Albert et al. 2005), and the observation that 
the pathogenic bloodstream-form particularly depends on glycolysis for a source of 
ATP. LmiPGAM, which is the corresponding enzyme in L. mexicana is also a subject 
of interest in kinetoplastid chemotherapy. The latter parasite however, possesses a 
very different biology compared to the former one, especially once it is inside the 
mammalian hosts. While the T. brucei bloodstream form lives freely in the human 
blood, the L. mexicana amastigote form lives within phagolysosomes of 
macrophages (Barrett et al. 1999), and thus possesses a more complicated life 
mechanism. Nevertheless, the high sequence similarity observed between the two 
iPGAMs and the fact that both enzymes possess unrelated structural properties with 
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the human dPGAM further augmented the values of these enzymes as potential drug 
targets. iPGAM has also been verified to be a cytosolic enzyme (Verlinde et al. 2001; 
Guerra et al. 2004; Gualdrón-López et al. 2011) and this also provides an advantage 
in better access for the drugs, rather than having to go through the glycosomal 
membrane to reach the target proteins.   
The iPGAM metal requirements. iPGAMs are classified as members of the alkaline 
phosphatase superfamily, which is characterised by enzyme metal dependency. The 
explicit requirement of Co2+ for structural and functional integrity of trypanosomatid 
iPGAMs has been widely elucidated, but remains controversial since the known 
cellular concentrations of Co2+ in trypanosomatids and other eukaryotes are 
insufficient in vivo. To address this problem, a new purification approach for the 
bacterially expressed enzyme has been designed in this study, by substituting Co2+ 
with Ni2+ for the initial IMAC purification step. Two additional purification stages 
were subsequently involved, which are the desalting and ion-exchange 
chromatography. The purified samples which were used for metal studies were 
therefore estimated to be free from Co2+ ions, and were also subjected to various 
structural and biochemical analyses.  
The different conformations and oligomeric states of LmiPGAM. Ion-exchange 
chromatography has successfully separated the bacterially expressed LmiPGAM into 
different conformational and oligomeric states, which have been characterised by a 
series of biophysical analyses, notably SEC-MALS. The enzyme was mainly 
observed in four states: the closed-form monomeric (P1), open-form monomeric 
(P2), and closed and open dimeric forms. The presence of higher order oligomers 
was also observed in the most unstable form of the enzyme (P3). Moreover, it was 
observed that in the presence of Co2+, the enzyme was pushed towards the closed-
form conformation, which is the active state of the enzyme. While this observation 
was noted in vitro, this may not be the case in vivo, where Co2+ was not present in 
access. Hence, it is postulated that the majority of the native enzyme may exist in the 
inactive open conformation. This may well be related to the low specific activity 
observed in the native enzyme (Guerra et al. 2004; Albert et al. 2005; Paul Michels, 
unpublished data), compared to the corresponding bacterially expressed one 
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(Poonperm 2005). The different types of analyses which were elucidated in this study 
also provide an understanding of the individual characteristics of each peak from the 
ion-exchange chromatography, which strikingly differ in terms of the shape and size 
of the molecules, the pace of catalytic function and metal content. Moreover, by 
comparing the structural aspects of the bacterial and trypanosomatid iPGAMs, it is 
very likely that these enzymes can be grouped into two different iPGAM families. 
This is observed by the difference in metal-mechanisms, which can be related to a 
larger open conformation of bacterial iPGAM compared to the trypanosomatid 
iPGAM. The former utilises both metal sites during catalysis, while the latter 
performs the catalytic function with a one-metal mechanism. 
The hyperactivation of iPGAM with Co2+. The activity of trypanosomatid iPGAM in 
vitro was shown to be maximally active in the presence of Co2+. The in vivo activity 
however, is one of the lowest among the glycolytic enzymes. ICP-OES and ICP-MS 
analysis demonstrated that Co2+ is essentially undetected in both the cytosol of T. 
brucei, and the bacterially expressed LmiPGAM. It is therefore concluded that the 
enzyme experiences hyperactivation in the presence of excess Co2+ in vitro.  
Mg2+ and Zn2+ may act as iPGAM regulators in vivo. By contrast, Mg2+ and Zn2+ 
were found to be in excess in vivo with regard to iPGAM metal sites. To further 
investigate the biologically relevant metals for iPGAM, the activity needed to be 
assayed in the presence of Mg2+ and Zn2+, together with a range of other divalent 
metal ions. Unfortunately, iPGAM activity cannot be readily measured in the 
absence of coupling enzymes in the continuous assay, and some of these enzymes, 
particularly ENO, are inhibited by higher concentrations of metals. To overcome this 
problem, a multimode-plate reader discontinuous assay has successfully been 
developed, with minimal metal interference on the coupling enzymes. The results 
revealed that of the biologically relevant metals, only Mg2+ can support the activity 
of iPGAM, although less than 50% in the presence of Co2+. Zn2+, on the other hand, 
exhibits an inhibitory effect on iPGAM. It is therefore suggested that Zn2+ may 
contribute to the lower activity measured in vivo in the absence of excess Co2+, and 
that iPGAM activity in the cell is balanced by the relative concentrations of Mg2+ 
and Zn2+. The discontinuous assay also revealed that the substrate:product ratio at 
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equilibrium in solution is 12:1, which is distinguishable from the 1:1 ratio observed 
from the crystal structure. The tighter binding of 2PGA may well be the reason 
behind this observation.        
Preliminary screening approaches for iPGAM. For drug design, two screening 
approaches were developed to find potential inhibitors for LmiPGAM. The first 
approach is performed by a collection of in silico virtual screening programs, 
comprising a similarity search, and subsequent docking and scoring experiments. 
The second approach is the high-throughput screening which is currently being 
conducted in the NIH, Bethesda. By compiling the outcomes from both screens, a 
secondary screen was conducted using both the continuous and discontinuous assays. 
Out of a collection of 11 compounds, two showed explicit inhibition of iPGAM at 
1mM, with 14% and 49% remaining activity by using the continuous assay. The 
results from the discontinuous assay however, exhibited only slight inhibition of 
these compounds on iPGAM, although tested at an identical concentration. Further 
inhibition analysis, such as medicinal chemistry and/or structure-activity relationship 
(SAR) thus may well be required to validate these observations.  
8.2 Significant contributions 
This study has contributed new ideas and has substantially improved the existing 
knowledge concerning the biochemical and structural aspects of trypanosomatid 
iPGAMs. These aspects are discussed in more detail below:  
i) Two different families of iPGAM are distinguishable by distinct metal-
mechanisms and structural properties 
The sequence alignment of iPGAM across a fairly wide range of organisms 
strikingly showed that the enzyme could be divided into two different families. The 
trypanosomatid and plant iPGAMs are grouped together, while the bacterial, 
nematode, algal and fungal iPGAMs may well be unified under a different family. 
The distinction is highlighted by the metal-mechanisms, where iPGAMs from the 
first family are likely to utilise one metal site during catalysis, whereas members 
from the second family utilise both sites for catalytic function. In addition, 
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trypanosomatid iPGAMs possess a smaller open conformation, while the bacterial 
iPGAMs exhibit substantial movement of the two domains, resulting in a larger 
apoenzyme conformation.      
ii) The separation of different forms and oligomeric states of iPGAM by 
ion-exchange chromatography 
 
LmiPGAM has successfully been separated into different forms and oligomeric states 
by ion-exchange chromatography. This observation can be the basis of obtaining the 
open-form structure, which is important for the purpose of drug design. The current 
closed-form enzyme provides tremendous structural information, but the poorly-
accessible catalytic site caused difficulties in drug design implementation. It is also a 
striking observation that iPGAM, although it has been reported as a monomer 
previously, may also form a dimer and higher-ordered oligomers in solution. The 
interesting behaviour of the enzyme in solution also provides indications of the 
preferable conditions for crystallisation.    
iii) The hyperactivation of iPGAM with Co2+ in vitro and low specific activity 
as observed in vivo  
 
One of the main aims of this study was to elucidate the biologically relevant metal 
requirements of iPGAM. Metal analyses therefore successfully revealed that Co2+, 
which was reported to support the trypanosomatid iPGAM activity, is essentially 
undetectable, both in the bacterially expressed enzyme, and also in the cytosol where 
the enzyme is located. This generates a new paradigm in understanding the nature of 
the enzyme in its native environment, where it is therefore suggested that iPGAM is 
hyperactivated by Co2+ in vitro. The insufficiency of Co2+ in vivo may result in low 
specific activity, which indicates that there are other biologically relevant metals, 
possibly Mg2+, that assumed the role of Co2+ in the native environment. iPGAM is 
thus suggested to be one of the key players in controlling the parasite glycolytic flux 
by a balance of Mg2+ and Zn2+ as its regulators. In the study by Achcar et al. 2012, 
iPGAM was shown to maximally control the glycolytic flux, based on the control 
coefficients that have been analysed in the dynamic model. This may affect the 
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amount of ATP produced, and if this enzyme is specifically inhibited, the parasite, 
particularly the T. brucei bloodstream form, may experience difficulties in surviving 
in the mammalian hosts.  
iv) The development of multimode-plate reader discontinuous assay 
The continuous coupling enzyme assay is a means of assaying iPGAM activity by 
coupling the reaction with other enzymes involved in the glycolytic pathway. 
Unfortunately, the poor tolerances of the coupling enzymes, notably ENO, to high 
concentrations of metal ions made it impossible to assay iPGAM activity in the 
presence of a range of metal ions. It was therefore crucial to develop an assay system 
which could minimise the metal interference on the coupling enzymes. This study 
has successfully developed a discontinuous assay which can be performed by using a 
more economical plate-reader format. The outcome revealed that Mg2+, which is the 
most abundant metal found in vivo, can support the activity of iPGAM, albeit at a 
lower level than Co2+. Zn2+ on the other hand, inhibits the enzyme. It is also a 
significant observation that in the absence of the other coupling enzymes in the initial 
reaction, the substrate:product ratio is 12:1 at equilibrium in solution, and not 1:1 as 
observed in crystal structure.    
v) The development of in silico virtual screens and high-throughput 
screens for LmiPGAM 
Both in silico virtual and high-throughput screens have been developed for 
LmiPGAM. These analyses thus provide potential inhibitor candidates for the 
enzyme, which are significantly important for drug development. Two of the 
compounds showed substantial inhibition at 1 mM concentration, and are worth 
further characterisation in the future.    
8.3 Future work  
The findings from this study have paved the path to a better understanding of the 
enzyme structural and functional properties, which are important in relation to drug 
design and discovery. A number of potential research studies covering various 
aspects can be conducted, as discussed below:   
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i) Structural aspects 
Biophysical characterisation provided substantial knowledge of the behaviour of 
iPGAM in solution. Based on these observations, it is indeed interesting to obtain the 
open-conformation crystal structure of LmiPGAM. This can be done either by: i) 
identifying the preferable condition to obtain only the open conformation that is 
stable in solution and ii) performing crystallisation trials based on the conditions that 
have been standardised for TbiPGAM. Thorough structural analysis could also be 
conducted for both the available closed-form LmiPGAM and open-form TbiPGAM, 
and residues involved in the hinge regions may be identified for explicit site-directed 
mutagenesis studies, as these residues may well be important in controlling the 
movement of the two domains. It is also interesting to observe the effect of divalent 
metals on the overall structure of iPGAM, which could be employed by fluorescence 
measurements/circular dichroisms analysis.  
ii) Biochemical aspects 
The metal analyses in this study have efficiently measured the concentration of the 
metals in both the purified protein and the cytosolic fractions. However, this type of 
analysis does not possess the ability to distinguish between the free and bound- 
metals in the samples. To further investigate this, it can be suggested that the 
macromolecules in the samples would have to be removed prior to the analysis, 
either by centrifugation with molecular weight cutoffs, or precipitation with 
trichloroacetic acid (TCA), where only the free metals can be detected afterwards. 
This may provide information on the availability of free metals that may bind to 
iPGAM in the native environment. More interestingly, better understanding of 
iPGAM metal requirement can be obtained by isolation of the native enzyme from 
the parasite, where subsequent structural and biochemical analyses can be performed 
to analyse the metal requirements. The low specific activity of iPGAM, especially in 
the bloodstream-form T. brucei has previously been observed, but a more thorough 
observation may be obtained by western blot analysis, where the concentration of 
iPGAM in both forms of parasites at different life stages can be compared. In 
addition, the specific activities of iPGAM in the different life stages of T. brucei and 
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L. mexicana would also be important to be measured, in conjunction with the western 
blot analysis.     
iii) Drug design and discovery 
Currently, LmiPGAM is one of the target molecules for high-throughput screens in 
the NIH, Bethesda, USA. The outcome from this analysis can be tested by secondary 
screens, where various biophysical and structural analyses can be conducted, for 
example kinetic studies using the enzymatic assays and thermal stability test. 
Compounds which exhibit substantial potency may well be analysed through specific 
protein-ligand interaction studies, for example surface plasma resonance (SPR) and 
isothermal titration calorimetry (ITC). The results from the inhibition analyses 
performed in this study may also be characterised by subsequent medicinal chemistry 
analysis such as SAR, as well as analysing the effects of related compounds that have 
been modified by changing the chemical groups towards the activity of the enzyme. 
It will also be of particular interest to carry out crystallisation experiments to solve 
the crystal structure of iPGAM with the inhibitors bound to the active site or the 
hinge region. It is also interesting to consider inhibitors of other members of the 
alkaline phosphatase superfamily to design potential inhibitors for iPGAM. The 
compounds from virtual screens in this study which have not yet been investigated as 
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Production of ATP by the glycolytic pathway in the mammalian pathogenic stage of protists from
the genus Trypanosoma is required for the survival of the parasites. Cofactor-independent
phosphoglycerate mutase (iPGAM) is particularly attractive as a drug target because it shows no
similarity to the corresponding enzyme in humans, and has also been genetically validated as a
target by RNAi experiments. It has previously been shown that trypanosomatid iPGAMs require
Co2+ to reach maximal activity, but the biologically relevant metal has remained unclear. In this
paper the metal content in the cytosol of procyclic and bloodstream-form T. brucei (analysed by
inductively coupled plasma-optical emission spectroscopy) shows that Mg2+, Zn2+ and Fe2+
were the most abundant, whereas Co2+ was below the limit of detection (o0.035 mM). The low
concentration indicates that Co2+ is unlikely to be the biologically relevant metal, but that
instead, Mg2+ and/or Zn2+ may assume this role. Results from metal analysis of purified
Leishmania mexicana iPGAM by inductively coupled plasma-mass spectrometry also show high
concentrations of Mg2+ and Zn2+, and are consistent with this proposal. Our data suggest that
in vivo cellular conditions lacking Co2+ are unable to support the maximal activity of iPGAM,
but instead maintain its activity at a relatively low level by using Mg2+ and/or Zn2+. The
physiological significance of these observations is being pursued by structural, biochemical and
biophysical studies.
Introduction
Metals are abundant in biological macromolecules, and about
one-third of all proteins contain metals that are essential for
diverse functions such as enzyme activity, gene expression and
cell signalling, as well as for the maintenance of structural
integrity. The burgeoning discipline of metalloproteomics is
providing insights into the wide range of functions of metallo-
proteins, and into the common structural signatures encoun-
tered in protein metal-binding sites.1–3 These studies are
also sounding notes of caution concerning the possibilities for
mis-identification of the native metal within a particular metallo-
protein because of (i) lack of selectivity of metal-binding sites, (ii)
variations in metal concentrations in different environments and
(iii) artefactual problems encountered during protein purification.
Replacement of a native metal by an alternative metal can have
a substantial impact on the properties of the metalloprotein,
and in the cases of metalloenzymes may even strikingly enhance
the activity above that of the native enzyme. The replacement of
Zn2+ by Co2+, Ni2+ or Cu2+ in aminopeptidase is an example
in which the non-native metals enhance activity by up to
10-fold.4 Developments in atomic spectroscopy have enabled
trace amounts of metals to be detected in scarce biological and
purified protein samples,5,6 and therefore have encouraged studies
to identify the biologically relevant native metal. Inductively
coupled plasma-optical emission spectroscopy (ICP-OES) and
inductively coupled plasma-mass spectrometry (ICP-MS) have
been used in this study to measure the metal concentrations in
subcellular samples derived from protist parasites and in purified
protein samples, respectively.
The glycolytic pathway of trypanosomatid parasites has been
identified as a possible drug target because the production of ATP
in the pathogenic bloodstream stage of trypanosomes is entirely
dependent on glycolysis.7 In particular, the glycolytic enzyme
cofactor-independent phosphoglycerate mutase (iPGAM) is an
attractive target because it is completely different from the
cofactor-dependent enzyme that catalyses the corresponding
reaction in humans,8 and because it has also been genetically
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validated as a drug target.9 Phosphoglycerate mutase (PGAM)
catalyses the interconversion between 3-phosphoglycerate and
2-phosphoglycerate in the glycolytic and gluconeogenic
pathways. Cofactor-independent PGAM (iPGAM) is active in
the absence of the cofactor 2,3-bisphosphoglycerate, and is found
in protists includingTrypanosoma brucei andLeishmania mexicana,
as well as in plants and in some nematodes, fungi, algae, bacteria
and archaea. All experimentally characterised iPGAMs are
monomeric with a mass of about 60 000 Da, and have been
classified as members of themetal-dependent alkaline phosphatase
superfamily.10 By contrast, cofactor-dependent PGAM (dPGAM)
found in humans and other vertebrates, and in some yeasts and
bacteria requires the bisphosphoglycerate cofactor for activity (but
no metals) and is usually dimeric or tetrameric with subunits of
about 27000 Da.11 The two types of PGAM are unrelated and
share no sequence similarity.
There is an absolute requirement for divalent metals by
iPGAM, and the enzyme is inactive after treatment with metal
chelators.12–14 The crystal structures of iPGAMs from Bacillus
stearothermophilus (Bs iPGAM)15 and from L. mexicana (Lm
iPGAM)16 share 33% sequence identity, and in their closed
conformations possess essentially identical topologies with all
16 active-site residues being the same (Fig. 1). The additional
availability of the crystal structure of iPGAM from Bacillus
anthracis (Ba iPGAM, 78% sequence identity to Bs iPGAM)
in a strikingly different open conformation has enabled
detailed structural and molecular dynamic comparisons
between the two Bacillus iPGAMs.17 The two metal binding
sites illustrated in Fig. 1 have different coordination geometries
in these open and closed iPGAM structures, indicating the
essential roles played by the metals not only for catalysis, but
also for enzyme conformation. Interestingly, the specific metal
required by iPGAMs varies from one organism to another,
despite overall conservation of the structure. Bs and Ba
iPGAMs require Mn2+,18 but T. brucei iPGAM (Tb iPGAM)
and Lm iPGAM prefer Co2+,19,20 although other divalent
metals may support low activity of trypanosomatid iPGAMs.
In addition, Mg2+ is favoured by nematode iPGAMs,21 and
Zn2+ is required by alkaline phosphatase, a more-distant member
of the metal-dependent phosphatase family.22 Plant iPGAMs are
also known to depend on divalent metals, but the identities of the
physiologically relevant metals remain controversial.
Co2+ is rare in nature, and it has been suggested that it, like
Ni2+, may in fact, represent a relic of early life before the
advent of dioxygen.23 In the reducing and sulphide-rich
conditions of early life, the availability of Zn2+ was low because
of its precipitation as a sulphide, but Co2+ and Ni2+ could
have acted as valuable metal biocatalysts. The change to a
dioxygen environment encouraged a switch to metal catalysts
such asMn2+ and Zn2+. In these circumstances, it is possible to
envisage that an enzyme active site that had originally evolved
to use Co2+ may also be able to bind Zn2+, but would function
with lower catalytic efficiency. It is relevant to note in this
context that epr, nmr and X-ray crystallographic studies of
metal binding sites such as those in carbonic anhydrase have
shown that it is particularly easy to substitute Zn2+ by other
metals such as Co2+.24–27 In these circumstances it is likely that
the ‘native’ metal used by a particular enzyme may be more a
function of the concentration of acceptable divalent metals in its
surroundings than of the selectivity of the enzyme metal
binding site.
A main goal of our research is to identify new drugs for the
treatment of neglected diseases such as human African trypa-
nosomiasis, Chagas disease and a range of leishmaniases
which are all caused by protists belonging to the family
Trypanosomatidae. Together, these parasites cause severe
public health and economic burdens on populations that
are often already caught in a tragic cycle of poverty, poor
nutrition and disease. As indicated previously, iPGAM is an
attractive drug target, but for high-throughput and virtual
screening, as well as for subsequent medicinal chemistry
strategies it is essential to be able to understand and manipulate
the conformation of the enzyme. This is particularly true for
iPGAM with its small active site, so that conditions may be
identified that favour the open conformation. Metals are likely
to be essential players in this work.
We now report the metal analyses of cytosolic
fractions from T. brucei, and of purified bacterially expressed
Fig. 1 Structure of iPGAM as illustrated by the enzyme from
L. mexicana.16 (a) A monomer of iPGAM is folded into two distinct
domains designated phosphatase and transferase. The two divalent
metal ions at the active site are shown by gold spheres. A Na+ ion
(grey sphere) is distant from the active site, and probably plays a
structural role. (b) The active site of iPGAM crystallised in the presence
of 4 mM Co2+. The 16 amino acid residues shown (Asp23 and Lys357
are mostly hidden by the sphere of M2) are highly conserved in all
iPGAMs. Those labelled in green are from the phosphatase domain,
and those in purple from the transferase domain. Ser75 becomes
phosphorylated during the catalytic mechanism. Metal site 1 (M1)
shows high occupancy even at low concentrations of Co2+ (10 mM),
but metal site 2 (M2) is only partially occupied under these conditions.
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Lm iPGAM samples by ICP-OES and by ICP-MS, respectively.
The results indicate that Zn2+ and Mg2+ instead of Co2+ are
the biologically relevant metals, and that the cellular activity of
iPGAM is only a small fraction of its potential activity.
Experimental
Preparation of T. brucei cytosolic fractions
T. brucei cytosolic fractions were prepared by differential
centrifugation as described previously, in isotonic buffer
(250 mM sucrose (UCB S.A., Brussels, Belgium), 25 mM
Tris-HCl (Fisher Scientific), pH 7.4, 1 mM EDTA (Fluka
Biochemika)).28 EDTA was included primarily as a proteolytic
inhibitor, but is also a useful form of metal sequestration. It
was not removed from the fractions, and would thus still be
present with its bound metals during the ICP-OESmeasurements.
Soluble proteins in the cytosolic fractions were obtained in the
supernatant after centrifugation at 50 000g. Seven samples
(3 mL each) were obtained that had been prepared on different
occasions: three cytosolic samples from in vitro cultured
procyclic insect-stage parasites (S1, S2, S3), and four cytosolic
samples from pathogenic bloodstream-form parasites (S4, S5,
S6 and S7). Samples S5 and S6 gave metal analysis results with
relatively high standard deviations, and have been omitted.
Protein determination
Concentrations of proteins in cytosolic samples were measured
by Bradford assay,29 with Coomassie Plus Protein Assay
Reagent supplied by Thermo Scientific, and with purified
Lm iPGAM as a standard. Concentrations of purified Lm
iPGAM were determined by UV absorbance at A280 nm
using a Jasco V-550 UV-VIS spectrophotometer using the
standard Beer–Lambert law, with known extinction coefficient
(42 080 M1 cm1) and molecular mass (60 723 Da).
Enzyme assays
iPGAM activity was measured by monitoring the conversion
of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate
(2-PGA) coupled with the oxidation of NADH to NAD+ by
lactate dehydrogenase (LDH) via enolase and pyruvate kinase.
Assays of each cytosolic fraction were done using aMultimode
Plate Reader-Molecular Devices M5 instrument, by the
addition of a 10 mL sample of the cytosolic fraction to give a final
reaction mixture of 100 mL containing 100 mM triethanolamine
(TEA)-HCl buffer pH 7.6 (Sigma Life Sciences), 1.5 mM 3-PGA
(Sigma-Aldrich), 5 mM MgCl2 (Fisher Scientific), 50 mM KCl
(Fisher Scientific), 0.8 mM NADH (Roche), 1 mM ADP
(Sigma-Aldrich), 2 units of enolase (Sigma-Aldrich), 4 units
of pyruvate kinase (Sigma-Aldrich) and 6 units of LDH
(Fluka Analytical). The decreased absorbance of NADH at
A340 nm was used to obtain the rate of reaction for specific
activity measurements (one unit corresponds to the conversion
of 1 mmol of substrate min1 mg1 protein under standard
conditions). Assays done during the purification of Lm
iPGAM used 10 mL samples containingB0.2 mg mL1 iPGAM
which were added into a cuvette to give a final reaction mixture
of 1000 mL containing 100 mM triethanolamine (TEA)-HCl
buffer, pH 7.6, 1.5 mM 3-PGA, 5 mM MgCl2, 50 mM KCl,
0.2 mM NADH, 1 mM ADP, 2 units of enolase, 4 units of
pyruvate kinase and 6 units of LDH. The decrease in A340 nm
was monitored using a Jasco V-550 UV-VIS spectrophotometer.
iPGAM expression and purification
Lm iPGAM with a C-terminal His6 tag was expressed
in Escherichia coli BL21(DE3) cells, and cell pellets were
collected by centrifugation, with storage at -80 1C as described
previously.30 Cell lysis was done with a Constant Systems TS
Cell Disruptor set to a maximum pressure of 22 000 psi in
buffer A (50 mM NaH2PO4 (AnalaR BDH), 300 mM NaCl
(Fisher Scientific) pH 8) with the addition of EDTA-free
Protease Inhibitor Mixture (Roche) tablets (1 tablet per
25 mL of extract). The extract was centrifuged for 45 min at
4 1C at 43 400g, and the supernatant injected onto an
immobilised metal affinity chromatography column (FastFlow
IMAC, GE Healthcare) pre-charged with 0.1 M Ni2+
(nickel(II) sulphate hexahydrate, Sigma-Aldrich), and washed
with water, then buffer A in an ÄKTAHPLC systemmaintained
at 10 1C. Following sample injection, the column was washed
with buffer A, followed by 20 column volumes of buffer
A containing 25 mM imidazole (Fisher Scientific). The Lm
iPGAM was then eluted with a step of buffer A containing
500 mM imidazole, and desalted and buffer exchanged on a
HiPrep 26/10 column (GE Healthcare) eluted with buffer B
(20 mM HEPES (Sigma Life Sciences) pH 7.6). The protein
was then buffer exchanged into 20 mM TEA-HCl, pH 7.6 and
50 mM NaCl using a PD10 column (GE Healthcare), and
concentrated using a Vivaspin concentrator (10000 MW cut
off) (GE Healthcare) toB2 mg mL1. The protein was stored in
the cold room (4 1C) for further biochemical and biophysical
assays or at 20 1C with the presence of 10% glycerol.
ICP-OES
ICP-OES was used to analyse cytosolic fractions with a Perkin
Elmer Optima 5300 DV instrument, using a radio frequency
(RF) forward power of 1400 W, with argon gas flows of 15, 0.2
and 0.75 L min1 for plasma, auxiliary, and nebuliser flows,
respectively. Using a peristaltic pump, the samples were taken
up into a Gem Tip cross-Flow nebuliser and Scotts spray
chamber at a rate of 1.50 mL min1. The instrument was
operated in axial mode, and the selected wavelengths for each
element were analysed in fully quantitative mode (three points per
unit wavelength). Three replicate runs per sample were carried
out. Initially two wavelengths were selected for each element, but
after the analysis was completed the following wavelengths were
chosen for reporting results: Co 228.616 nm, Cu 327.393 nm,
Fe 238.204 nm, Mg 285.213 nm, Mn 257.610 nm, Ni 231.604 nm
and Zn 206.200 nm.
To assess the limit of detection (LOD) for each metal and
the matrix effects of the buffers, a range of calibration
standards was prepared both in deionised water (18O, Elga
USF) and in EDTA-free cytosol buffer (250 mM sucrose
(Fisher Scientific), 25 mM Tris-HCl (Sigma Life Sciences),
pH 7.4). Standards of 0, 0.1, 10 and 100 mg L1 were prepared
by sequential dilution from single element 1000 mg L1 stock
solutions (Fisher Scientific). With all of the calibration lines
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0.9992 or better. Ten blank samples of each buffer were
analysed after the instrument was calibrated to calculate the
limits of detection for the analysis. LOD = 2.26*SDb/Slope
(where SDb is the standard deviation of the 10 blanks and
2.26 is the student t-test at the 95% confidence limit). The
limits of detection are indicated in Fig. 3.
For analysis of the samples, a range of calibration standards
from 0–500 mg L1 was prepared in cytosol buffer. The majority
of the samples fell in the range 200–500 mg L1, and results were
calculated against a calibration from 10–500 mg L1. However
where values were lower than 20 mg L1, the samples were
reintegrated against a calibration only extending to 10 mg L1.
Where values fell below the limit of detection they were quoted as
a o value.
It is relevant to mention that attempts were initially made to
analyse the cytosolic fractions by ICP-MS, but were found to
be unsuitable because of technical problems.
ICP-MS
Purified protein samples were analysed using an Agilent
7500ce (with octopole reaction system) instrument, employing
an RF forward power of 1540 W and reflected power of 1 W,
with argon gas flows of 0.82 L min1 and 0.2 L min1 for
carrier and makeup flows, respectively. For the collision cell
the helium flow was 0.6 L min1. Sample solutions were taken
up into the Micro mist using a peristaltic pump at a rate of
approximately 1.2 mL min1. Skimmer and sample cones were
made of nickel. The instrument was operated in spectrum
multi-tune acquisition mode and five replicate runs per sample
were employed. Each mass was analysed in fully quantitiative
mode (three points per unit mass). The following masses
were selected for analysis: 55Mn, 59Co and 63Cu which were
analysed in ‘standard gas mode’, and 26Mg, 56Fe, 60Ni and
66Zn which were analysed in ‘helium gas mode’ using the
collision cell to remove any polyatomic interferences.
Calibration standards with a range of metal concentrations
(0, 1, 10 and 100 mg L1) were prepared by sequential dilution
from single element 1000 mg L1 stock solutions (Fisher
Scientific) in 20 mM TEA buffer pH 7.6 and 50 mM NaCl,
as well as in water to assess matrix effects. Samples were
analysed using the standards prepared in 20 mM TEA buffer
pH 7.6. Ten blank samples of the 20 mM TEA buffer pH 7.6
buffer were analysed to calculate the LOD for each metal, and
are indicated in Fig. 5. Where values fell below the limit of
detection they were quoted as a o value.
Bioinformatics
Protein structure diagrams were generated using the program
PyMOL.31 The calculated extinction coefficient and molecular
mass of Lm iPGAMwere obtained from the Expasy ProtParam
website (http://web.expasy.org/protparam/).
Results and discussion
Preparation and characterisation of Tb iPGAM cytosolic fractions
Trypanosomatids possess a unique subcellular organelle, the
glycosome, with multiple copies in each cell which sequester
the first seven of the ten glycolytic enzymes. iPGAM however,
is located in the cytosol8,20,32 along with enolase and pyruvate
kinase. Cytosolic samples were prepared at the Université
catholique de Louvain, Brussels, Belgium from both procyclic
and bloodstream stages of T. brucei. The former stage occurs
in the tsetse fly vector, whereas the latter stage corresponds to
the pathogenic form found in mammalian blood. The cytosolic
fractions were analysed by SDS-PAGE (Fig. 2), and gave sharp
bands indicative of the absence of proteolytic degradation.
The patterns of bands are broadly similar across all the
fractions, with the exception of a prominent band with a mass
of B50 kDa in sample S4. The identity of this protein is
not known.
The protein concentrations of the fractions showed variation
(i.e. from 2.8 to 8.1 mg mL1), so the results for specific activity
and for metal contents were all normalised to 1 mg of protein.
The protein concentrations, iPGAM specific activities and
estimated iPGAM concentrations of the fractions are given in
Table 1. The specific activities were measured for the cytosolic
fractions with no additional Co2+. It can be seen that the
specific activities of iPGAM in the procyclic cytosolic fractions
were higher than in the bloodstream-form cytosolic fractions.
As anticipated, the addition of Co2+ gave a substantial
enhancement of activity (about 10-fold, data not shown).







, and absence of Co
2+
The concentrations of seven different metals (Co2+, Cu2+,
Fe2+, Mg2+, Mn2+, Ni2+ and Zn2+) were measured by ICP-
OES analysis of cytosolic fractions from procyclic- and blood-
stream-form T. brucei. This type of analysis gives the total
metal concentrations, and does not distinguish between metals
bound to macromolecules or to EDTA, and those unbound.
Elemental standards were prepared as described in the Experi-
mental section, and gave linear concentration-response plots
in both water and in cytosol buffer. Any background readings
or noise signals collected from the control data were deducted
from the readings of the samples. Mg2+, Zn2+ and Fe2+ were
found to be the most abundant metals (B200, 30 and 15 mM,
respectively; Fig. 3), with Cu2+, Mn2+ and Ni2+ below 1 mM,
Fig. 2 Electrophoretic analysis of cytosolic fractions. A 12%
SDS-PAGE gel was used with 5 mL samples of each cytosolic fraction.
The masses (in kDa) of standard marker proteins are indicated in lane
M. Abbreviations: M, marker proteins; S1–S3, cytosolic fractions
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and Co2+ below the limit of detection (o0.035 mM). It can
be seen that the samples from the two different life stages of T.
brucei gave similar results.
The specific activity of bacterially expressed Tb iPGAM
purified in the absence of Co2+ is B25 mmol min1 mg1
protein,8,19 very similar to the value of 21 mmol min1 mg1
protein determined for pure bacterially expressed Lm iPGAM
in this study (see next section). The cytosolic concentrations of
Tb iPGAM may be estimated from the specific activity of the
pure enzyme compared to the specific activities within
the cytosolic fractions, and give a value of approximately
10-50 mM (Table 1). It is clear from the ICP-OES results
that the Co2+ concentrations in the cytosolic fractions are
o0.035 mM, and are therefore insufficient to satisfy even a
small proportion of the iPGAM present.
Purification and characterisation of Lm iPGAM
The bacterial expression system for Lm iPGAM was the same
as described previously.20 In the present study however,
purified Lm iPGAM was obtained in the absence of added
Co2+ from a two-step purification procedure: IMAC chromato-
graphy and desalting with buffer exchange (Fig. 4). The
Ni2+-containing IMAC column in this procedure replaced the
previously used Co2+-containing Talon (Clontech) column,30
and the 10 mM CoCl2 used throughout previous purification
procedures was omitted. The yield of protein obtained from 1 L
of cell culture was found to be B20 mg. SDS-PAGE analysis
showed that the purified Lm iPGAM gave a single prominent
band with mass B60 700 Da, corresponding to the expected
mass (Fig. 4). The specific activity was calculated to be
21 mmol min1 mg1 protein for the conversion of 3-PGA to
2-PGA, similar to the value of 26 mmol min1 mg1 protein
obtained for pure bacterially expressed Tb iPGAM that had
also been purified on a Ni2+ IMAC column without the
addition of any divalent metals.19 Lm iPGAM purified in the
Edinburgh laboratory from a GE Healthcare IMAC column pre-
charged with 0.1 M Co2+ or from a Talon column had specific
activities of 370 2 mmol min1 mg1 orB400 mmol min1 mg1
protein,33 respectively. These values correspond closely with Lm
iPGAM purified from a Talon column in the Brussels laboratory
with a specific activity of 419  4 mmol min1 mg1.20 The
activity assays for all these enzymes were carried out in the
presence of Co2+, and clearly all gave an approximately 20-fold
enhancement of activity over Lm iPGAMpurified and assayed in
the absence of Co2+.
ICP-MS analysis of purified Lm iPGAM fails to detect Co2+
The metal content of the essentially homogenous purified
bacterially expressed Lm iPGAM was analysed by the more
sensitive ICP-MS technique. As for ICP-OES, the concentra-
tions of seven different metals (Co2+, Cu2+, Fe2+, Mg2+,
Mn2+, Ni2+ and Zn2+) were measured. Elemental standards
were prepared as described in the Experimental section, and
gave linear concentration-response curves in both water and in
enzyme storage buffer (20 mM TEA-HCl, pH 7.6 and 50 mM
NaCl). In the case of the purified enzyme, Mg2+ was the most
abundant metal (as it was in the cytosolic fractions), but the
amount of Zn2+ was substantially enhanced, and approached the
concentration of Mg2+ (Fig. 5). The concentration of Co2+ was
0.01 mM, above the limit of detection (o0.0002 mM), but very low
compared to the concentration of iPGAM (0.99 mM). Taken
together, these results show clearly that despite Co2+ being the
Table 1 iPGAM molar concentration in T. brucei cytosolic fractions
S1a S2 S3 S4 S7
Protein concentration (mg mL1) 4.0 3.9 2.8 8.1 5.4
Specific activity (nmol min1 mg1 protein) 16.0 19.7 6.29 1.12 5.80
iPGAM concentration in cytosolic fractions (mmoles L1)b 50.1 60.3 13.8 7.12 24.5
a Samples: S1, S2 and S3 are procyclic fractions; S4 and S7 are from bloodstream parasites. b The calculation was made using the assumption that
pure iPGAM has a specific activity of 21 mmole min1 mg1 protein (under the same assay conditions as those used to measure the activity of
iPGAM in the cytosol).
Fig. 3 ICP-OES of cytosolic fractions from procyclic and blood-
stream-form T. brucei. The concentrations of metals in the cytosolic
fractions are shown. The blue bars correspond to the procyclic cytosolic
fractions S1, S2 and S3, whereas the pink bars indicate bloodstream
cytosolic fractions S4 and S7. (a) Results for the relatively abundant
metals, Fe2+, Mg2+ and Zn2+, with the y axis scale 0–200 mM.
(b) Results for the less abundant metals, Co2+, Cu2+, Mn2+ and
Ni2+, with the y axis scale 0–1.0 mM. The values for Co (0.0130–
0.0296 mM) are below the limit of detection (o0.0352 mM). The
following limit of detection values (all mM) were obtained (see Experi-
mental section): Fe, 0.0819; Mg, 0.495; Zn, 0.122; Co, 0.0352; Cu, 0.116;
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metal that enables Tb iPGAM and Lm iPGAM to be maximally
active, it is not present in the enzyme in cytosolic fractions or in
enzyme purified in the absence of added Co2+. The molar ratios
of Mg2+ and Zn2+ to Lm iPGAM in the purified enzyme were
B8 and B6 mmoles of metal to 1 mmole of Lm iPGAM,
respectively, indicating that either or both of these metals
may be the preferred metal(s) in vivo. By contrast, Mn2+ that
is known to be the preferred metal for bacterial iPGAMs15,18
was present in the purified Lm iPGAM at a molar ratio of less
than 0.3. It is noteworthy that the concentration of Ni2+ was
low, despite the purification being done on an IMAC column
charged with Ni2+.
Mg2+ and Zn2+ are likely to be the biologically relevant metals
of trypanosomatid iPGAMs
It is generally accepted that enzymes are evolving by natural
selection to attain a state of optimal catalytic activity, often
with adaptation to a particular biological environment. As an
example, the activity of the glycolytic enzyme triose phosphate
isomerase is limited only by diffusion of substrate onto, and
product off, the enzyme, and is therefore thought to have
evolved to almost catalytic perfection.34 There is thus an
understandable tendency to correlate the highest specific
activity of an enzyme in vitro with its ‘native’ state in vivo.
This is clearly not the case for trypanosomatid iPGAMs where
the optimal activity (by a factor of ten or more) is obtained
with Co2+, but the concentration of this metal is essentially
undetectable in the parasite cytosol. In this respect, iPGAM
is not alone, and carboxypeptidase A,35 aminopeptidase,4 alcohol
dehydrogenase,36 50-nucleotidase37 and catechol dioxygenase38
are just some among many examples of Zn2+-containing
enzymes in vivo that are hyperactive when Co2+ replaces the
Zn2+ in vitro.
The results of ICP-OES indicate that only Mg2+ and Zn2+
are sufficiently abundant in the parasite cytosol to support the
activity of a significant proportion of the iPGAM present
(Fig. 3 and Table 1), whereas Cu2+, Mn2+ and Ni2+ were all
well below the concentration of iPGAM. A similar trend is
observed with the ICP-MS analysis of purified Lm iPGAM in
which only Mg2+ and Zn2+ are sufficiently abundant to
support the activity of the enzyme (Fig. 5). It thus seems that
the biologically relevant metal for this enzyme is likely to be
either Mg2+ or Zn2+, or both. As mentioned previously,
iPGAM belongs to the metal-dependent alkaline phosphatase
superfamily10 most of whose members require two divalent
metals at the active site. Four enzymes are particularly
well characterised structurally: E. coli alkaline phosphatase,22
Bs iPGAM (closed conformation),15 Ba iPGAM (open
conformation)17 and Lm iPGAM.16 Alkaline phosphatase uses
Fig. 4 Purification of Lm iPGAM. The two-step procedure involved
(a) IMAC via the enzyme’s C-terminal His tag on a Ni2+-charged
column, followed by (b) desalting and buffer exchange with a HiPrep
26/10 column. SDS-PAGE gels of peak fractions from both steps are
shown. The standard protein markers are as in Fig. 2. The purified
enzyme was homogenous with the expected mass of 60 700 Da, as
shown by the SDS-PAGE gel in panel b. Blue traces correspond to
absorbance at 280 nm, and the green trace in panel a indicates the
concentration of imidazole.
Fig. 5 ICP-MS analysis of purified Lm iPGAM. The relative molar
concentrations of metals and purified Lm iPGAM are shown.
(a) Abundant metals, Fe, Mg and Zn, with the y axis scale 0–8.
(b) Low abundance metals, with the y axis scale 0–0.25. The following
limit of detection values (all mM) were obtained (see Experimental
section): Fe, 0.0313; Mg, 0.195; Zn, 0.00652; Co, 0.000238;
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two Zn2+ ions, Bs iPGAM two Mn2+ ions, but Lm iPGAM
by contrast, appears to function with a one-metal mechanism.
Of the two metal sites of Lm iPGAM (Fig. 1), only site M1
shows high occupancy, with site M2 having only low occupancy
(6%) even at 4 mMCo2+. Moreover, when site M2 is occupied,
the side chain of Ser75 that is phosphorylated during catalysis
adopts a position unfavourable for phospho transfer.16 Site M1
has octahedral geometry, indicating that it has a preference for
Mg2+ and Co2+ (MESPEUS database, http://mespeus.bch.ed.
ac.uk/MESPEUS/_1.jsp). The poorly occupied site M2 has
tetrahedral geometry with a likely preference for Zn2+. It is
not possible at this stage to decide definitively which metal is the
biologically relevant one, and indeed it may be that both metals
can support trypanosomatid iPGAM activity.
On a note of caution, it can be mentioned that the discovery
that Tb iPGAM and Lm iPGAM are optimally active with
Co2+ was an accident, and a direct consequence of two
experimental developments: (i) the use of His tags as a very
convenient purification method for bacterially expressed proteins,
and (ii) the availability of the Co-containing Talon IMAC resin
with enhanced affinity for His tags. Both innovations were
adopted by the Brussels and Edinburgh research groups, and
have been very efficient for the purification of large quantities of
several trypanosomatid glycolytic enzymes, including iPGAMs.
Furthermore, routine enzyme stability studies were carried out on
Tb iPGAM and Lm iPGAM as a strategy to improve the
outcome of crystallisation trials.33 These studies showed that
Co2+ was an excellent stabilisation agent for the trypanosomatid
iPGAMs, and 10 mMCoCl2 was thereafter frequently included in
buffers.
An important corollary of the findings in this paper is that
the specific activity of trypanosomatid iPGAM in vivo is
relatively low compared with the specific activities of other
glycolytic enzymes.9 This is thus another reason why it is an
attractive drug target because it exerts a higher flux control
than most of the other glycolytic enzymes under typical
metabolic conditions. The only exception is glyceraldehyde
3-phosphate dehydrogenase, which has a similar flux control
coefficient9 when measured under the same metabolic conditions.
Moreover, as previously mentioned, there is essentially no
problem about species specificity of inhibitors because human
and parasite PGAMs share no similarity in structure or
mechanism.
Conclusion
ICP-OES was used to determine the divalent metal contents of
cytosolic fractions from procyclic and bloodstream-form
T. brucei, and now provides for the first time essential infor-
mation relevant to understanding the in vivo properties of
trypanosomatid metal-dependent enzymes. Of particular
interest is the metal dependency of iPGAM, which has pre-
viously been shown to be maximally active in the presence of
Co2+. The ICP-OES results show clearly that the biologically
relevant metal for this enzyme cannot be Co2+ which was
undetectable in the cytosolic fractions. It is likely that iPGAM is in
fact a relatively inefficient Mg2+ and/or Zn2+-dependent enzyme.
The significance of these observations is being further explored
with the development of a new discontinuous plate-reader activity
assay coupled to enolase, pyruvate kinase and lactate
dehydrogenase to be carried out with minimal metal inter-
ference of the latter enzymes. An understanding of the in vivo
metal requirements of iPGAM will be important for the design
and implementation of a drug discovery programme currently
in progress.
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Appendix I  
Appendix I (a) 
 
Bradford standard curve 



























The Bradford curve was constructed by using BSA in the range of 1.5, 1, 0.75, 0.5, 
0.38, 0.25 and 0.19 mg/ml. BSA dilutions were carried out with a sucrose buffer (250 
mM sucrose, 25 mM Tris-HCl pH 7.4). 20 µl of each concentration of BSA were 
mixed with 980 µl of the assay reagent (Coomassie PlusTM Protein Assay Reagent) 







Appendix I (b) 
 
The un-tagged LmiPGAM expression trial 
 
The un-tagged LmiPGAM expression trials at 37°C. Wells 1,3,5,7,9,11,13 and 15 are 
the induced samples, whereas wells 2,4,6,8,10,12 and 14 are the un-induced samples 
(negative controls).  The expression conditions for each sample are listed below: 



















BL21 (DE3) pLysS 
Rosetta (DE3) pLysS  
Rosetta (DE3) pLysS  
BL21 (DE3) 
BL21 (DE3) pLysS 
Rosetta (DE3) pLysS 










Expression trials were also conducted at 20°C and 30°C. The results were observed 





Appendix I (c) 
 






A standard curve of Kav versus log molecular weight (MW) for standard proteins (F  
= ferritin, C = conalbumin, CA = carbonic anhydrase and R = ribonuclease A) which 
were eluted from Superdex 200 10/300 column. The buffer contains 20 mM TEA pH 







Appendix I (d) 
 
ICP-OES standard curves 
 
Co 228.616


















































































































































The calibration curves of concentration (in ppm or mg/L) versus intensity for ICP-
OES analysis. The concentrations of divalent metals are in the range of 0.001, 0.01, 
0.1, 1 and 10 ppm. The experiment was performed by using sucrose buffer (250 mM 












Appendix I (e) 
 
ICP-MS standard curves 
 
Co (mass 59)

























        


























      
Fe (mass 56)
























     






















































     
Ni (mass 60)


























          
Zn (mass 66)



























The calibration curves of concentration (in ppb) versus counts per second (cps) in 
ICP-MS analysis. The concentrations of divalent metals are in the range of 0, 1, 10 
and 100 ppb (µg/L). The experiment was performed by using 20 mM TEA pH 7.6 












Appendix I (f) 
 
Discontinuous assay standard curves 
Absence of added metals
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The discontinuous assay calibration standards were generated in the presence of three 
different concentrations of metals, and plotted as 2PGA concentrations versus 
NADH absorbance at A340 nm. The 2PGA concentrations which were used to start 
the reaction are in the range of 0.63 mM, 0.31 mM, 0.16 mM, 0.08 mM and 0 mM.  
The curve fit and R2 value were only shown for the 0.05 mM concentration, as this is 
the calibration standard used for 2PGA concentration measurement. 
 
 
 
 
 
